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Abstract 
 
A conventional 2D (two-dimensional) culture, in T-flasks or multi-well plates, is commonly 
performed for the stem cell development; however, it is time and labour consuming process. 
Moreover, it is impractical to scale-up to high cell number production. Growing stem cells inside 
bioreactor might be a solution. 3D bioreactor is not only a solution for scalable production but 
also a mimic environment for in vivo system. Herein, sparged-type bioreactors (e.g. airlift 
bioreactor) were chosen as bioreactors to differentiate murine embryonic stem cells (mESCs) 
into type II pneumocytes in the lung. There are two main sections in this thesis: the design of 
airlift bioreactor using computational fluid dynamics (CFD) and the differentiation of mESCs 
into the alveolar progenitor cells in a sparged bioreactor. The airlift bioreactors provide a better 
environment, which theoretically has been known to simulate the gas-exchange interface 
encountered in the lung alveoli. They require a low power input and provide a low shear 
environment with good mixing. The hydrodynamics (gas holdup, superficial liquid velocity, and 
shear rate) and mass transfer (kLa, the volumetric mass transfer coefficient) features of different 
airlift designs were determined by CFD. The simulations were based on a 3D transient model, 
Eulerian-Eulerian approach, and two-phase liquid/gas model with all phases being treated as 
laminar flow. The superficial gas velocity was varied from 0.001 m/s to 0.02 m/s. The 
simulation results indicated that the hydrodynamics were corresponded to the data found in 
literatures and the gas holdup were agreed with an experiment validation. The CFD results also 
suggested that in which range of superficial gas velocity (ug) that the system can be operated 
without any fluctuation in terms of the hydrodynamics. In addition, the airlift bioreactor is 
suitable for shear sensitive cells with high mass transfer rate, e.g. kLa, = 180 hr-1 at ug= 0.01 m/s 
and normoxia (20% O2) condition. Hence, the results from these simulations have been initially 
utilised as a promising hypothesis to design an airlift bioreactor for the scalable and 
automatable culture in multiphase bioreactors. For the second part, mESCs were encapsulated 
in a calcium-alginate hydrogel to create a 3D environment then the encapsulated cells were 
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grown in both 3D static culture, in a T-flasks, and the sparged bioreactor. The gas, 5% CO2 and 
20% O2, was directly sparged into the bioreactor. The A549 conditioned medium was used to 
induced the mESCs to the endodermal lineages, targeting for the alveolar type II cells, type II 
pneumocytes. The differentiated cells expressed lung cell markers: SPC (pneumocyte type II), 
and FoxA2 (endoderm marker). In experiments, the relative expression of SPC markers reached 
the maximum level, 10-fold increase, at day 14 and day 20 for 3D static culture and the sparged 
bioreactor, respectively. After day 20 of the differentiation process, the pneumocyte-like cells in 
static culture trend to lose their SPC expression whereas the cells in sparged bioreactor 
maintain relatively high SPC markers. At the end of a differentiation protocol, day 30, it was 
observed that both systems highly expressed the endodermal makers, FoxA2, i.e. approximately 
2000-fold increase for static culture and 5000-fold increase for the sparged bioreactor. In 
conclusion, the direct gassing in the sparged bioreactor not only enhanced the differentiation of 
embryonic stem cells into type II pneumocytes but also mimicked the in vivo environment in the 
lung therefore the differentiated cells can maintain the lung phenotype for a long term culture, 
up to 5 weeks in vitro culture. This in vitro system would be beneficial for drug screening and 
regenerative medicine applications.  
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Nomenclatures 
 
Symbol Meaning Units 
   
g Acceleration due to gravity m/s2 
A Area m2 
d  Column diameter m 
H  Column height m 
c Concentration mol/m3 
  Density kg/m3 
Td  Draft tube diameter m 
∆ Gradient  
UH Heat transfer coefficient W/(m2·K) 
H Henry’s constant L·atm/mol 
𝑴  Interphase momentum transfer  
J Mass flux mol/m2.s 
k Mass transfer coefficient mol/(s·m2)/(mol/m3) or 
m/s 
D Molecular diffusion coefficient  m2/s 
K Overall mass transfer coefficient  
P Power W 
p  Pressure Pa 
Re  Reynolds number  - 
?̇? Shear rate s-1 
U Superficial velocity m/s 
u  Velocity vector m/s 
µ Viscosity Pa ∙ s 
V  Volume m3 
  Volume fraction, phase holdup - 
kLaL Volumetric mass transfer coefficient s-1 
t Time s 
   
Subscripts   
B Bottom section  
c Column, circulation  
d, D downcomer  
t-b Draft tube bottom  
t Draft tube section  
t-t Draft tube top  
G, g Gas  
s Gas separator section  
i Inlet section, interphase  
L Liquid  
𝛼, 𝛽 phase  
r, R Riser  
   
Superscripts   
D Drag force  
* Equilibrium stage  
L Lift force  
VM Virtual mass force  
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Dimensionless numbers 
 
𝑅 diameter ratio, 𝑑𝑐 𝑑𝑡⁄  
𝑆 slenderness ratio, 𝑙𝑡 𝑑𝑐⁄  
𝑀 bubble separation group, 𝑑𝑠 4𝑑𝑐⁄  
𝑋𝑡 draft-tube bottom clearance ratio, ℎ𝐵 𝑑𝑡⁄  
𝑌𝑡 draft-tube top clearance ratio, ℎ𝑠 𝑑𝑡⁄  
𝜀𝑔 gas holdup, 𝑉𝑔 (𝑉𝑔 + 𝑉𝐿)⁄  
𝐷𝑅 disengagement ratio, (𝑑𝑐 𝑑𝑠⁄ ){(𝑅
2 − 1) 𝑅⁄ } 
𝐸𝑢′ modified Euler number,∆𝑃 𝑝𝑢𝑔
2⁄  
𝐹𝑟 Froude number, 𝑢𝑔 (𝑔𝑑𝑐)
0.5⁄  [also defined as  𝑢𝑔
2 𝑔𝑑𝑐⁄ ] 
𝐺𝑎 Galileo number, 𝑔𝜌𝐿
2𝑑𝑐
3 𝜇2⁄  
 𝐺𝑟 Grashoff number, 𝑔𝜌𝐿(𝜌𝐿 − 𝜌𝑔)𝑑𝑏
3 𝜇𝐿
2⁄  
 𝑆𝑐 Schmidt number, 𝜇𝐿 (𝜌𝐿𝐷𝐿)⁄  
 𝑆ℎ Sherwood number, 𝑘𝐿𝑎𝑑𝑐
2 𝐷𝐿⁄  
𝑊𝑒𝑜 Weber number for the orifice, 𝑣𝑜
2𝑑𝑜𝜌𝑜 𝜎⁄  
 
Abbreviationss  
  
2-D Two dimensional 
3-D Three dimensional 
AIDS Acquired immunodeficiency syndrome 
BMP Bone morphogenetic protein 
BMSC Bone marrow marrow mesenchymal stem cell 
CFD Computational fluid dynamics 
COPD Chronic obstructive pulmonary diseases 
DMEM Dulbecco's modified eagle medium 
E Embryonic day 
EB Embryoid body 
ECM Extracellular matrix 
EGF Epidermal growth factor 
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ESC Embryonic stem cell 
F12 Ham's F-12 Nutrient Mixture 
FGF2 fibroblast growth factor 2 
FoxA2 Forkhead box protein A2 
GAPDH Glyceraldehyde 3-phosphate dehydrogenase 
GM-CSF Granulocyte macrophage colony stimulating factor 
GVHD Graft-versus-host disease 
hESC Human embryonic stem cell 
HIV Human immunodeficiency virus 
IL-6,  Interleukin-6 
IL-8,  Interleukin-8 
IMDM Iscoves modified Dulbeccos medium 
iPSC Induced pluripotent stem cell 
LIF Leukemia inhibitory factor 
mESC Murine embryonic stem cell 
MSC Mesenchymal stem cell 
NEB Neuro epithelial body 
NFG Nerve growth factor 
Oct4 Octamer-binding transcription factor 4 
P Postnatal day 
PDGF Platelet-derived growth factor 
PNEC Pulmonary neuroendocrine cell 
RPE Pigment epithelium 
RPMI Roswell Park Memorial Institute medium 
RWV Rotating wall vessels 
SABM Small airway basal medium 
SAGM Small airway growth medium 
SCNT Somatic cell nuclear transfer 
SPC Surfactant Protein C 
TE Tissue engineering 
TGFβ Transforming growth factor beta 
VEGF Vascular endothelial growth factor 
WHO Wold health organisation 
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Mathematic operators 
 
Vector operators for Cartesian coordinate system in which i, j, and k are unit vectors in the three 
coordinate direction. 
∇= [
𝜕
𝜕𝑥
,   
𝜕
𝜕𝑦
,   
𝜕
𝜕𝑧
] 
For vectir fuvtion 
𝑼 (𝑥,   𝑦,   𝑧) 
𝑼 = [
𝑼𝑥
𝑼𝑦
𝑼𝑧
] 
The divergence of 𝑼 is defined by: 
∇ ∙ 𝑼 = [
𝜕𝑼𝑥
𝜕𝑥
,   
𝜕𝑼𝑦
𝜕𝑦
,   
𝜕𝑼𝑧
𝜕𝑧
] 
The dyadic operation (or tensor product) of two vectors, 𝑼 and 𝑽, is defined as: 
𝐔 ⊗ 𝐕 = [
𝑼𝑥𝑽𝑥 𝑼𝑥𝑽𝑦 𝑼𝑥𝑽𝑧
𝑼𝑦𝑽𝑥 𝑼𝑦𝑽𝑦 𝑼𝑦𝑽𝑧
𝑼𝑧𝑽𝑥 𝑼𝑧𝑽𝑦 𝑼𝑧𝑽𝑧
] 
By using specific tensor notation, the equations relating to each dimension can be combined into a 
single equation. Thus, in the specific tensor notation become:  
∇ ∙ (ρ𝑼 ⊗ 𝑼) =
[
 
 
 
 
 
 
𝜕
𝜕𝑥
(ρ𝑼𝑥𝑼𝑥)
𝜕
𝜕𝑦
(ρ𝑼𝑥𝑼𝑦)
𝜕
𝜕𝑧
(ρ𝑼𝑥𝑼𝑧)
𝜕
𝜕𝑥
(ρ𝑼𝑦𝑼𝑥)
𝜕
𝜕𝑦
(ρ𝑼𝑦𝑼𝑦)
𝜕
𝜕𝑦
(ρ𝑼𝑦𝑼𝑧)
𝜕
𝜕𝑥
(ρ𝑼𝑧𝑼𝑥)
𝜕
𝜕𝑦
(ρ𝑼𝑧𝑼𝑦)
𝜕
𝜕𝑦
(ρ𝑼𝑧𝑼𝑧)]
 
 
 
 
 
 
 
The curl of a vector field, curl(F) or∇ × 𝐅, is defined as the vector field having magnitude equal to the 
maximum "circulation" at each point and to be oriented perpendicularly to this plane of circulation for 
each point (http://mathworld.wolfram.com/Curl.html). 
∇ × 𝐅 = ||
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1. INTRODUCTION 
 
1.1 Motivation 
 
Respiratory diseases are leading causes of death worldwide. In the UK, lung diseases 
kill one in five people and the cost to National Health Services (NHS) is extremely 
high (Lane et al., 2007). Table 1.1 shows the top 10 leading causes of death in middle 
and high income countries, based on statistic from 194 countries in the WHO (World 
Health Organisation) database. In 2008, it was estimated that 58 million people died 
around the world. Respiratory diseases are among the biggest killers in the developed 
countries (Table 1.1: ranked 3rd, 5th, and 6th). Even in the developing countries (e.g. 
Thailand), over 20% of the top 10 mortalities was caused by respiratory diseases. 
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Hence, effective treatment of these diseases would possibly prolong patients’ life, but 
could also enhance the development of the countries as a whole. 
 
Table 1.1 Leading Causes of Death in 2008. Source: WHO; World Health 
Organisation. http://www.who.int/mediacentre/factsheets/fs310/en/index.html (last 
access: 05 September 2012) 
 
Middle-income countries Deaths 
in 
millions 
High-income countries Deaths 
in 
millions 
1. Ischaemic heart disease 5.27 1. Ischaemic heart disease 1.42 
2. Stroke and other 
cerebrovascular disease 
4.91 2. Stroke and other 
cerebrovascular disease 
0.79 
3. Chronic obstructive 
pulmonary disease 
2.79 3. Trachea, bronchus, lung 
cancers 
0.54 
4. Lower respiratory 
infections 
2.07 4. Alzheimer and other 
dementias 
0.37 
5. Diarrhoeal diseases 1.68 5. Lower respiratory 
infections 
0.35 
6. HIV/AIDS 1.03 6. Chronic obstructive 
pulmonary disease 
0.32 
7. Road traffic accidents 0.94 7. Colon and rectum 
cancers 
0.30 
8. Tuberculosis 0.93 8. Diabetes mellitus 0.24 
9. Diabetes mellitus 0.87 9. Hypertensive heart 
disease 
0.21 
10. Hypertensive heart 
disease 
0.83 10. Breast cancer 0.17 
 
To date, many types of lung diseases are only treatable with transplantation from 
organ donors which could give patients an extra 10 to 20 years of active life. The 
difficulty of finding a match donor and the availability of donated organs are many of 
the main reasons which drive researchers to find alternative ways to improve the 
treatment. For attempts that to find alternative approaches for lung disease treatments, 
several efforts have been developed by using artificial organs (Lick et al., 2001; Nolan 
et al., 2011), stem cells from patients; adult stem cells (Albera et al., 2005), the 
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embryonic stem cells (ESCs), or induced pluripotent stem cells; iPSCs (Soh et al., 
2012; Ghaedi et al., 2013; Huang et al., 2013). It is possible to use a mechanical 
ventilation device as an artificial lung, but it was found that one of the greatest 
complications arose from the long-term (more than 30 days) use of the device (Nolan 
et al., 2011). In addition, one of the main problems with the use of native adult stem 
cells in the lung therapy is low turnover which involves ‘cell-aging’, therefore, 
limiting the recovery process. On the other hand, the use of ESCs or iPSCs becomes 
more practical as it offers self-renewal and pluripotency ability as long as challenges 
such as controlled and efficient differentiation are addressed. 
Tissue engineering is a multidisciplinary field that combines engineering, physical 
sciences, biology, and medicine to repair or replace tissues and organ functions 
(Bronzino and Institute of Electrical and Electronics Engineers., 2000 (Bronzino and 
Institute of Electrical and Electronics Engineers., 2000). An example of tissue 
engineered products that could be used in treating respiratory diseases is the  
transplantable alveolar epithelial type II cells (type II pneumocytes) which could also 
be potentially useful in the treatment of other lung diseases including chronic 
obstructive pulmonary diseases, COPD (Lau et al., 2012). The contribution of 
engineering research in tissue engineering includes controllability, reproducibility, and 
scale up feasibility of the bioprocess products.  
Current cell culture techniques for the expansion or differentiation of stem cells often 
involve the use of 2D (2-Dimentional) flasks or Petri dishes. However, this 
conventional method is labour-intensive and difficult to scale-up for large scale 
production. Therefore, culturing the cells in a 3D (3-Dimentional) bioreactor system 
offers a better solution to overcome the limitation of 2D culture. The 3D bioreactors 
provide a dynamic environment which mimics the in vivo cell development, is suitable 
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for scale-up application, and make it easy to control culture parameters such as pH, 
nutrient and waste levels. A bioreactor is an essential device for culturing mammalian 
cells as it will produce dependable, predictable, and free of contaminant products 
(Panoskaltsis et al., 2005; Portner et al., 2005). In addition, bioreactor provides a 
culture environment that could potentially meet clinical application requirement for 
tissue engineered products. 
One of the problems associated with bioreactors for tissue engineering applications is 
a small scale of a bioreactor reactor system makes it difficult to monitor parameters by 
electronic probes. Trial-and-error and rule-of-thumb approaches may not be suitable 
for cell culture systems because the operating cost is considerably high. Therefore, the 
use of computational design tool such as computational fluid dynamics (CFD) is 
attractive approach. CFD was already used in the chemical engineering field, 
particularly in the reactor or fermenter designs and characterisations. The advantages 
of CFD includes: (i) spatial distribution of the interested parameters is shown in the 
system, and (ii) the scale effect can be included in the simulation. Hence, the cost can 
be reduced due to the fact that bioreactors are designed and characterised before they 
are built, and the operating conditions are simulated before experiments are run. 
Moreover, in some cases where bioreactor systems are relative small, measuring 
probes are impractical. CFD can be uses as a characterising tool in order to predict 
some operating conditions, such as a distribution of shear stress, in such bioreactor 
systems.  
So far, most of the research efforts on lung cell differentiation have focused mainly on 
producing type II pneumocytes. In the lung, there is an important part called alveoli 
which are lined with two types of cells: type I and type II pneumocytes. Type I is 
responsible for the CO2/O2 exchange in the lung and type II is responsible for the 
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production and secretion of surfactants. Moreover, type II can replicate and 
differentiate to replace damaged type I pneumocyte. Therefore, the production of type 
II pneumocyte is an essential step in the development of effective therapies for the 
treatment of respiratory diseases associated with alveolus malfunctions. 
Recent works have shown that murine embryonic stem cells (mESCs) can differentiate 
into the distal lung progenitor cells, pneumocyte type II cells (Ali et al., 2002). There 
were more attempts on using adult stem cells and embryonic stem cells, including 
human embryonic stem cells (Samadikuchaksaraei et al., 2006) et al., 2006) in order 
to differentiate the cells into type II pneumocytes, but the efficiency of the 
differentiation is still considerably low. In order to improve efficiency, the 3D 
structure application using encapsulation of mESCs in hydrogel, and a dynamic 
bioreactor, namely rotating wall vessels (RWVs) had been implemented (Siti-Ismail et 
al., 2012). It has been shown that the 3D culture system not only produces higher cell 
numbers but also increases the differentiation efficiency (Siti-Ismail et al., 2012) 
characterised by the percentage of pneumocyte type II in the final product. However, 
the differentiated cells cultured in the RWVs have been found to lose their genotype 
after the 2 weeks of differentiation process, especially SPC (Surfactant Protein C 
which represents phenotype of pneumocyte type II cells) gene expression. The SPC 
expression is important for early differentiation of type II pneumocyte cell functions. 
Therefore, improvement on the type of bioreactors is needed, in order to (1) maintain 
the in vitro SPC expression of differentiated cells and (2) mimic the lung environment 
which exposes the cells to the outside atmosphere. 
The lungs are the largest organs that are exposed to the outside air. In order to mimic 
the lung environment inside a body, the gas or air needs to be introduced to a 
bioreactor. Hence, an airlift bioreactor is suitable for this purpose. The airlift 
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bioreactors are pneumatic bioreactors, which exploit hydrostatic pressure differences 
to circulate the fluid (Petersen and Margaritis, 2001). The airlift bioreactor consists of 
two bubble columns which place concentrically. The inner column is called riser 
whereas the annular space is call downcomer. The gas/air is fed at the bottom of the 
column through a gas sparger. The fluid inside the airlift bioreactor is lifted to flow 
upward via the riser column (draft tube), when the gas/liquid mixture is reached the 
top of the column (gas-liquid separator section), the gas will leave the column while 
the liquid will circulated back to the bottom via the downcomer. With the direct 
contact of gas and liquid inside the airlift bioreactor, the mass transfer of oxygen is 
high compared to other types of bioreactors such as stirred tank bioreactor. Moreover, 
this airlift bioreactor might be used as biomimetic system for the lung cell 
environment. 
Therefore, the overall aim of this project was to develop a bioreactor system for 
embryonic stem cells proliferation and differentiation into lung progenitor cells, i.e. 
alveolar type II cells (pneumocytes type II). This was achieved through two steps 
which included design, and testing of bioreactors. During the first phase of this study, 
an airlift bioreactor was designed and simulated using CFD software, CFX (Ansys), 
and the computational results were validated by experimental data and from 
literatures. An Airlift bioreactor was chosen for the production of lung cells 
(pneumocyte type II) as it offers efficient oxygen transfer and has no moving agitator, 
hence, it is suitable for shear sensitive cells. The main focus of the second phase was 
to differentiate the mESCs into pneumocyte type II. The protocol developed by a 
previous work (Siti-Ismail et al., 2012) but the basal medium was changed using a 
defined component one which has been shown to minimise the cost. The effect of gas 
sparging was also studies to assess the ability of the bioreactor to maintain the gene 
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expression of differentiated cells toward lung cell lineages, especially pneumocyte 
type II cells.  
 
1.2 Objectives 
 
In order to achieve the bioprocessing of differentiation of mESCs into the alveolar 
lineage cells, the specific objectives of this work were: 
1. To design the airlift bioreactor for production of pneumocyte cells 
The model-based design approach by CFD simulation was employed in order to 
design the sparged bioreactors, namely airlift bioreactors. 
 
2. To model the airlift bioreactor using computational fluid dynamics (CFD) 
The same CFD models, basically on the hydrodynamics of the airlift bioreactors, were 
added for more complexities to model by considering the transient behaviours and the 
mass transfer. 
 
3. To culture the murine embryonic stem cells (mESCs) in the airlift 
bioreactor 
The 3D encapsulated mESCs was cultured inside the airlift bioreactor and compared 
with the 3D static system. The effect of antifoams that reduce the bubble formation 
was also studied. 
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4. To differentiate embryonic stem cells (ESCs) into pneumocytes 
The pluripotent mESCs were differentiated into distal lung progenitors, pneumocyte 
type II. The basal media was changed by defined components for cost saving. The 
laborious 3-step-prototocol–(i) expansion of pluripotent mESCs, (ii) embryo body 
formation, and (iii) terminal differentiation– was replaced by the single step protocol. 
The effect of sparging gas on the differentiated cells was also studied. 
 
1.3 Thesis structure  
 
This chapter contains an introduction and objectives of the thesis. The following 
chapters will explain the main works conducted in this study. 
Chapter 2 covers the relevant theoretical background and literature on both 
computational fluid dynamics (CFD) and cell culture experiments related to the 
differentiation of embryonic stem cells into alveolar type II cells. 
Chapter 3 presents the methods and procedures which were used in this thesis. The 
experiments included some techniques such as maintenance of murine embryonic stem 
cells (mESCs), encapsulation of mESCs in alginate beads, differentiation of mESCs 
toward alveolar cells, and characterise of differentiated cells.  
Chapter 4 explains CFD models for the design of the multiphase bioreactors, i.e. airlift 
bioreactors, by CFD simulations.  
Chapter 5 is related to the fundamentals of using CFD to design airlift bioreactors. 
Two different designs are compared with the in-house airlift bioreactor in order to 
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improve the airlift bioreactor performance. Hydrodynamics—gas holdup, liquid 
velocity, and shear rate—are compared in three different designs of the airlift 
bioreactors. Some simulated parameters are compared with corresponding experiment 
data. 
Chapter 6 describes the use of CFD to maximise the airlift bioreactor performance. 
Computational modelling of the oxygen transfer in the bioreactors is also included. 
This chapter describes the airlift bioreactor in a transient manner. Moreover, the 
possibility of three-phase simulation by CFD is also demonstrated.  
Chapter 7 addresses the possibility of using antifoams in the bioreactor. Different 
types of antifoams are recommended for a better use in a bioreactor in which a foam 
formation may cause damage to the system and the cultured cells. 
Chapter 8 presents detailed results on differentiation of murine embryonic stem cells 
into alveolar type II cells. Based on defined commercial medium, a modified protocol 
is proposed which can significantly reduce the maintenance cost (10 times lesser for 
the medium alone). This chapter focuses the 3D systems only, both in static and 
bioreactor systems. 
Chapter 9 concludes the main findings of this research and highlights the specific 
achievements based on the objectives of the work. Recommendations are also 
suggested for future works in order to bring this work closer to real applications. 
Appendices consist of all relevant data, equations, and models. Moreover, the 
multiphase bioreactor models have been implemented into the commercialised 
rotating wall vessel (RWV) designed by NASA: The National Aeronautics and Space 
Administration. 
  
 
 
 
 
 
 
2 LITERATURE REVIEW 
 
2.1 Tissue engineering and regenerative medicine 
 
We are facing many challenges of healthcare problems: aged-associated diseases (e.g. 
cardiovascular disease, osteoporosis, type 2 diabetes, and Alzheimer's disease), 
genetic disorder diseases (e.g. cystic fibrosis), and environment-associated-diseases 
(e.g. lung diseases). New approaches to cure some of these diseases are urgently 
needed as treatments that rely on transplantation of donated organs may be insufficient 
to support an increasing number of patients in the world. 
Regenerative medicine is a process of producing or regenerating damaged or 
malfunctioned cells, tissues, or organ to restore body’s normal functions. The term 
‘Regenerative medicine’ was used before ‘Tissue engineering’ but it was less defined 
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(Meyer, 2009). Regenerative medicine combines areas in gene/cell therapy, 
transplantation surgery, reconstructive surgery, and tissue engineering 
As shown in Figure 2.1, tissue engineering (as a component of regenerative medicine) 
was defined as in vivo or ex vivo manipulation of biological tissues with organic, 
inorganic, or synthetic materials for a purpose of restoring specific functions (Jenkins 
et al., 2003). 
 
Figure 2.1 Regenerative medicine (Jenkins et al., 2003). Regenerative medicine 
combines the following fields of study: tissue engineering, reconstructive surgery, 
transplantation surgery, and gene/cell therapy. 
 
Tissue engineering utilises knowledge of cell biology, engineering (e.g. material 
science, bioreactor design and control), chemistry (e.g. biochemical factors which 
affect the cell survival and differentiation), and medicine. As shown in Figure 2.2, a 
general overview of tissue engineering consists of the insolation and expansion of 
cells including autologous and/or exogenous cells, the cell culture process which 
includes conventional 2D (2-dimentional) culture using tissue culture flaks or dishes 
and 3D (3-dimentional) culture system using bioreactors, and finally, the tissue-
engineered cells or products are transplanted into a patient’s body by an authorised 
Tissue engineering Reconstructive surgery
Transplantation surgery Gene/Cell therapy
Regenerative 
Medicine
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physician. Hence, tissue engineering is a multidisciplinary field which requires 
different expertise of knowledge in many fields. 
 
 
Autologous cells or 
Exologous cells (ESCs, 
iPSCs)
Cell isolation and 
expansion
Cell seeding on scaffold
In vitro culture
Bioreactor or 
static culture
Implantation
ESCs, iPSCs
 
Figure 2.2 A schematic diagram of tissue engineering definition (Lee and Mooney, 
2001; Stock and Vacanti, 2001). Tissue engineering combines knowledge from many 
fields for cell isolation and expansion, in vitro culture in static condition or bioreactor, 
and cell/organ transplantation by physicians. ESCs: Embryonic stem cells, iPSCs: 
Induced pluripotent stem cells. 
 
Some examples of tissue-engineered cells or products are already available in the form 
of organs such as bladder (Atala et al., 2006), trachea (Macchiarini et al., 2008), and 
skin (Ma et al., 2003). Tissue-engineered bladder is one of the most successful 
products up to date. Biopsy samples of patients with myelomeningocele—with high-
pressure or poorly compliant bladders—were taken from the patient’s bladder; the 
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biopsy was then seeded in a bladder-shaped collagen scaffold. After 7 weeks of in 
vitro culture, the tissue-engineered bladder was transplanted back into the patient 
(Atala et al., 2006). This is an example of the use of an autologous cell source and 3D 
scaffold to regenerate a cell construct. Another example is the tissue engineering of 
human airway, where autologous epithelial cells and mesenchymal stem cell (MSC)-
derived chondrocytes from a patient (a 30-year old woman with end-stage 
bronchomalacia) were cultured on the decellular trachea from a donor. The graft was 
transplanted into the left main bronchus of the recipient. In the near future, more 
tissue-engineered products are expected for clinical trials (Fujino et al., 2012). 
As mentioned in Chapter 1, lung diseases are one of the leading causes of morbidity 
and mortality. In the US alone, lung diseases are the third leading cause of death with 
more than 400,000 deaths annually (Ghaedi et al., 2013). Lung epithelia remain 
among the least studied lineages derived from embryonic stem cells and induced 
pluripotent stem cells in vitro (Samadikuchaksaraei et al., 2006; Longmire et al., 
2012; Mou et al., 2012; Ghaedi et al., 2014). 
 
2.2 Anatomy and function of the lung 
 
An average human lung contains 300 – 500 million alveoli, having a total area of 
approximately 75 m2 – for CO2/O2 gas exchange. The complexity of mammalian lungs 
makes it a difficult target for regenerative medicine (Lane et al., 2007). The lung itself 
contains a combination of cells from several distinct cell lineages as shown in Figure 
2.3. More than 40 cell types are presented in a respiratory system (McQualter and 
Bertoncello, 2012). There are at least four types of endoderm-derived epithelium 
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whereas smooth muscle, fibroblast, and vascular cells are derived from mesoderm 
(Neuringer and Randell, 2004) in a respiratory system. The various types of cells, 
including alveolar epithelium, interstitial fibloblasts, myofibroblasts, and pulmonary 
endothelium, are necessary to form alveolar septa (Neuringer and Randell, 2004). 
Trachea
(20)
Bronchi
(2
2-11
)
Bronchioles
(2
12-16
)
Alveoli
(220-23)
Lung compartments
(order of branching)
 
Figure 2.3 Schematic diagram of stem cell compartment in the lung. Adapted from 
Garcia et al. (2012). There are several compartments: trachea (20), bronchi (22-11), 
bronchioles (212-16), alveoli (220-23). The numbers in the superscript represent the order 
of branching e.g. alveoli are 20th – 23rd generations of the branching whereas trachea 
is the parent airway. There are stem cells located in each compartment of the lungs. 
 
The stem/progenitor cells of the pulmonary epithelia are considered to be basal and 
mucous cells in the proximal airways, Clara cells in the bronchioles, and type II 
pneumocytes in the alveoli (Bishop, 2004). More details about lung epithelial stem 
cells are given in Table 2.1 which also describes functions of lung epithelial cells. 
Understanding the local stem cells in each lung compartment will help researchers to 
identify target cells for specific damaged compartment in the lung. 
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Table 2.1 Cells with stem or progenitor characteristics in the lungs (Otto, 2002). In 
each compartment of the lung, there are stem cells which can differentiate into their 
daughter cells. 
Epithelial stem cell niche Functional 
compartment 
Daughter cells 
Tracheal basal cell Patch/clone Mucous, ciliated, 
Neuroendocrine 
Tracheal mucus-gland 
duct cell 
Gland/patch Mucous, ciliated, 
Neuroendocrine 
Tracheal secretory cell Patch/clone Mucous, ciliated, 
Neuroendocrine 
Bronchiolar Clara cell Patch/clone Mucous, ciliated, type I/II 
pneumocyte 
Alveolar type II 
pneumocyte 
Alveolus Type I and II pneumocyte 
(Clara cells) 
Neuroendocrine PNEC*/NEB+ PNEC (and Clara cells) 
 
* PNEC (Pulmonary neuroendocrine cell), + NEB (Neuro epithelial body) 
 
For example, the tracheal basal, tracheal mucus-gland duct, tracheal secretory cells 
can give rise to mucous, ciliated, and neuroendocrine cells. The bronchiolar Clara 
cells can differentiate into mucous, ciliated, type I/II pneuomocyte cells. 
In the distal section of the lung, the alveoli are lined with two types of cells, named 
type I and type II pneumocytes. Type I pneumocytes are responsible for gas exchange 
occurring in the alveoli which have radii of 0.05 mm but increase to around 0.1 mm 
during inhalation. These cells are large and squamous shaped covering 95% of the 
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total surface area. Unfortunately, type I pneumocytes cannot replicate and are 
extremely susceptible to a number of toxic insults. Type II pneumocytes are cuboidal 
cells and play important functions in order to (Wang et al., 2007): 
 Synthesise, store and secrete surfactant, which reduces surface tension, 
preventing alveolus from collapsing. 
 Transport ions from the alveolar fluid into the interstitium, thereby 
minimising alveolar fluid and maximising gas exchange. 
 Serve as progenitor cells for type I pneumocytes, which is particularly vital 
during reepithelialisation of the alveolus after lung injury. 
 Provide pulmonary host defence by synthesising and secreting several 
complementary proteins including C3 and C5 as well as numerous cytokines 
and interleukins that modulate lymphocyte, macrophase, and neutrophil 
functions. 
 
A mammalian lung development comprises of six stages: embryonic, pseudogladular, 
canalicular, saccular, alveolar, and maturation of microvascularture. Figure 2.4 shows 
a timeline of the lung development in both human and mouse. In mouse (Berger et al., 
2011), the embryonic stage begins at E9.5 (Embryonic day 9.5) with the budding of 
the primitive lung mass from the ventral gut epithelium, accompanied by septation 
from the oesophagus. At E12, the lung bud forms the primary trachea and pulmonary 
bronchi. In the pseudoglandular phase, expansion of the bronchial tree and formation 
of the bronchi and bronchioles occur. 
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Pseudoglandular Canalicular Saccular
Alveolar 
(Postnatal)
Human
Mouse
7 – 16 wks
E10.5 – 16.5
16 – 24 wks
E16.5 – 17.5
24 - 36 wks
E16.5 – P5
36 wks – 7 yrs (P)
P5 – P30
Developmental stage
 
Figure 2.4 Chronological stages of lung development in mouse and human (Shi et al., 
2007). There are four stages of the lung development: pseudoglandular, canalicular, 
saccular, and alveolar. E: Embryonic day, P: Postnatal day. 
 
Alveolar epithelial cells are first observed together with the formation of terminal sacs 
and vasculature in the canalicular stage. The numbers of terminal sacs increase 
continually with further vascularisation in the saccular stage, while differentiation of 
type I and II cells occurs. In the alveolar stage, terminal sacs develop into mature 
alveolar ducts and alveoli (Warburton et al., 2000). The pulmonary vasculature 
expands and remodels throughout the lung development. The main events are 
summarised in Table 2.2, which can be used to identify the correct stage of lung 
development, based on changes in cell numbers, morphologies, and functionalities of 
cells. Researchers who try to differentiate embryonic stem cells (ESCs) into the lung 
lineages could refer to this knowledge of lung development as a guide together with 
the gene expression of differentiated cells to characterise the differentiated cells. 
There are two main components in tissue-engineered constructs: i) tissue constructs 
and ii) cells. The cell sources for tissue engineering and regenerative medicine 
applications are still a challenging issue (Lavik and Langer, 2004). Ideally, the cell 
sources should be easily differentiated into a desired type of cells while maintaining 
high expansion capability. Moreover, tissue-engineered products should not cause any 
rejection and long-term usages of immunosuppression drugs should be avoided. 
| 18 
 
Table 2.2 Stages of lung development in human (Voelkel and MacNee, 2008).  
Stage Major Events 
Embryonic 
(3 – 7 wks) 
Lung budding from the foregut endoderm, with formation of 
trachea and main stem bronchi 
Pseudogladular 
(7 – 16 wks) 
Airway division completed, with formation of 25,000 terminal 
bronchioles; cartilage, smooth muscle cells derived from 
mesenchyme 
Canalicular 
(16 – 24 wks) 
Capillarisation, with acinar formation; type I and II epithelial 
cells first differentiate 
Saccular 
(24 – 36 wks) 
Progress thinning of epithelial cells; terminal saccular formation; 
surfactant production 
Alveolar 
(postnatal) 
Appearance of true alveoli; alveolar septation and expansion of 
air space 
 
2.3 Stem cells 
 
Stem cells have the capability of self-renewal, multilineage differentiation, and in vivo 
functional reconstruction of a given tissue (Reya et al., 2001). Stem cells are classified 
according to their differentiation capability: pluripotent and multipotent cells (Vats et 
al., 2002; Ulloa-Montoya et al., 2005). Pluripotent stem cells, i.e. embryonic stem 
cells, can differentiate into three somatic germ layers (Figure 2.5) that are essential for 
organism development: mesoderm, ectoderm, and endoderm. On the other hand, the 
multipotent stem cells, adult stem cells, have limited ability to differentiate into 
specific cells of one tissue or germ layer depending on the niche of the adult stem cells 
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e.g. different blood lineages are differentiated from CD34(+) cells in a cord blood unit 
(Lim et al., 2011). 
ESCs are isolated from the inner cell mass of the blastocyst after the fertilisation 
process from an egg and sperm cells (Figure 2.5). Mouse ESCs were first derived and 
cultured in vitro in 1981 (Evans and Kaufman, 1981; Martin, 1981) and in 1998 the 
first human ESCs were derived in vitro (Thomson et al., 1998).  
ESCs are known to be pluriponent, which means that they are able to differentiate into 
any desired cell lineages, such as haematopoietic cells, endothelial cells (in the blood 
vessel), cardiomyocytes, neurons, chondrocytes (in the cartilage), osteoblasts (in the 
bone), adipocytes (fat), and pneumocytes (in the lung). Furthermore, ESCs can self-
renew and proliferate in culture almost indefinitely. There were many attempts to 
differentiate murine ESCs into mature cells such as alveolar type II (pneumocyte) cells 
(Siti-Ismail et al., 2012), insulin-producing cells (Wang et al., 2009), osteogenic cells 
(Hwang et al., 2009), and erythrocytes red blood cells(Fauzi et al., 2012) and so 
forth. 
Some examples of multipotent stem cells are hematopoietic stem cells (HSCs) which 
can differentiate into all types of mature blood cells, and mesenchymal stem cells 
(MSCs) which differentiate into bone and cartilage (Pittenger et al., 1999). Moreover, 
in 2011, the discovery of the adult stem cells in the human lung made it possible to use 
autologous cells in cell therapies for lung diseases (Kajstura et al., 2011).  
 
| 20 
 
Endoderm Ectoderm Mesoderm
Liver
Gut
Pancreas
Lung
Brain
Skin
Hair
Blood
Muscle
Bone
Cartilage
Somatic 
lineages
Germ lineage
Egg/Sperm
Fertilised egg Blastocyst
Embryonic stem cell 
(Pluripotent)
Embryonic 
stem cell
Inner cell mass 
(Pluripotent)
In vitro
In vivo
 
Figure 2.5 A schematic diagram showing differentiation property of ESCs which was 
adapted from Ulloa-Montoya et al. (2005). Embryonic stem cells can be grown in 
vitro and differentiated into all three germ layers: ectoderm, mesoderm, and 
endoderm. 
 
Recently, researchers have shown that somatic cells can be reprogrammed to behave 
like ESCs and they are called induced pluripotent stem cells (iPSCs). Mouse iPSCs 
were first generated from mouse fibroblast (Takahashi and Yamanaka, 2006) by 
simultaneously introducing four genes: Oct3/4, Sox2, c-Myc, and Klf4. A similar 
approach was used to generate the first human iPSCs in 2007 (Takahashi et al., 2007) 
which made it possible to harness the autologous somatic cells in the tissue 
engineering and regenerative medicine applications. Currently, researchers have been 
able to use the principle of somatic cell nuclear transfer (SCNT) to generate 
pluripotent ESCs (Tachibana et al., 2013). The nucleus from a somatic cell was 
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transferred into an oocyte. This reprogramming of cells to ESCs can generate patient-
matched nuclear transfer (NT)-ESCs and could possibly solve the problem regarding 
to GVHD (Graft-versus-host disease) for organ/cell transplantation. 
Although there are more ethical concerns on using ESCs in clinical treatments, ESCs 
can be considered as an unlimited source for tissue engineering applications. Adult 
stem cells which are endogenous sources of cells are limited in expansion capability 
(Polak and Bishop, 2006). In some cases, harvesting adult stem cells from patients 
might introduce serious effects on the patients such as aspiration of bone marrow cells 
(Hernigou et al., 2013). The iPSCs are relatively new in tissue engineering. However, 
the cost for an effective approach to generate patient’s own iPSCs needs to be 
addressed as well as the process involving virus transfection which might have cross 
effects on human and cause tumour formation (Miyazaki et al., 2012; Gokhale and 
Andrews, 2013). 
Currently, there are two ongoing clinical trials using human embryonic stem cells 
(hESCs)-derived retinal pigment epithelium (RPE) in patients with Stargardt’s 
macular dystrophy and dry age-related macular degeneration (the cause of blindness). 
The hESCs-derived RPE cells were injected into the subretinal space of each patient’s 
eye. After four months of the injections, there were no signs of hyperproliferation, 
tumorigenicity, ectopic tissue formation, or rejection (Schwartz et al., 2012). Knowing 
that adult cells are difficult to differentiate and isolate, hESCs can potentially be used 
as a cell source in regenerative medicine as they offer unlimited source of cells in 
culture. 
Lung tissue engineering is still at its infancy compared to tissue engineering of other 
organs (Kubo, 2012). A number of differentiation processes have been developed in 
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seeking an improved culture method for producing mature lung cells in vitro. The 
efficiency of differentiation of ESCs towards lung lineages is still considered low. 
Lung tissue engineering involves many complex processes, analogous to the organ 
itself.  
 
2.3.1 Pneumocyte type II differentiation from stem cells 
 
Cell culture is the process in which animal or plant cells are grown under ex vivo 
conditions. The application of cell culture could be found in many areas such as cell 
therapies, tissue engineering, and model systems for drug screening. The most 
established differentiation method for ESC lines is based on the formation of three-
dimensional aggregates, embryoid bodies (EBs). The growth and development of EBs 
in many ways recapitulate early embryonic event including spatial organisation and 
formation of three embryonic germ layers and their derivatives. However, EB 
formation requires specific condition and skilled researchers (Randle et al., 2007).  
The alveolar epithelial cells (type II pneumocytes) can be derived in vitro from murine 
ES cells (Ali et al., 2002). Ali et al. found that upon removal of leukemia inhibitory 
factor (LIF), EB cells were formed in a maintenance medium. Differentiated ESCs 
were kept in the same medium or transferred to serum-free small airway growth 
medium for further 3 or 14 days of culture, however, heterogeneous production of cell 
cultures were observed. They also claimed that no SPC (Surfactant protein C, 
pneumocyte type II marker) expression was found in differentiating cells grown under 
the same condition without the formation of EB. Regarding the effect of medium 
composition on type II pneumocyte yield (Rippon et al., 2004), it was concluded that 
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most individual SAGM growth factors were inhibitory for type II pneumocyte 
differentiation, with the largest increase of approximately 3-fold SPC expression being 
observed upon removal of retinoic acid and triiodothryonine. Studies on the effect of 
co-culture techniques using mESCs co-cultured with embryonic mesenchyme from 
distal lung showed an increase expression of SPC genes up to 14-fold (van Vranken et 
al., 2005). 
There were many attempts trying to differentiate stem cells from many sources into 
pneumocyte type II by different methods (Table 2.3). EB formation required a skilled 
scientist and it is a labour intensive process. Co-culture is very difficult to obtain an 
approval because there is a chance of infection by unknown factors. Moreover, in 
order to achieve a higher cell number, 3D culture system is needed because the 
traditional 2D culture is limited by the amount of cells that can be produced. 
Many studies are focusing on unlimited sources of cell (e.g. iPSCs and ESCs). The use 
of iPSCs might provide differentiated cells to overcome the problem of immune 
rejection. However, the cost of iPSC culture is considerably high (Moretti et al., 
2013). Therefore, the uses of ESCs are still promising and more clinical trials related 
to ESCs are expected to be conducted.  
Soh and colleagues (Soh et al., 2012) developed a step-wise differentiation protocol in 
which hESCs or iPSCs were induced to differentiate into definitive endoderm in 100 
ng/mL of Activin A and 0.5% FBS (Fetal bovine serum) as described in another 
reference (D'Amour et al., 2005). Definitive endoderm differentiation lasted for 5 
days, after that, the differentiated cells were cultured in fetal lung-conditioned medium 
for another 7-10 days. The final step was lung epithelial cell expansion: the 
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differentiated cells from step two were cultured in lung epithelial medium (Simon and 
Green, 1985) before transplantation.  
Recently, Ghaedi et al. (2013) also used iPSCs to produce both type I and type II 
pneumocytes. In summary, the differentiation protocol consists of 22 days 
pnuemocyte type II differentiation and 7 days for the maturation of type II to type I 
pnuemocytes. The protocol began from the definitive endoderm induction by Activin 
A for 6 days. The period from day 6 to day 8 was called anterior foregut endoderm 
formation which was achieved by using a SB431542 and NOGGIN containing 
medium. The type II pnuemocyte differentiation lasted from day 8 to day 21, the 
differentiation contained growth factors such as EGF, KFG, WNT3a, FGF10 and the 
basal medium was IMDM with 10% FBS. The final stage was called maturation of 
type II to type I pneumocyte in which the differentiated cells were induced to 
differentiate into type II by either growth factors or exposure to the gas-liquid 
interface in a bioreactor. A study performed by the same group employed a custom-
made rotating bioreactor with a gas-liquid interface to produce functional alveolar 
cells (Ghaedi et al., 2014). Following this example researchers have attempted to 
produce pneumocytes from pluripotent stem cells which have more potential to 
differentiate than adults stem cells (Polak and Bishop, 2006). Moreover, the use of a 
bioreactor will not only help to produce a high cell number but also enhance the 
differentiation toward functional alveolar cells. 
Although, there has been more than 10 years research on the development of lung 
tissue, there is no robust protocol applying specific differentiation factors 
(Schmeckebier et al., 2013). Efforts have been made to improve the efficiency (based 
on a differentiated cell population) of the differentiation. The use of 3-dimensional 
(3D) environment and a bioreactor might overcome the problems associated with the 
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conventional 2D systems. In a 3D system, cells are more likely to experience 
conditions which mimic the in vivo microenvironment. Furthermore, 3D platforms can 
support larger number of cells than conventional 2D culture. 
 
2.3.2 Three-dimensional culture of stem cells 
 
Culturing cells on a 2D surface has been shown to be insufficient for cell culture 
applications (Lee et al., 2008). In 2D cell culture cells are grown on plastic 
dishes/plates which do not represent the in vivo environment. 2D cultures are labour-
intensive, time-consuming, operating-dependent, and impractical to scale-up 
processes. Producing a single unit of red blood cells would require a surface area 
equivalent to two tennis courts (Giarratana et al., 2005; Timmins and Nielsen, 2009) 
which is approximately equal to 70,000 T-75 flasks. 
Generally, the use of 3D culture is to seed cells onto a 3D scaffolds which may be 
synthetic or natural materials. Scaffolds provide a 3D environment which is desirable 
for cell differentiation and proliferation (Meyer, 2009). In the case of lung 
differentiation from ESCs, there are attempts to grow mESCs on natural and synthetic 
scaffolds, e.g. natural-derived hydrogels (Siti-Ismail et al., 2012), polymeric 
biomaterials: poly-lactic-co-glycolic acid (PLGA) and decellular lung scaffolds 
(Jensen et al., 2012). However, using decellular lung structure is dependent on donors 
which limit the number of patients who can benefit from this procedure (Wagner et 
al., 2013).  
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Table 2.3 Differentiation of stem cells into alveolar type II cells. There are many cell sources 
for alveolus stem cells: murine (m) and human (h) embryonic stem cells (ESCs), bone marrow 
mesenchymal stem cells (BMSCs), induced pluripotent stem cells (iPSCs). SAGM: small 
airway growth medium, SABM: small airway basal medium, DMEM: Dulbecco's modified 
eagle medium, Iscoves modified Dulbeccos medium, F12: Ham's F-12 Nutrient Mixture, 
RPMI: Roswell Park Memorial Institute medium. 
References Cell 
sources 
Culture media Summary 
(Ali et al., 2002) mESCs SAGM EB formation and 30 day 
of differentiation 
(Ma et al., 2011) BMSCs SAGM Co-cultured with lung 
mesenchymal cells 
(Lin et al., 2010b) mESCs DMEM, SABM Total of 28 differentiation 
with the first 10 days for 
EB formation 
(Roszell et al., 2009) mESCs IMDM/F12 Dissociated seeding 
method for 11 days 
(Samadikuchaksaraei 
et al., 2006) 
hESCs SAGM 28 days of differentiation 
with 7 days of EB 
formation 
(Siti-Ismail et al., 
2012) 
mESCs SAGM Single stem differentiation 
of encapsulated mESCs in 
rotating wall vessel  
(Soh et al., 2012) hESCs and 
iPSCs 
RPMI Step-wise hES/hiPS cell 
differentiation protocol: 4- 
5 days of endoderm 
formation, 7 – 10 days of 
lung lineage cell 
differentiation and 3 – 5 
days of lung 
epithelial cell formation 
(Ghaedi et al., 2013) iPSCs RPMI, IMDM A total of 29-day 
differentiation from iPSCs 
to AT1 (Alveolar type I) 
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Moreover, the decellular scaffolds provide poor mechanical strength. When PLGA is 
used as scaffolds for mESC differentiation into pneumocyte type II cells, the scaffolds 
needed to be coated by natural ECM proteins (collagen I, laminin, fibronectin, and 
matrigel) in order to enhance cell attachment (Lin et al., 2006; Lin et al., 2010a). 
Moreover, a stiffness of a scaffold could inherently differentiate the seeded cells 
(epithelial) towards mesenchymal phenotype cells (Mondrinos et al., 2006; Lanza et 
al., 2007). Therefore, using natural and versatile scaffolds may offer a solution for 3D 
culture of stem cells for lung development. For example, hydroxyethyl methacrylate-
alginate-gelatin (HAG) cryogel was used to grow human lung epithelial cells (L-132) 
for 3 weeks; however, the scaffold was prepared at very low temperature with the use 
of many chemicals (Singh et al., 2013). 
One of the main problems in tissue engineering is producing sufficient number of cells 
with an appropriate phenotype (Malda and Frondoza, 2006). The use of microcarrier 
offers a solution by providing a large surface area for culturing monolayer cells: one 
gram of microcarriers can provide a surface area equivalent to fifteen 75-cm2 flasks. 
For example, the anchorage-dependent cells such as human mesenchymal stem cells 
(hMSCs) were cultured on microcarriers (non-porous Plastic P-102L) in a five litre 
stirred-tank bioreactor, which yielded 1.7×105 cells/ml (equivalent to 65 fully-
confluent T-175 flasks) of MSCs (Rafiq et al., 2013). However, growing cells on the 
surface of microcarriers cannot protect them from any potential damage caused by 
shear stress because the cells are exposed to culture media directly. In some areas in a 
bioreactor (e.g. near an impeller region), shear force is high compared to other 
regions. Alternatively, encapsulated cells in microporous scaffold/hydrogel can shield 
cells from hydrodynamics shear forces. (Wilson and McDevitt, 2013). Encapsulation 
of stem cells permits mass transport of nutrients and metabolic wastes while restricting 
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the immune molecules and cells. It also enables expansion in scalable suspension 
bioreactors for bioprocessing and transplantation in vivo (Wilson and McDevitt, 
2013). Furthermore, encapsulation of cells in hydrogel can mimic extracellular matrix 
(ECM; a composite material which contains a complex mixture of fibrous proteins and 
heteropolysaccharides) that supports cell growth and differentiation (Hwang et al., 
2009; Tibbitt and Anseth, 2009; Du et al., 2013). 
 
2.3.3 Hydrogels in tissue engineering and regenerative medicine 
 
Hydrogels have been used in regenerative medicine for many applications because of 
their biocompatibility, flexible methods of synthesis, range of constituents, and 
desirable physical characteristics (Slaughter et al., 2009). Hydrogels can serve as 
scaffolds which provide structure integrity to tissue constructs. Hydrogels can be 
classified in many categories based on various characteristics such as the nature of 
side groups (neutral or ionic); method of preparation (homo- or co-polymer); physical 
structure (amorphous, semicrystaline, and hydrogen bonded); and responsiveness to 
physiologic environment stimuli such as pH, ionic strength, and temperature (Hamidi 
et al., 2008). Hydrogels are formed from natural or synthesis materials and used in 
many applications such as tissue engineering and drug delivery (Lee and Mooney, 
2001). 
Alginate is a popular choice in tissue engineering applications (Sun and Tan, 2013). 
Alginate is a water-soluble linear polysaccharide extracted from brown seaweed and is 
composed of alternating blocks of 1-4 linked α-L-guluronic and β-D-mannuronic acid 
residues. An alginate solution forms a hydrogel in the presence of multivalent cations 
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usually divalent Ca2+, Ba2+ or Sr2+(Bauwens et al., 2005). These cations, mostly Ca2+, 
can take part in interchain binding between the blocks of guluronic residues in alginate 
strands and give rise to a 3D network in the form of a hydrogel. Figure 2.6 describes 
the model of this network, “egg-box”, (Akasha and Elouz, 2012). A divalent calcium 
cation fits into the guluronate block structure like eggs in an egg box. This binds the 
alginate polymer together by forming junction zones, resulting in gelation of the 
solution. 
There are different gel networks in hydrogels: superficial crust, a subsurface, a 
cavities, shaft and shaft clusters, a medium gelled zone, and a weak gelled zone 
(Bambrick et al., 2011). The gelation occurs at the outer layer, superficial crust, first. 
The superficial crust is formed by the highest concentration of calcium and alginate to 
make the hydrogels tighter. The volume of hydrogel gradually reduces due to the 
tightening of the superficial crust by water expulsion. The unbond alginate molecules 
at the centre of the hydrogels then move to the boundary space with high calcium 
content, during this reaction-diffusion process, microfractures, shafts, and cavities are 
formed. This simple and reproducible gelation process makes calcium-hydrogel an 
attractive choice as for the microcarrier in bioreactor systems which require a 
reproducible and homogeneous environment (Hwang, 2008). 
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Figure 2.6 A schematic diagram of the ‘‘egg-box’’ model in low and high CaCl2 
concentration. 
 
In order to achieve cell culture in a bioreactor system, selection of a suitable scaffold 
is needed. There are many sizes and shapes of the scaffolds such as cylinder, disk, and 
sphere. Cylindrical and disk shaped scaffolds can give rise to complicated motion in a 
bioreactor whereas a sphere shaped scaffold is more desirable due to its homogeneous 
size and simple motion inside a bioreactor (Hwang, 2008). In sphere shaped scaffolds, 
mass transfer of nutrients from the surrounding environment to the inside of scaffolds 
is more uniform compared to other shapes, therefore, enhanced mass transfer can be 
achieved. The motion of sphere shaped scaffolds inside a bioreactor is simpler, 
making it easier to evaluate and model. 
 
 
| 31 
 
2.4 Bioreactors 
 
Bioreactors are important part in any tissue engineering (TE) strategy as they aid the 
construction of three-dimensional functional tissues (Salehi-Nik et al., 2013). Most 
bioreactors can provide culture control, optimisation, standardisation, scale up 
feasibility, and an automatic operation for cultivation of cells. Tissue-engineered 
products from bioreactor systems are more likely to be dependable, predicable and 
free of contaminants. Therefore, bioreactors provide a culture environment that could 
potentially meet the requirements for clinical application of tissue engineered products 
(Placzek et al., 2009). 
There are many types of bioreactor which are appropriate for culturing a specific cell 
lineage. Spinner flask bioreactors, rotating-wall vessels, hollow-fibre bioreactors, 
perfusion-mode bioreactors, are frequently mentioned in cell cultivation for tissue 
engineering application. 
A summary of advantages and disadvantages of using bioreactors for stem cell 
application is given in Table 2.4. Using bioreactors not only help to increase the cell 
number for the bioprocess but can also mimic an in vivo environment. Various 
bioreactors have been used in tissue engineering and regenerative medicine (Martin et 
al., 2004). 
Researchers have successfully improved the yield of human cell culture using 
bioreactors. For example, hESCs and hiPSCs were scaled up to a clinically relevant 
cell number (2×109 cells) in a stirred suspension bioreactor (Abbasalizadeh et al., 
2012). Uniform sizes of cell aggregates were also achieved but the fold expansion 
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decreased by increasing the agitation rate probably due to the high shear environment 
(Abbasalizadeh et al., 2012). 
 
Table 2.4 Advantages and disadvantages of various bioreactors. Adapted from C. Ma 
(Ma, 2008).  
Type of 
Bioreactor 
Advantages Disadvantages 
Suspension/Stirred  Homogenous 
environment 
 Easy Sampling 
 Easy to scale up 
 Do not permit cell-cell 
interaction 
 Mechanical agitation induce 
shear stress 
Hollow-fibre  Continuous process 
 Shear-free 
 Difficulty in retrieving cells 
 Difficulty in monitoring 
parameters 
 Spatial inhomogeneous 
environment 
Perfusion  Continuous process  
 Support stromal layer  
 Clinical Application 
 Scale up difficulties  
 Difficult to monitor the 
parameters 
Airlift  Easy to scale up 
 Homogenous 
environment 
 Support high density 
growth 
 Support stromal layer 
 Bubble breakage cause cell 
damages 
 
Spinning flask bioreactors have been used for cell seeding into 3D scaffolds by 
convective mass transfer. Stirring of the medium through this method enhances 
external mass-transfer which makes the seeding process more efficient. ESCs can be 
differentiated into cardiomyocytes on CultiSpher-S microcarriers in a spinner flask 
(Akasha and Elouz, 2012). 
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Rotating-wall vessel provides a dynamic culture environment with low shear stress 
and high mass-transfer rate. The vessel wall can be rotated at a rate that balances all 
three forces - drag, centrifugal, and net gravitational forces - inside the bioreactor; thus 
the culture medium is in suspension state. A scalable rotating wall vessels were used 
to differentiate mESCs into osteoblasts (Hwang et al., 2009), pneumocytes type II 
(Siti-Ismail et al., 2012), and Erythrocytes (Fauzi et al., 2012). 
Hollow-fibre bioreactors have also been used successfully for cell culture. This type of 
bioreactor has been used for culturing highly metabolic and sensitive cell types such 
as hepatocytes (Planchamp et al., 2003). More recently it has been used for 
hematopoietic stem cell expansion because the production cost can be saved by using 
different flow rates of nutrients and growth factors. An expansion of 13.9 fold with a 
high cell number, 1.53×109 cells, of enucleated red blood cells was achieved using this 
system. However, harvesting cells from this system is a considerably difficult process 
which results in cell death during the extraction of cells from scaffolds (Macedo, 
2011). 
Another example of bioreactors used in cell culture is perfusion-mode bioreactors 
which mediate flow through the pores of the scaffold which is used for seeding or 
culturing 3D constructs e.g. bones (Cha, 2010). A perfusion-mode bioreactor was used 
in the differentiation of mESCs toward bone-like tissues. Animal studies have been 
performed by transplanting the encapsulated cells in alginate beads into a rabbit with 
cranial defect, and the results showed that there were formations of cells close to bone 
defect with no signs of tumour formation or immune rejection (Cha, 2010). In order to 
achieve higher cell numbers, a redesign of the whole bioreactor system might be 
needed. Since the system is relatively small, the use of online probes is impractical. 
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The selection of a bioreactor system for mammalian cell cultivation beyond bench 
scale is dependent on whether the cells are adherent, suspension grown as single cells 
or aggregates (Figure 2.7). The principles of selecting bioreactors for stem cell 
cultivation and their differentiation methods are basically the same as those for 
mammalian cell culture processing (Ulloa-Montoya et al., 2005). 
Suspension cells can be grown as simple suspension (in stirred vessel, bubble column, 
or roller bottle) or these cells can be grown in macroporous microcarrier (in stirred 
vessel or stationary system: inside a T-flask). Cell aggregates, e.g. embryoid body 
(EB), were expanded in a high cell number (one million cells per ml) in stirred 
bioreactor (Cormier et al., 2006). It is also possible to use other types of suspension 
mode—such as bubble column—for expanding the cell aggregates. Murine embryonic 
stem cells are adherent cells traditionally grown on tissue culture flasks. For the 
purpose of increasing cell number, surface culture and microcarriers are needed. 
Surface culture includes roller bottle and multiplate parallel plates. There are two 
types of microcarriers: macroporous microcarriers and surface microcarriers which are 
employed in stirred bioreactors. 
Therefore, the selection of bioreactors based on the nature of cell growth is important 
to achieve an optimal cell number needed in each culture. Besides the nature of cell 
growth, bioreactors should provide a microenvironment that cells experience in vivo. 
Efforts have been made on designing bioreactors that can mimic in vivo environment, 
for example, human embryonic stem cells (hESCs) were seeded on decellularised 
bone scaffolds in a perfusion bioreactor which induced hydrodynamic shear for 
enhancing osteogenic differentiation of hESCs (Marolt et al., 2012). 
 
Suspension cells
Cell cultivation methods
Simple 
suspension
Stirred 
vessel, 
bubble 
column
Cell aggregates
Roller bottle
Surface 
culture
Adherent cells
Stirred vessel MicrocarriersOther 
suspension 
modes (bubble 
column, etc.)
Macroporous 
microcarriers
Roller bottle Multiplate 
parallel plates
Surface 
microcarrier
Macroporous 
microcarriers
Stirred vessel
Stirred vessel Stationary (flat bed, 
membrane reactor)
 
Figure 2.7 A schematic diagrams showing cell cultivation method applicable for expansion and differentiation of stem cells (Ulloa-Montoya et 
al., 2005). The guideline of using bioreactors in cell culture depends on morphology of cell—i.e. suspension cells, cell aggregates, or adherent 
cells—of cells in a culture conditions.  
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Different bioreactors have been applied in lung tissue engineering, in order to achieve 
a high cell number and to mimic a 3D environment. For example, the high aspect ratio 
vessel (Siti-Ismail et al., 2012) and perfusion-mode bioreactor, the latter was used to 
culture a whole rodent lung for in vitro study (Petersen et al., 2011). However, few 
studies have paid attention to bioreactor systems with a gas-liquid interface. In this 
present work, an efficient bioreactor is required for a high number production of 
differentiated cells. Based on the physiology of the lung which makes direct contact 
with air, the sparged type bioreactors—a bubble column, an airlift bioreactor, or a 
normal spared bioreactor—would be more suitable compared to other types of 
bioreactors, because gas or air could be fed inside the bioreactors. This approach is 
referred to as ‘biomimetic’ culture for lung tissue engineering since cells inside a 
sparged bioreactor experience conditions similar to the in vivo environment.  
A sparger is a device for introducing a stream of gas in the form of small bubbles into 
a liquid (Treybal, 1980). Sparged vessel or bubble column bioreactor usually has a 
simple horizontal tubular configuration with a sparger at the base. An airlift bioreactor 
is a modified version of bubble column where one tube is placed concentrically in 
another tube. 
Since it offers better hydrodynamics and mass transfer performance compared to 
conventional bubble columns (van Baten and Krishna, 2003), an airlift bioreactor was 
chosen for this project. 
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2.5 Airlift bioreactor 
 
An airlift bioreactor has been extensively used as a fermentation vessel in the 
biotechnology industry. It offers the following advantages (Williams, 2002):  
 Simple design with no moving parts or agitator shaft seals, for less 
maintenance, less risk of defects and easier sterilisation. 
 Low shear rate, for greater flexibilitythe system can be used for growing 
both plant and animal cells. 
 Efficient gas-phase disengagement. The gas and liquid are efficiently 
separated at the top part of the airlift bioreactor compared to the bubble 
column.  
 Large, specific interfacial contact-area with low energy input. 
 Well-controlled flow and efficient mixing. 
 Well-defined residence time for all phases. 
 Increased mass-transfer due to enhanced oxygen solubility achieved in large 
tanks with greater pressures. 
 Large-volume tanks possible, increasing the output. 
 Greater heat removal vs. conventional stirred tanks. 
However, airlift bioreactors also have several disadvantages (Williams, 2002): 
 High initial capital investments due to large-scale processes. 
 Greater air throughput and higher pressure needed, particularly for large-scale 
operation. 
 Low friction with an optimal hydraulic diameter for riser and downcomer. 
 Low efficiency of gas compression. 
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 Inherently impossible to maintain consistent levels of substrate, nutrients, and 
oxygen with a circulation of organisms through the airlift bioreactor and a 
changing of its conditions. 
 Inefficient gas/liquid separation when foaming occurs. 
These disadvantages could be minimised by optimising the design of airlift bioreactor 
systems (Williams, 2002). The airlift bioreactor offers a number of desirable features 
for cell cultivation of pneumocyte cells. It can also be made to mimic the environment 
of pneumocyte cells which are directly exposed to the atmosphere. 
There are four district sections in an airlift bioreactor (Figure 2.8): the riser, normally 
the draft tube; the downcomer, the annulus; the base; and the gas-liquid separator, at 
the top. There are two types of airlift bioreactor: an external loop and internal loop 
airlift bioreactor. The main difference between them is that the external loop airlift 
bioreactor consists of two separate columns connecting the top and the base by a 
horizontal section, whereas the internal loop airlift bioreactor (Figure 2.8) consists of 
two concentric columns.  
The most important design parameters reported in the literature are: gas holdup, liquid 
circulation velocity, ‘true’ superficial gas velocity, mixing, shear rate, aeration rate, 
and volumetric mass transfer coefficient, 𝑘𝐿𝑎. 
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Figure 2.8 Internal loop airlift bioreactor configuration. 1: gas sparger, 2: riser, 3: gas-
liquid separator, 4: downcomer. Arrows represent the direction of circulating liquid 
inside the airlift bioreactor. 
 
2.5.1 Parameters in airlift bioreactors 
 
The interrelationship between liquid circulation velocity and other airlift bioreactor 
characteristics are shown in Figure 2.9. For example, the liquid circulation is 
controlled by gas holdups in the riser and the downcomer. The gas holdups are also 
affected by changes in bubble rise velocity. In addition, the liquid velocity/circulation 
determines the level of turbulence, which affects the fluid-reactor wall heat transfer 
coefficients, the gas-liquid mass transfer, and the shear forces. 
Therefore, detailed understanding of the spatial distribution of flow and mass transfer 
related parameters is crucial, especially for small scale (100 mL working volume in 
2 
1 
3 
4 
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this study) bioreactors such as those employed in stem cell research. Experimental 
based empirical correlations may not be valid in all designs of airlift bioreactors. On 
the other hand, computational fluid dynamics (CFD) can be used to simulate the flow 
and mass transfer in bioreactors and to obtain quantitative information on flow 
patterns and mass transfer performance. Moreover, CFD simulation can be used as an 
in silico design tool to determine the optimal geometrical configuration and operating 
conditions for a given application. 
 
Heat transfer
Liquid velocity
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Figure 2.9 A schematic flow-chart of interrelationships between the liquid circulation 
velocity and other bioreactor performance characteristics (Chisti, 1989). UH: heat 
transfer coefficient, kLaL: volumetric mass transfer coefficient.  
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2.5.2 Mass transfer theory 
 
Mass transfer of oxygen is often a rate-limiting step in the aerobic bioprocess due to 
the low solubility of oxygen in the medium (Garcia-Ochoa and Gomez, 2009). In an 
airlift bioreactor, oxygen needs to be transferred from air bubbles (gas phase) to the 
cell within which biochemical reactions take place. 
Figure 2.10 shows the steps it takes for, oxygen to transfer from a bubble to cells. 
There are eight mass transfer resistances in this process: (1) the gas film inside the 
bubble, (2) the gas-liquid interface, (3) the liquid film at the gas-liquid interface, (4) 
the bulk liquid, (5) the liquid film surrounding the cell, (6) the cell-liquid interface, (7) 
internal cell resistance, and (8) resistance at the sites of biochemical reaction. In 
practice, not all these resistances are important (Chisti, 1989). In a turbulent operating 
condition where convective transport is dominant, resistance in the bulk liquid 
(resistance 4) can be neglected because a well-mixed condition is achieved. In case of 
immobilised Candida tropicalis in alginate gel beads for phenol biodegradation in a 
bubble column, results showed that the gas-liquid interphase mass transfer (i.e. 
resistance 2 in Figure 2.10) was the rate-limiting step (Jia et al., 2010). 
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Figure 2.10 A diagram of the transfer of oxygen from a gas phase to a cell which is 
suspended in a liquid medium. Adapted from Chisti (1989). There are eight resistances 
in suspended cells in a liquid medium system. In case of immobilised cell system, the 
resistances to oxygen transfer from liquid phase to inside edge of microcapsule (i.e. 
liquid to microcapsule and transmembrane resistances) can be added (Sharp et al., 
1998).  
 
Mass transfer in airlift bioreactors is commonly analysed using the Film Theory 
(Figure 2.11) which is based on the Fick’s law of diffusion.  
 
Gas Liquid
flux
CALi
CAL
pAG
pAGi
 
Figure 2.11 A Schematic diagram of mass transfer between gas and liquid phase 
based on film theory. CALi: concentration of species A at liquid interphase, CAL: 
concentration of species A in liquid phase, pAG: a partial pressure of species A in gas, 
phase and pAGi: a partial pressure of species A at gas film interface.  
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The resistance to transfer in each phase is localised in a thin film close to the interface. 
The molar flux of diffusing species (𝐽𝐴) is related to the concentration gradient (∆𝐶)  
𝐽𝐴 =
𝐷
∆𝑥
∆𝐶         (2.1) 
where 
𝐷
∆𝑥
is known as the mass transfer coefficient, k, 𝐷 is the molecular diffusivity of 
species A in the gas film. 
For the liquid film, the molar flux is given by: 
𝐽𝐴𝐿 = 𝑘𝐿(𝐶𝐴𝐿𝑖 − 𝐶𝐴𝐿)       (2.2) 
where 𝐶𝐴𝐿𝑖 is the concentration of component A at the gas/liquid interface, and 𝐶𝐴𝐿 is 
the concentration of the same species in the liquid. Assuming that there is no 
resistance at the interface, mass transfer through the stagnant film is only due to 
molecular diffusion. 
𝐽𝐴𝐿 = 𝐽𝐴𝐺 = 𝐽𝐴       (2.3) 
Hence: 
𝐽𝐴 = 𝑘𝐿(𝑐𝐴𝐿𝑖 − 𝑐𝐴𝐿) = 𝑘𝐺(𝑝𝐴𝐺 − 𝑝𝐴𝑖)    (2.4) 
where 𝑝𝐴𝑖 is the partial pressure of component A at the gas/liquid interface, 𝑝𝐴𝐺 is the 
partial pressure of component A in the gas. 
Assuming that the interfacial concentrations are in equilibrium, the flux may be 
expressed as the steady state conditions. 
𝐽𝐴 = 𝐾𝐿(𝑐𝐴
∗ − 𝑐𝐴𝐿) = 𝐾𝐺(𝑝𝐴𝐺 − 𝑝𝐴
∗ )     (2.5) 
where 𝐾𝐿and 𝐾𝐺 are the overall liquid-side and overall gas-side mass transfer 
coefficients, respectively, which are given by: 
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1
𝐾𝐿
=
1
𝑘𝐿
+
1
𝐻𝑘𝐺
       (2.6) 
and, 
1
𝐾𝐺
=
1
𝑘𝐺
+
𝐻
𝑘𝐿
       (2.7) 
If the gas has a low solubility in the liquid, then the Henry’s law constant is large and 
1 𝑘𝐿⁄ >> 1 (𝐻𝑘𝐺)⁄ , thus, the mass transfer on the liquid side is the controlling 
resistance. Let the flux be as follows: 
𝐽𝐴 = 𝑘𝐿(𝑐𝐴
∗ − 𝑐𝐴𝐿)       (2.8) 
since the transfer rate and the flux are related by: 
𝑎𝐽𝐴 =
𝑑𝑐𝐴𝐿
𝑑𝑡
        (2.9) 
the following expression can be obtained: 
𝑑𝑐𝐴𝐿
𝑑𝑡
= 𝑘𝐿𝑎(𝑐𝐴
∗ − 𝑐𝐴𝐿)       (2.10) 
where a is the interfacial area per unit liquid volume. 
 
2.5.3 Gas holdup 
 
The gas void fraction, gas holdup, is defined as: 
𝜀 =
𝑉𝐺
𝑉𝐺+𝑉𝐿
        (2.11) 
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where 𝑉𝐺 and 𝑉𝐿 are gas and liquid (slurry) volumes in an airlift bioreactor, 
respectively. The individual riser and downcomer gas holdups, 𝜀𝑟 and 𝜀𝑑, respectively, 
are related to 𝜀 by: 
𝜀 =
𝐴𝑟𝜀𝑟+𝐴𝑑𝜀𝑑
𝐴𝑟+𝐴𝑑
       (2.12) 
The gas holdup is a crucial factor in reactor design because the total design volume 
has to accommodate the maximum holdup. 
 
2.5.4 Liquid circulation velocity 
 
The liquid circulation velocity in an airlift bioreactor is induced by the difference in 
fluid density between the riser and downcomer. 
A mean circulation velocity (𝑈𝐿𝑐) is defined as: 
𝑈𝐿𝑐 =
𝑥𝑐
𝑡𝑐
        (2.13) 
where 𝑥𝑐is the circulation path length and 𝑡𝑐 is the average time for one complete 
recirculation. 
The relation between liquid velocities in the riser and downcomer is shown as: 
𝑈𝐿𝑟𝐴𝑟 = 𝑈𝐿𝑑𝐴𝑑       (2.14) 
The superficial liquid velocity, which is defined as the volumetric flow rate through a 
unit cross-sectional area of empty column (Bird et al., 2002), is different from the true 
liquid velocity (the interstitial velocity (𝑉?̇?)) because the flow of the liquid occupies 
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only a part of a bioreactor depending on the liquid holdup (1 − 𝜀) The liquid velocity 
and superficial velocity are related as follows: 
𝑉𝐿𝑟̇ =
𝑈𝐿𝑟
1−𝜀𝑟
        (2.15) 
And,  
𝑉𝐿𝑑̇ =
𝑈𝐿𝑑
1−𝜀𝑑
        (2.16) 
The liquid circulation velocity affects the level of turbulence, the fluid-reactor wall 
heat transfer, the gas-liquid mass transfer, and the shear to the microorganisms.  
Most of chemical engineering designs are based on non-dimensional parameters, 
which are applicable to the design of a concentric tube airlift bioreactor. All non-
dimensional parameters are defined as shown in nomenclatures (page xxi). 
 
2.5.5 Mass transfer correlations 
 
For draft-tube sparged concentric tube airlift bioreactors (Merchuk et al., 1994), the 
mass transfer correlation presented by the Sherwood number (Sh), representing the 
ratio of convective to diffusive mass transport, is given by: 
𝑆ℎ = 17.3𝑥103𝐹𝑟0.9𝑀−3.4𝐺𝑎0.13𝑋𝑡
−0.07𝑌𝑡
−0.18   (2.17) 
where 𝐹𝑟 is Froude number (the ratio of inertial forces to gravity force), 𝑀 is the 
bubble column separator to column diameter ratio, 𝐺𝑎 is Galilei number (the ratio of 
gravity forces to viscous forces), 𝑋𝑡 is bottom clearance ratio, and 𝑋𝑡 is top clearance 
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ratio. The influence of apparent viscosity is represented by 𝐺𝑎. The higher the 
viscosity, the lower the mass transfer rate. The effect of superficial gas velocity on 
mass transfer can be seen in term of 𝐹𝑟 number. 𝑀 has a more significant effect on the 
mass transfer than clearance at the draft-tube bottom and draft-tube top. 
 
2.5.6 Gas holdup correlations 
 
The gas holdup, volume fraction of the gas, is different in each section of the airlift 
bioreactor. The following correlations are recommended for calculating gas holdup in 
the riser (𝜀𝑟), downcomer (𝜀𝑑), and separator (𝜀𝑠), respectively. The value of holdup in 
the gas separator is approximately the same as that of the total holdup (𝜀𝑡𝑜). The 
correlations 2.18 – 2.20 were taken from a literature (Merchuk et al., 1994). 
 
𝜀𝑟 = 1.5𝐹𝑟
0.87𝑀−0.4𝑋𝑡
−0.19𝑌𝑡
−0.2     (2.18) 
𝜀𝑑 = 4.76𝐹𝑟
1.3𝐺𝑎−0.09𝑀−3.8𝑋𝑡
0.65     (2.19) 
𝜀𝑡𝑜 = 𝜀𝑠 = 0.29𝐹𝑟
1.05𝑀−2.5𝑋𝑡
0.1𝑌𝑡
−0.07    (2.20) 
 
The main parameter that affects the gas holdup is 𝐹𝑟, which represents the influence 
of gas input rate. The apparent viscosity only affects gas holdup in the downcomer, 
whereas the airlift bioreactor geometric parameters (𝑀, 𝑋𝑡 , and 𝑌𝑡) are important for 
gas holdup in all sections except for the downcomer section where the draft-tube top 
clearance, 𝑌𝑡, is not important. 
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2.5.7 Dynamic pressure drop correlations 
 
The following equation (2.21) is generally used to predict the pressure drop in a 
concentric tube airlift bioreactor. The bottom clearance ratio, 𝑋𝑡, and the bubble 
column separator to column diameter, 𝑀, strongly influence the pressure drop because 
of their effects on liquid velocity. Substituting the superficial gas velocity (𝑢𝑔) into 𝐹𝑟 
reveals that the pressure drop correlation, 𝐸𝑢′is a function of 𝑢𝑔
0.5. 
𝐸𝑢′ = 0.858𝐹𝑟−1.51𝐺𝑎0.06𝑋𝑡
−1.1𝑀4.2    (2.21) 
These correlations (mass transfer, gas holdup, and dynamic pressure drop) are valid 
only within the operating conditions summarised in Table 2.5. 
 
Table 2.5 Operating parameters that are valid for sections: mass transfer (2.5.5), gas 
holdup (2.5.6) and dynamic pressure drop (2.5.7) calculations. 𝑑𝑐: column diameter, 
𝑑𝑡: draft tube diameter, 𝑢𝑔: gas velocity, 𝒈: acceleration due to gravity, 𝜇: viscosity, 
𝜌𝐿: liquid density.  
Dimensionless numbers Definitions Range 
Froude number (𝑭𝒓) 𝑢𝑔 (𝒈𝑑𝑐)
0.5⁄  6x10-4 – 3.5x10-2 
Galileo number (𝑮𝒂) 𝒈𝜌𝐿
2𝑑𝑐
3 𝜇2⁄  3x107 – 6.0x1011 
Draft-tube bottom 
clearance ratio (𝑿𝒕) 
ℎ𝐵 𝑑𝑡⁄  0.04 – 0.4  
Bubble column 
separator to column 
diameter (𝑴) 
𝑑𝑠 4𝑑𝑐⁄  0.22 – 0.34 
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2.5.8 Shear rate correlations 
 
The average shear rate (?̇?) is only depend on the superficial gas velocity in the riser, 
𝑢𝑔𝑟. The expressions for shear rate in an airlift bioreactor are given equation 2.22 and 
2.23 (Yu et al., 2007), which can be used in a particular range of superficial gas 
velocities only. These correlations were based on a non-Newtonian liquid, the CMC 
(carboxy methyl cellulose) solution. 
?̇? = 5000𝑢𝑔𝑟          𝑓𝑜𝑟 0.04 ≤ 𝑢𝑔𝑟 ≤ 0.1 𝑚. 𝑠
−1   (2.22)  
?̇? = 1000𝑢𝑔𝑟          𝑓𝑜𝑟 𝑢𝑔𝑟 ≤ 0.04 𝑚. 𝑠
−1    (2.23) 
To extend the prediction of average shear rate, the following equations were proposed 
(Meng et al., 2004). 
?̇? = 2800𝑢𝑔𝑟          𝑓𝑜𝑟 𝑢𝑔𝑟 ≤ 0.08 𝑚. 𝑠
−1    (2.24) 
This correlation is widely used for many types of non-Newtonian solutions: i.e. CMC 
(carboxyl methyl cellulose), PA (polyacrylate), and PAA (polyacryl amide). 
 
2.5.9 Sparger design considerations 
 
For satisfactory gas distribution from a ring sparger, the Weber number (𝑊𝑒𝑜)—based 
on orifice diameter—should satisfy the following condition (Bhavaraju et al., 1978; 
Kilonzo et al., 2007). 
𝑊𝑒𝑜 = 𝑣𝑜
2𝑑𝑜𝜌𝑜 𝜎𝐿⁄ > 2      (2.25) 
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Where 𝑣𝑜 , 𝑑𝑜, 𝜌𝑜, and 𝜎𝐿are the gas velocity, orifice diameter, the gas density, and 
surface tension of the liquid phase, respectively. In normal cases where gas emerging 
from submerged orifices at a very low rate, bubbles periodically form at the orifice, 
reach a certain size, and then break away. For liquid media with a reasonably low 
viscosity, bubble diameter is a function of the interfacial tension and density as 
indicated in equation (2.26). This correlation is valid for slow bubbling in a constant 
volume region. The exponent would be ½ when static surface tension is used (Fair, 
1967; Kantarci et al., 2005; Kar et al., 2005). 
𝑑𝑏 = 1.82 [
𝑑𝑜𝜎𝑔𝑐
(𝜌𝐿−𝜌𝑔)𝑔
]
1 3⁄
      (2.26) 
Where db is the bubble diameter, do is the orifice diameter, 𝜎 is the interfacial surface 
tension, 𝜌 is the density of each phase, g is the gravitational acceleration, and gc is the 
conversion factor: 32.174 lbm-ft per lbf-sec
2.  
The geometry and size of an airlift bioreactor influence its hydrodynamics and mass 
transfer performances (Merchuk et al., 1994; Gavrilescu and Tudose, 1998a; 
Gavrilescu and Tudose, 1998c; Gavrilescu and Tudose, 1998b; Gouveia et al., 2003; 
Blazej et al., 2004a; Yazdian et al., 2009; Luo and Al-Dahhan, 2012). It was reported 
that an increase in aspect ratio of height to diameter (H/Dc) reduced the mixing time 
(Dahman and Margaritis, 2008). A greater than 1 cross-sectional area ratio of the 
downcomer to the riser (AD/AR ranging from 1.2 – 2.0) should be used to accomplish 
a distribution of solid phase in a three-phase airlift bioreactor (Klein et al., 2003). It 
was found that the higher of the ratio of draft tube diameter to the column diameter 
(Dt/Dc), the higher liquid circulation area. As a result, the dead zone inside an airlift 
bioreactor can be minimised (Vesvikar and Al-Dahhan, 2005). 
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Table 2.6 Airlift bioreactor design parameters. The configuration of an airlift 
bioreactor is shown in Figure 5.8 (Chapter 5).  
Variables Values References 
Aspect ratio (H/Dc) 10 
10 
(Najafpour, 2007) 
(Kilonzo et al., 2007) 
Ratio of draft tube to column diameter 
(Dt/Dc) 
0.7 (Vesvikar and Al-Dahhan, 
2005) 
Ratio of downcomer to riser area 
(AD/AR) 
0.63 (Gouveia et al., 2003) 
Disengagement ratio (DR) 0.566 (Kar et al., 2005) 
Draft-tube bottom clearance ratio 
(HB/Dt) 
0.25 (Kar et al., 2005) 
Draft-tube top clearance ratio (HS/Dt) 1.25 (Kar et al., 2005) 
   
 
The bottom clearance (HB) was found to affect the downcomer gas holdup (d) while 
the top clearance (HS) had no influence on the downcomer gas holdup. The d 
increased with an increase in HB (Kilonzo et al., 2007).  
 
2.6 Computational fluid dynamics modelling of multiphase bioreactors 
 
Multiphase system represents a system that has more than one fluid, e. g. gas bubbles 
in a sparge bioreactor, oil-gas-water in an oil pipe line or rig, the slurry flow of solid 
particles in water, and encapsulated cells in hydrogels. In a bioreactor, the culture 
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medium may contain both liquid and gas phases; the latter can be oxygen or air 
bubbles, introduced to a bioreactor. When hydrogels are used for encapsulated cells 
inside a bioreactor, the hydrogels are usually considered as a solid phase. 
In stem cell bioprocessing, gas-liquid bioreactors are normally operated in the bubbly 
flow regime, a homogeneous flow regime (Krishna et al., 1999; Ratcliffe et al., 2012). 
Moreover, the assumption of uniform distribution of bubble size was valid at low 
superficial gas velocity for CFD simulation of gas-liquid bubble column system 
(Kumar et al., 1995). The simplest bubble-driven flow is a gas-liquid system, where 
liquid is the continuous phase and gas is the dispersed phase. The flow is normally 
driven by buoyancy. Moreover, the gas holdup is considerably low compared to the 
continuous phase. 
In the past, sparged bioreactors (such as airlift bioreactor) were designed based on 
empirical or semi-empirical correlations (Chisti, 1998; Petersen and Margaritis, 2001) 
which relate the operating parameter (superficial gas velocity) to the liquid circulation 
velocity, gas holdup, mass transfer coefficients, etc. Although a number of models, 
were developed to explain the phenomena inside an airlift bioreactor, based on bulk 
energy balance and momentum balance equations (Merchuk et al., 1994; Daley, 
2012), they were one or two-dimensional models and required gas holdup correlations 
and empirical coefficients of the hydraulic friction to estimate the liquid circulation 
velocity. 
Recently, there were attempts (Glover et al., 2000; van Baten et al., 2003b; Huang et 
al., 2007; Jia et al., 2009; Luo et al., 2011) to use CFD (Computational Fluid 
Dynamics) to model and study the local characteristics, gas holdup; liquid velocity; 
and shear rate distribution, of both bubble column and airlift bioreactors. CFD became 
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popular because it can be used as a design tool to test the effect of geometric changes 
on the performance of the system, and to provide information at both local and global 
levels. 
In this thesis, the commercial CFD software, CFX 11, was used to simulate the 
hydrodynamics and mass transfer process inside the airlift bioreactors. CFX employs 
the finite volume discretisation method. Discretisation is a class of numerical methods 
for approximation of differential equations by using a system of algebraic equations at 
different discrete locations in space and time. The domain is discretised into small 
grids (meshes) and the discrete equations give information at each grid. There are 
three different discretisation techniques: finite difference (FD), finite volume (FV), 
and finite element (FE) method. 
The first technique, finite difference method, is based upon the use of so-called 
“Taylor series” to build a library or toolkit of equations that describe the derivatives of 
a variable as the differences between values of the variable at various points in space 
or time. In the second method, the finite element method, the domain over which the 
partial differential equation applied is split into a finite number of sub-domains and 
known as elements. On each element a simple variation of the dependent variables is 
assumed and this piecewise description is used to build up a picture of how the 
variables vary over the whole domain. Lastly, the finite volume method, is similar in 
some ways to the finite difference method, but some implementations of it also draw 
on features taken from the finite element method. The finite volume method was 
developed specially to solve the equations of heat transfer and fluid flow. The 
governing partial differential equations are converted into numerical form by a 
physically based transformation of the equations (Shaw, 1992) 
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CFD simulations of multiphase flow are based on two approaches: Eulerian–
Lagragian and Eulerian–Eulerian approach. In Eulerian–Lagrangian approach, 
Navier–Stokes equations are solved only for the continuous phase because it is 
assumed that the dispersed phase consisting of particles transports along with the 
continuous phase. In Eulerian–Eulerian or multi–fluid approach, Navier–Stokes 
equations are solved for the dispersed and continuous phase separately as these phases 
are assumed to be interpenetrating continua. For problems with a high solid holdup, 
the Eulerian–Lagrangian approach may require longer computational time because of 
the tracking process of particles (Michele and Hempel, 2002).  
CFD simulation studies that use Eulerian–Eulerian approach are found in the 
literature, for two-and three-phase bubble columns (Michele and Hempel, 2002), 
three-phase bubble column (Anil et al., 2007), comparison between airlift and bubble 
reactors (van Baten et al., 2003a), airlift reactors (van Baten et al., 2003a), three-phase 
airlift loop reactor (Jia et al., 2007), rotating wall vessel (Kwon et al., 2008), Phenol 
degradation in an internal loop airlift bioreactor (Feng et al., 2007), and simulation of 
gas distributor in bubble column reactors (Bahadori and Rahimi, 2007). 
A summary of relevant CFD studies found in the literature is shown in Table 2.7. 
Most of the columns are large systems, with greater than 100 mL working volume. 
Other numerical models of airlift bioreactors are summarised in Table 2.8, where the 
most promising model is tank-in-series model which considers different parts of an 
airlift bioreactor as a series of tanks and uses the principle of material balance in each 
tank to solve the problem. The 1-Dimentional (1D) model such as tank-in-series 
considers the flow in the airlift bioreactor through a series of equal sized, well-mixed 
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stirred tanks and the mixing characteristics of the riser, downcomer, gas-liquid 
separator, and the base sections are different (Znad et al., 2004) 
 
Table 2.7 Summary of CFD studies of airlift reactors. 
Application Reactor dimension References 
Gas–liquid–solid system, 0.14 x 0.14 x 0.45 m3, 
Rectangular column 
(Jia et al., 2007) 
Gas–liquid system, 1.818 m of liquid height, 0.147 
m column internal diameter,  
32-L concentric draft- tube 
airlift reactor 
(Blazej et al., 2004b) 
Gas–liquid–solid system, 3 m length, 0.30 m internal 
diameter, conical-bottom 
cylindrical column 
(Padial et al., 2000) 
Air–water system, 
 
i) inner diameter 0.15 m, length 
2 m 
ii) inner diameter 0.174 m, 
length 2 m 
(van Baten et al., 
2003a) 
Air-water system, 
microalgae culture 
2 and 40 L (Xu et al., 2012) 
 
A set of first-order differential equations for material balance of micro-organism, 
substrate, product, and dissolve oxygen was solved simultaneously (Vafajoo et al., 
2011). Although, the calculation of 1D model is faster than the 2D and 3D models, 1D 
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models are more suitable for situations where the airlift bioreactor is well designed 
and the main purpose is to maximise the production of the desired products. For the 
design stage of an airlift bioreactor, the 2D and 3D models would be needed because 
small changes in the bioreactor’s geometry can affect its performances. 
 
Table 2.8 Other numerical models of airlift bioreactors based on tank-in-series 
models. 
Application Reactor dimension References 
Water–air system, 
Fermentation of gluconic acid 
by the strain Aspergillus niger 
12, 40, and 200 dm3 
volume columns 
 
(Sikula et al., 2007) 
Production of gluconic acid by 
fermentation 
10.5 dm3 volume column (Znad et al., 2004) 
Wastewater treatment 0.08 m3 volume column (Meng et al., 2004) 
 
2.7 Summary 
 
There is a need to develop a platform for culturing and differentiating stem cells into 
type II pneumocytes for use in cell-based therapies and lung tissue engineering. Issues 
related to differentiation protocols, cell sources and bioreactors are still challenging 
burdens in lung tissue engineering. In this thesis, embryonic stem cells were used due 
to their high potential to differentiate into pneumocyte cells. The use of an airlift 
bioreactor would not only produce a high number of cells but also mimic the lung in 
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vivo environment. Moreover, CFD can be used to design and fine-tune the bioreactor 
operating conditions and geometries prior to running biological experiments. 
  
 
 
 
 
 
 
3 METHODOLOGY 
 
This chapter provides details of general materials and methods of techniques used to 
accomplish experimental works for this thesis. The computational fluid dynamics 
(CFD) models used in this thesis will be described in chapter four.  
 
3.1 Cell Culture 
 
The cell culture works were performed in a temperature and gas-controlled incubator 
(Galaxy R CO2 incubator (Model No. 170-300), New Brunswick Scientific (UK) 
Ltd.). The temperature was controlled at 37 oC. The gas composition was controlled 
using air, CO2, and N2. Generally, as shown in Figure 3.1, the CO2 level was adjusted 
at 5% (by volume) and the O2 level was at 20% (normoxia). 
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N2CO2
Incubator
Vent
Gas regulator
Filter
 
Figure 3.1 Schematic diagram of cell culture and gas flow system. CO2 supply 
with/without N2 was used to adjust the gas composition inside an incubator for cell 
culture. The gases were regulated by the gas regulators. All gases used in the system 
were passed through filters to ensure the sterilisation inside the cell culture system. 
 
3.1.1 Murine Embryonic Stem Cell (mESC) Culture 
 
Culture of undifferentiated mESCs was performed on 2D (2-Dimentional) tissue flasks 
following the conventional method of expanding mESC in standard culture system. 
The undifferentiated mESC, ES-E14Tg2a (ATCC (American Type Culture 
Collection) – LGC (Laboratory of the Government Chemist) Standards Partnership, 
UK), was cultured in maintenance medium which contained Dulbecco’s Modified 
Eagle’s Medium (DMEM) (Gibco, Invitrogen) high glucose/no pyruvate 
supplemented with 10% (v/v) fetal bovine serum (FBS; Invitrogen), 1% (v/v) of 10 
µg/mL Penicillin-Streptomycin (Invetrogen), 1% (v/v) of 2 mM L-glutamine 
(Invetrogen), 0.1 mM B-mercaptoethanol (all supplied by Gibco, Invitrogen UK) and 
1000 U/ml ESGRO (LIF, Leukaemia Inhibitory Factor) (Chemicon, Millipore 
Upstate, UK). The expansion of the 2D cell culture was performed in T-75 flasks 
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(Nunc) and the seeding density was 40,000 – 80,000 cells per cm2. The cells were 
passaged every two or three days when they reached 70 – 80 % confluence. The 
passage number was kept under 20 (< p. 20). For the cell storage, the monolayer 
mESCs were detached from the flasks by 0.05% trypsin-EDTA for 4-5 minutes 
followed by deactivation of trypsin with the FBS-containing medium. The cell 
suspension was centrifuged at, 1000 rpm (220 g) for 5 minute, followed by 
resuspension of the cell pellet in cell freezing medium (5% DMSO in 95% FBS 
solution). An amount of 1 mL of suspension cells containing 5 – 8 x106 cells per mL 
was put in a 1.5 cryopreserved vials. For the freezing process, the cryopreserved vial 
was initially placed in a Scientific Nalgene Mr Frosty freezing container (Fisher), and 
stored in a -80 oC freezer overnight. A purpose of this step is to control the reduction 
of temperature at the rate -1 oC/minute inside the freezing container to avoid any cold-
shock for the cells. The process continued by transferring all the vials to the liquid 
nitrogen tank at the temperature of -196 oC for long-term storage. 
 
3.1.2 A549 cell line culture 
 
Conditioned medium from A549 culture was used for triggering mESC differentiation 
into alveolar type II cells.  
Cells of the human type II pneumocyte adenocarcinoma line (A549, ATCC:American 
Type Culture Collection, Virginia, USA) were defrosted and grown on the T-175 
flasks (Nunc, UK) in F12 Kaighn’s Nutrient supplemented with 10% (v/v) fetal 
bovine serum (FBS; Invetrogen, UK), 1% (v/v) of 10 µg/mL Penicillin-Streptomycin 
(Invetrogen) and 1% (v/v) 2mM L-glutamine(Invitrogen, UK)). For the cell harvest 
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and storage, the similar procedures as the mESC culture were applied except the 
detachment of the A549 cells was performed using 0.25% trypsin-EDTA for 8-10 
minutes.  
For the conditioned medium collection, an amount of 2×106 cells were batch cultured 
for 3 days. The conditioned medium was collected on day 3 followed by filtered 
through a 0.22 μm filter (Millipore Upstate, UK). The collected medium was stored at 
-80o C prior for long storage. 
 
3.1.3 3-Dimentional (3D) culture of mESCs 
 
3.1.3.1 Encapsulation technique 
The alginate hydrogel was used for mESCs encapsulation process consisting of 1.1% 
(w/v) low viscosity alginic acid from brown algae (Sigma Aldrich, UK) and 0.1% 
(v/v) bovine gelatin (Sigma Aldrich, UK). The stock solution was prepared by 
dissolving the alginic acid powder in Phosphate-Buffered Saline (PBS), pH 7.4. The 
mixture was left to stir overnight as the acid powder was difficult to dissolve. Prior to 
the encapsulation, the 0.1% (v/v) gelatin was added. 
Monolayer mESCs cultured in T-75 flasks (Nunc, UK) were detached using enzymatic 
treatment with 0.05% (w/v) trypsin-EDTA without calcium and magnesium (Gibco, 
Invitrogen UK). Cell counts were performed using trypan blue (Sigma Aldrich, UK) 
or Erythrosin B stain solution (ATCC) to get 20,000 cells per bead. The cells were 
centrifuged at 1,000 rpm (revolutions per minute) for 5 minutes, and the supernatant 
was removed. Following the process, the cell pellets were resuspended in alginate 
solution forming single cell-gel alginate mixture. 
| 62 
  
In order to get a uniform bead size, a Pharmacia peristaltic pump (Model P-1; 
Amersham Biosciences, UK) was used (Figure 3.2). Cell-gel alginate solution was 
passed through a small tubing at a flow rate of 20 rpm and at a drop height of 30 mm 
using a 25-gauge needle (Becton Dickinson, UK). The tubing was autoclaved and 
washed a few times with sterile PBS. Beads were formed into a sterile, room 
temperature solution containing 100 mM calcium chloride (CaCl2) (Sigma Aldrich, 
UK) and 10 mM (4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid) (HEPES) 
(Sigma Aldrich, UK), in double DI (deionised, the electrical resistance ≥ 18.2 M) 
water (pH 7.4). The liquid cell-alginate solution was discharged from the pump and 
formed gel-bead immediately in contact with the CaCl2 solution, forming spherical 
beads (2.3-2.5 mm in diameter after swelling). The beads were gently stirred in CaCl2 
solution for six to eight minutes at room temperature and then washed three times in 
PBS and placed into culture medium. 
 
peristaltic pump 
Cell-alginate solution
Needle station
Calcium solution
 
Figure 3.2 Schematic diagram of mESC encapsulation process. The mixture of cells 
(total of 107 cells) and 4 mL alginate (1.1% (w/v) in PBS) was passed through a 
peristaltic pump and a 25G needle, then, was dropped from 30 mm to 100 mM CaCl2. 
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3.1.3.2 Alginate bead dissolution buffer 
Ca-Alginate hydrogel beads were dissolved by sodium citrate buffer, a calcium 
clelator (Masuda et al., 2003). A sterile depolymerization buffer was used to dissolve 
the beads that consisted of Ca2+-depletion solution with 50 mM tri-sodium citrate 
dihydrate (Sigma-Aldrich), 77 mM sodium chloride (BDH Laboratory supplies, UK) 
and 10 mM HEPES (Sigma Aldrich, UK). These ingredients were dissolved in PBS. 
Collected beads were washed twice before adding the dissolving solution. Then, the 
beads were incubated at 37 oC for about five minutes while being stirred gently. The 
solution that contained dissolved beads was centrifuged at 3,000 rpm (1,990 g) for 9 
minutes and the cell pellet was washed once with PBS and was centrifuged again, at 
3,000 rpm for 9 minutes. 
 
3.1.4 Differentiated mESCs into alveolar type II pneumocytes 
 
For cost saving and the possibility to use a defined component basal medium, the 
combination of IMDM (Iscove's Modified Dulbecco's Medium)/F12-K (Ham's F-12K 
(Kaighn's) Medium) in a ratio of 3:1 was used as a basal media for the differentiation. 
The medium composition was adapted from the literature (Roszell et al., 2009). The 
F-12K was used instead of F-12. The defined media are needed for clinical 
applications because the effect of medium’s compositions can be defined. 
The differentiation medium contained an equal ratio of basal medium and conditioned 
medium. Figure 3.3 shows the differentiation timeline of the mESCs into the type II 
pneumocytes. The cells were cultured for the expansion period of 3 days in mESCs 
maintenance medium. Following the process, the medium was changed to 
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differentiation medium which contained basal medium and A549 conditioned medium 
with a ratio of 1:1. Hence, Day 3 on the timeline means Day 0 of the differentiation 
period.  
 
 
Figure 3.3 Timescale of culturing mESCs into pneumocyte type II cells. The mESCs 
were expanded in maintenance media for three day then the differentiation started at 
Day three and the differentiated cells can be analysed, e.g. every 10 days.  
 
3.2 Imaging 
 
3.2.1 Light microscopy 
 
Phase contrast microscopes, Leica DMIL inverted microscopes (Leica, Germany), 
were used for routine cell growth observation, counting cells or capturing the phase 
contrast image. The cell growth and cell viability were performed using the 
haemacytometer by the dye exclusion method. The cells were stained using Erythrosin 
B stain solution (ATCC). On haemacytometer surface, there are nine (1 mm x 1 mm) 
grids and the depth of the haemacytometer is 0.1 mm, the average of cells per grid was 
determined by the average of number of cells of the four corner’s grids and the middle 
grid. The total cell number per millilitre was calculated by multiplying the average cell 
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number per grid (n) with dilution factor (d) and conversion factor 104 (1000 mm3 = 1 
cm3 = 1 mL). 
Cell per mL = 𝑛 ∙ 𝑑 ∙ 104       (3.1) 
For the standardisation, the cells which were on the line of the right and the bottom of 
the grid were excluded from the cell counting.  
The cell structures, the alginate bead morphologies, and cell clusters were examined 
and captured by phase contrast Leica DMIL inverted microscopes (Leica, Germany) 
equipped with colour Olympus DP50 (Olympus) or black and white, F-view camera 
(Soft Imaging System GmbH, Munster, Germany). The camera unit was connected to 
the computer (Intel  Xeon  CPU 2.27 GHz, 1.00 GB RAM, Windows XP) with 
analySISD software (Soft Imaging System).   
 
3.2.2 Fluorescence imaging 
 
Fluorescence images were captured from an inverted Olympus BX51 microscope 
(Olympus, Essex, UK) equipped black and white, high resolution charge coupled 
device (CCD) Camera (Soft Imaging Systems GmbH, Germany) with analySISD 
software which was installed on desktop computer (Intel  Xeon  CPU 2.27 GHz, 
1.00 GB RAM, Windows XP). Fluorescence imaging was used to determine live/dead 
analysis or cell staining. 
For live/dead analysis, cells inside hydrogel were evaluated using LIVE/DEAD 
Viability/Cytotoxicity Kit for mammalian cells (Invitrogen). According to the 
manufacturer suggestion, the 3D cells encapsulated in hydrogels were collected and 
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washed twice with PBS. The samples were incubated at 37 oC with 200 mL of 4 mM 
EthD-1 and 2 mM calcein AM solution for 30 minutes. Following the process, the 
samples were washed several times with PBS and visually evaluated with the 
Olympus BX51 microscope for the fluorescence expression. The live cells were 
detected at different wavelengths. FITC (fluorescein isothiocyanate) and GFP (green 
fluorescent protein); TRITC (tetramethyl rhodamine isothiocyanate) and Texas Red; 
and nuclear counterstain with DAPI (4'-6- Diamidino-2-phenylindole) were viewed at 
an excitation wavelength of 490 nm, 570 nm, and 360 nm, respectively. 
 
3.3 Reverse Transcriptase-PCR 
 
3.3.1 Ribonucleic acid (RNA) extraction 
 
RNA was extracted from cultured cells using the total RNA isolation kit (Qiagen Ltd., 
UK) according to the manufacturer’s protocol. Briefly, attached cells were trypsinised 
and spun down to get a cell pellet. The pellet was then dissolved in 350 to 600 μl, 
depending on the cell number, lysis buffer which contained 10 μl/ml -
mercaptoethanol. Cell lysates were resuspended gently a few times until there was no 
visible sign of cell clumps and transferred to the QIAshredder tube (Qiagen LtD., UK) 
to homogenise the cell lysate. The tube was centrifuged at maximum speed for two 
minutes. To purify the RNA, equal volumes of ethanol were added to sample 
solutions, gently mixed and then transferred into the RNeasy mini spin column 
(Qiagen Ltd, UK), after that, centrifugation at 15,000 rpm for 15 seconds. 700 μl of 
RW1 buffer was added to the column and centrifuged at maximum speed (15,000 rpm, 
22,000 g) for 15 seconds. 500 μl RPE solution was added to a new two-ml tube and 
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centrifuged again at 15000 rpm for two minutes. Lastly, the column was transferred to 
a new tube and 30 μl of RNAse-free water added in the middle of the membrane 
carefully and centrifuged at maximum speed for 60 seconds. Finally, the extracted 
RNA was diluted 20 times and the concentration and purity (at 260/280 nm) of RNA 
extracted was measured using an UV spectrophotometer (Eppedndorf BioPhotometer, 
Germany). Samples were stored at -80o C prior to long storage for further use. 
 
3.3.2 Polymerase chain reaction (PCR) amplification 
 
1μg total RNA in a final volume of 20μl was reverse-transcribed into cDNA using the 
Thermoscript reverse transcription-polymerase chain reaction (RT-PCR) system 
(Promega, UK). Oligo (dt) 20 was used to prime RT reactions, which enabled the 
same cDNA to be PCR-amplified with different sites of genespecific primers. 
Denaturing of the RNA template and primer was done by incubation at 65 oC for five 
minutes and later placed on ice while adding the master mix to the reaction. The 
master mix contains the following; 4 μl of 5X cDNA synthesis buffer (250mM Tris 
acetate pH 8.4, 375 mM potassium acetate, 40 mM magnesium acetate, stabilizer), 1 
μl of 0.1 M dithiothreitol (DTT) (a reducing agent for the RTase), 40 U RNase Out (an 
RNase inhibitor), 1 μl RNase free water, 2 μl of 10mMdNTP mix and 15U/ μl 
ThermoScript RT. The reaction mixtures were transferred into a thermal cycler (G-
storm) and incubated at 50oC for 30 minutes followed by 85oC for five minutes. 
Negative controls were performed in the absence of cDNA template. The positive 
control was total whole lung RNA (Clontech). cDNA samples were stored at -20 oC 
prior to use.  
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3.4 Live/Dead assay 
 
In situ live and dead cells can be visualised using LIVE/DEAD® 
Viability/Cytotoxicity Assay Kit (Molecular Probes, Invitrogen ,UK). Live cells are 
distinguished by the presence of ubiquitous intracellular esterase activity, determined 
by the enzymatic conversion of the virtually non-fluorescent, cell-permeant calcein 
AM to the intensely fluorescent calcein. The polyanionic dye calcein is well retained 
within live cells, producing an intense uniform green fluorescence (EX/EM ~495 
nm/~515 nm). EthD-1 enters cells with damaged membranes and undergoes a 40-fold 
enhancement of fluorescence upon binding to nucleic acids, thereby producing a 
bright red fluorescence in dead cells (EX/EM ~495 nm/~635 nm). A 4 mM EthD-1 
and 2 mM calcein AM solution (Molecular Probes, Invitrogen, UK) diluted in PBS 
was added to live cells or alginate beads and incubated at room temperature for 30 
minutes, in the dark. After incubation, the solution was aspirated and a small amount 
of PBS was added to the cells to prevent dehydration. The cells and beads were then 
photographed within 30 minutes using an inverted IX70 (Olympus, Southall, UK) 
fluorescent microscope to visualise the proportion of live and dead cells. 
 
3.5 MTS assay 
 
CellTiter 96® AQueous Non-Radioactive Cell Proliferation Assay (Promega, UK) was 
use to assessed the mESC viability and proliferation by fluorescent method. According 
to the manufacturer protocol, the alginate beads containing mESCs were harvested and 
washed with PBS. The MTS solution was diluted (five times) with the maintenance 
medium. The analysis was conducted in 24-well plates, by putting the alginate bead 
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and the diluted MTS solution. The 24-well plate was incubated in 37 oC incubator for 
three hours before the 100 μL of the product solution was transferred to the 96-well 
plate for the fluorescent measurement. 
 
 
MTS Formazan 
 
Figure 3.4 Chemical structures of MTS and formazan salt. The MTS tetrazolium 
compound is reduced by cells into a coloured formazan product. 
 
The formazan is formed by dehydrogenase enzymes which found in metabolically 
active cells. The quantity of the formazan product was measured by the absorbance at 
490 nm which was directly proportional to the viable cells. MTS is the short name for 
3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-
tetrazolium, inner salt. The absorbance was measured by the ELx 808 microplate 
reader (Bio-TEK Instruments, USA). 
A standard curve was generated using the amount of total metabolic activity produced 
from the same cultured cells proportional to the number of viable cells. For the final 
data analysis, the fluorescence values were normalised to a standard value of 
metabolic activity determined by the MTS assay. 
 
 
| 70 
  
3.6 Nutrient and metabolite analysis 
 
The media or supernatants were collected in the 1.5 mL in Eppedndorf tubes for the 
nutrient and metabolite analysis.  The Nova Bioprofiler 400 (Nova Biomedical, U.K.) 
was used to analyse the medium samples. There are eight measured parameters , as it 
is shown in Table 3.1, which can classified in the categories as (1) 
nutrients/metabolites: glutamine, glutamate, glucose, lactate, and ammonium; (2)  
acid/base status: pH, PO2, and PCO2; (3) Electrolytes: Sodium and Potassium. 
Moreover, the machine can calculate parameter such as osmolality, air saturation, 
CO2, saturation, and HCO3. 
There are two measuring technologies in the Bioprofiler machine: electrochemical 
(biosensors) and amperometric electrodes. 
 Electrochemical (biosensors); Potentiometric Electrodes (pH, PCO2, NH4+, 
Na+, K+, Acetate) 
Potentiometric-based electrodes measure charged ions and have a sensing membrane 
that is selective to the ion being measured. They develop a voltage proportional to the 
concentration of the measured ion. 
 Amperometric Electrodes (PO2, Glucose, Lactate, Glutamine, Glutamate) 
The basic amperometric electrode is the oxygen electrode, which consists of an 
oxygen-permeable membrane covering a platinum cathode. 
Glucose, lactate, glutamine, and glutamate biosensors are amperometric electrodes 
that have immobilised enzymes in their membranes. They develop a current 
proportional to the substrate being measured. 
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 Table 3.1 The measured parameters from the Nova Bioprofile 400. 
Parameter Test methodology Measuring range Imprecision 
resolution 
Glutamine Enzyme/Amperometric 0.2 – 6.0 mmol/L 5.0% 
Glutamate Enzyme/Amperometric 0.2 – 6.0 mmol/L 5.0% 
Glucose Enzyme/Amperometric 0.2 – 15.0 g/L 5.0% 
Lactate Enzyme/Amperometric 0.2 – 5.0 g/L 5.0% 
Ammonium Ion Selective Electrode 0.2 – 25.0 mmol/L 5.0% 
pH Ion Selective Electrode 5.00 – 8.00 pH 
units 
±0.01% 
PO2 Membrane 
Amperometric 
0 – 800 mmHg 5.0% 
PCO2 Membrane 
Potentiometric 
3 – 200 mmHg 5.0% 
Na+ Ion Selective Electrode 40 – 220 mmol/L 1.5% 
K+ Ion Selective Electrode 1.0 – 25.0 mmol/L 3.0% 
 
3.7 Statistical analysis 
 
SigmaStat (Systat Software UK Ltd, UK, version 3.5) was used for calculation of 95% 
confidence intervals (p < 0.05) among experimental results by using two-way 
ANOVA (analysis of variance). Scale bars, which were shown, were represented ± SD 
(standard derivation).  
  
 
 
 
 
 
 
4 THEORETICAL AND COMPUTATIONAL MODELS 
 
This chapter summarises theoretical and computational fluid dynamic models for 
multiphase flows of sparged bioreactors such as airlift bioreactors and bubble 
columns. The models for, multiphase flow and mass transfer, are applied in the design 
and analysis of airlift bioreactors presented in chapters 5 and 6. 
 
4.1 Multiphase flow  
 
A multiphase flow refers to a system that contains at least two fluids, e.g. gas-liquid, 
liquid-liquid, gas-solid, liquid-solid, and gas-liquid-solid systems. In a multiphase 
system, a summation of phase holdup (phase fraction) is equal to unity, i.e. 
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∑ 𝜀𝑖 = 1
𝑛
𝑖=1
 (4.1) 
 
where 𝜀𝑖 is a holdup of phase i. A system can be either two-phase (e.g. gas and liquid) 
or three-phase (e.g. gas, liquid, and solid). 
Typical, gas-liquid two-phase flow regimes in a vertical pipe are illustrated in Figure 
4.1. At low gas velocities, the flow is in the bubbly flow regime which is commonly 
found in biological systems (Koynov et al., 2006). In bubbly flow, the gas is dispersed 
as small bubbles in a continuous phase which is liquid. As gas velocities increase, 
small bubbles start to coalesce and form gas slugs (Figure 4.1 (b)). Further increase in 
gas velocities would result in annular flow which is characterised by a fast moving gas 
core, surrounded by a thin liquid film along the wall. At very high gas holdup is 
observed in mist flow where velocity of the continuous gas flow is very high, and the 
liquid phase forms droplets which are dispersed in the gas phase. 
 
Figure 4.1 A schematic diagram of two-phase flow regimes in a vertical pipe at 
increasing superficial gas velocity (Wilkes, 2006). (a) bubbly, (b) slug, (c) annular, 
and (d) mist flow. The gas is shown in white and liquid is green.  
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4.2 Hydrodynamic equations 
 
The Eulerian model implemented in ANSYS CFX v. 11 was chosen to simulate the 
gas-liquid flow inside the airlift bioreactor. ANSYS CFX is a finite volume method-
based general purpose CFD code which has been widely used for a variety of 
applications. The fundamental governing equations are described below. 
The continuity equations: 
𝜕(𝜀𝑖𝜌𝑖)
𝜕𝑡
+ ∇ ∙ (𝜀𝑖𝜌𝑖𝒖𝑖) = 0 (4.2) 
 
The momentum equations: 
𝜕(𝜀𝑖𝜌𝑖𝒖𝑖)
𝜕𝑡
+ ∇ ∙ (𝜀𝑖(𝜌𝑖𝒖𝑖 ⊗ 𝒖𝑖))
= −𝜀𝑖∇𝑝 + ∇(𝜇𝑖𝜀𝑖(∇𝒖𝑖 + (𝒖𝑖)
𝑇)) + 𝑀𝑖𝑙 + 𝜀𝑖𝜌𝑖𝒈 
(4.3) 
 
Where 𝒖, 𝜇, and 𝜌 are the velocity vector, viscosity, and macroscopic density of phase 
i, respectively, p is pressure, 𝑀𝑖𝑙 is the interphase momentum exchange between 
phases i and liquid phase, and 𝒈 is the gravitational force. Usually, the density of the 
culture medium is approximately 103 kg m−3, which is similar to that of water; and the 
viscosity is in the range of (0.5–2.0)10−3 Pa .s (Yu et al., 2007). 
 
4.3 Interphase momentum transfer models 
 
Interphase momentum transfer, 𝑴𝛼𝛽, occurs due to interfacial forces acting on each 
phase 𝛼, as a result of interaction with another phase 𝛽. The total force on phase 𝛼 due 
to interaction with other phases is denoted as: 
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𝑴𝛼 = ∑ 𝑴𝛼𝛽
𝛽≠𝛼
 (4.4) 
 
The interfacial forces between two phases are of the same magnitude but opposite 
direction, so the net interfacial forces sum to zero: 
𝑴𝛼𝛽 = −𝑴𝛽𝛼 ⇒ ∑ 𝑴𝛼
𝛼
= 0 (4.5) 
 
The total interfacial force acting between two phases may arise from several 
independent effects, such as interphase drag, 𝑀𝛼𝛽
𝐷 , lift force, 𝑀𝛼𝛽
𝐿 , and virtual mass 
force, 𝑀𝛼𝛽
𝑉𝑀. 
A drag is a resistance force which slows the motion of a body moving through a fluid. 
While the drag forces act along the direction of the fluid flow, the lift force is 
perpendicular to the fluid flow. The lift force acts on a particle due to velocity 
gradients in the continuous phase. The lift force acting on a dispersed phase g in a 
continuous phase l is defined as:  
𝑀𝑙𝑔
𝐿 = 𝐶𝐿𝜌𝑙𝜀𝑔(𝒖𝑔 − 𝒖𝑙) × (∇ × 𝒖𝑙) (4.6) 
 
 
where 𝐶𝐿 is a non-dimensional lift coefficient and ∇ × 𝒖𝑙 is curl (𝒖𝑙). The virtual mass 
or added force is an inertia added to a system because of acceleration or deceleration 
forcing a body to move some volume of surrounding fluid as it moves through, and 
because the object as well as fluid cannot occupy the same physical space 
simultaneously. For simplicity this can be modelled as some volume of fluid moving 
with the object. However, the virtual mass force was not included in this study. 
The momentum exchange between the gas and liquid phase is given by: 
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𝑀𝑙,𝑔 = −𝑀𝑔,𝑙 = [
3
4
𝐶𝐷
𝑑𝑔
𝜌𝑙] 𝜀𝑔(𝒖𝑔 − 𝒖𝑙)|𝒖𝑔 − 𝒖𝑙| (4.7) 
 
where 𝐶𝐷 is the drag coefficient and 𝑑 is the diameter. The interphase drag coefficient 
(𝐶𝐷) for sparsely distributed fluid particles was calculated either from Isshii-Zuber 
drag model (equation 4.8 and 4.9) or Grace drag model. 
According to Issii-Zuber drag model, the drag coefficient is approximately constant, 
independent of Reynolds number, but dependent on particle shape through the 
dimensionless group known as Eötvös number which measures the ratio of 
gravitational and surface tension forces. 
𝐶𝐷 =  
2
3
√𝐸?̈? (4.8) 
 
Where the Eötvös number was defined as: 
𝐸ö =  
𝒈(𝜌𝐿 − 𝜌𝑔)𝑑𝑏
2
𝜎
 (4.9) 
 
where 𝑑𝑏 is the equivalent diameter of the bubbles and 𝑑𝑏 is 1 mm in the simulations 
presented in this study. 
The Grace drag model is formulated for flow past a single bubble. The drag 
coefficient in the distorted particle is given by: 
𝐶𝐷(ellipse) =  
4
3
𝒈𝑑
𝑈𝑇
2
(𝜌𝑙 − 𝜌𝑔)
𝜌𝑐
 (4.10) 
 
where the terminal velocity 𝑈𝑇 is given by: 
𝑈𝑇 =
𝜇𝑐
𝜌𝑐𝑑𝑝
𝑀−0.149(𝐽 − 0.857) (4.11) 
 
Morton number is defined as: 
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𝑀 =
𝜇4𝒈(𝜌𝑙 − 𝜌𝑔)
𝜌2𝜎3
 (4.12) 
and: 
𝐽 = {0.94𝐻
0.757         2 < 𝐻 ≤ 59.3
3.42𝐻0.441                𝐻 > 59.3
 (4.13) 
 
𝐻 =
4
3
𝐸𝑜𝑀−0.149 (
𝜇𝑐
𝜇𝑟𝑒𝑓
)
−0.14
 (4.14) 
 
𝜇𝑟𝑒𝑓 = 0.0009 kg ∙ m
−1 ∙ s−1 is the molecular viscosity of water at 25 oC and 1 bar. In 
Ansys-CFX, spherical particle shapes and spherical cap are automatically taken into 
account. 
For sparsely distributed solid particles, at low particle Reynolds numbers, the drag 
coefficient for flow past spherical particles may be computed analytically. The result 
is Stokes’ law, which may be written as: 
𝐹𝐷 =  3𝜋𝑢0𝐷𝑝 (4.15) 
 
where 𝐹𝐷is the force related to drag.  
The equation for the terminal velocity of a sphere at low Reynolds number is also 
given by Stokes’ law: 
𝑢𝑡 =  
𝒈𝐷𝑝
2(𝜌𝑝 − 𝜌 )
18𝜇
 (4.16) 
 
In theory, Stokes’ law is valid only when Reynolds number of the solid particle is 
considerably less than unity.  
𝐶𝐷 =  
24
𝑅𝑒
,          𝑅𝑒 ≪ 1 (4.17) 
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For particle Reynolds numbers that are sufficiently large for inertial effects to 
dominate viscous effects, the drag coefficient becomes independent of Reynolds 
number: 
𝐶𝐷 =  0.44          1000 ≤ 𝑅𝑒 ≤ 1𝑥10
5 (4.18) 
 
In the transitional region between the viscous and inertial regimes 0.1 < 𝑅𝑒 < 1 −
2 × 105 for spherical particles, both viscous and inertial effects are important. Hence, 
the drag force coefficient is a complex function of Reynolds number, which must be 
determined from experiments. Several empirical correlations are available, and the 
correlation implemented in CFX is that of Schiller and Nauman (Ansys, 2006) 
𝐶𝐷 =  
24
𝑅𝑒
(1 + 0.15𝑅𝑒0.687) (4.19) 
 
This equation has been modified in CFX as: 
𝐶𝐷 = 𝑚𝑎𝑥 (
24
𝑅𝑒
(1 + 0.15𝑅𝑒0.687),   0.44) (4.20) 
 
For densely distributed solid particles, Wen Yu drag model can be applied, which is 
described by the following equation:  
𝐶𝐷 = 𝜀𝑐
−1.65 ∙ 𝑚𝑎𝑥 (
24
𝑅𝑒
(1 + 0.15(𝑅𝑒′)0.687),   0.44) (4.21) 
     𝑅𝑒′ = 𝜀𝑐𝑅𝑒 
𝑅𝑒 =
𝜌𝑙𝑑𝑠|𝒖𝑠−𝒖𝑙|
𝜇𝑙
 
(4.22) 
This has the same function form as the Shiller Nauman correlation, with a modified 
Reynolds number, and power law correction, both depending on the continuous phase 
holdup, 𝜀𝑐. 
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4.4 Turbulence modelling in multiphase flow 
 
The conservation of mass or the continuity equation (4.2) and conservation of 
momentum equation (4.3) are exact equations for laminar flow. Most of chemical 
engineering works are related to turbulent flow.  
The eddy viscosity hypothesis is assumed to hold for each turbulent phase. Diffusion 
of momentum in phase 𝛼 is governed by effective viscosity: 
𝜇𝛼𝑒𝑓𝑓 = 𝜇𝛼 + 𝜇𝑡𝛼 (4.23) 
 
where 𝜇𝑡𝛼 is the turbulence induced viscosity. In the 𝑘 − 𝜖 model, turbulent viscosity 
is modelled as: 
𝜇𝑡𝛼 = 𝐶𝜇𝜌𝛼 (
𝑘𝛼
2
𝜀𝛼
) (4.24) 
 
where 𝐶𝜇 = 0.09. 
The transport equations for 𝑘 (the turbulence kinetic energy) and 𝜖 (the turbulence 
eddy dissipation) in a turbulent phase are assumed to take a similar form to the single 
phase transport equations: 
𝜕
𝜕𝑡
(𝜀𝛼𝜌𝛼𝑘𝛼) + ∇ ∙ (𝜀𝛼 (𝜌𝛼𝑼𝛼𝑘𝛼 − (𝜇 +
𝜇𝑡𝑎
𝜎𝑘
) ∇𝑘𝛼)) = 𝜀𝛼(𝑃𝛼 − 𝜌𝛼𝜖𝛼) (4.25) 
 
𝜕
𝜕𝑡
(𝜀𝛼𝜌𝛼𝜖𝛼) + ∇ ∙ (𝜀𝛼 (𝜌𝛼𝑼𝛼𝜖𝛼 − (𝜇 +
𝜇𝑡𝑎
𝜎𝜖
) ∇𝜖𝛼))
= 𝜀𝛼
𝜖𝛼
𝑘𝛼
(𝐶𝜖1𝑃𝛼 − 𝐶𝜖2𝜌𝛼𝜖𝛼) 
(4.26) 
 
where 𝐶𝜖1 = 1.44, 𝐶𝜖2 = 1.92, 𝜎𝑘 = 1.0, 𝜎𝜖= 1.3. 
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Although more complex turbulence models are available in Ansys-CFX, the 𝑘 − 𝜖 
model was adopted for its simplicity and robustness. 
 
4.5 Interphase mass transfer 
 
Interphase mass transfer occurs when mass is transferred from one phase into another. 
Mass transfer is represented by: 
The species transport equation: 
𝜕(𝜀𝑖𝜌𝑖)
𝜕𝑡
+ 𝛻 ∙ (𝜀𝑖𝜌𝑖𝒖𝑖) = 𝑆𝑖 + Γ𝑖 (4.27) 
 
where 𝑆𝑖 describes mass sources and Γ𝑖 is the mass flow rate per unit volume into 
phase i due to interphase mass transfer: 
Γ𝑖 = ∑ Γ𝑖𝑗
𝑁𝑝
𝑗=1
 (4.28) 
 
Γ𝑖𝑗 is the mass flow rate per unit volume from phase j to phase i which is the opposite 
direction from phase i to phase j. Summation of all interphase mass become zero. 
Γ𝑖𝑗 = −Γ𝑖𝑗 ⇒ ∑ Γ𝑖
𝑁𝑝
𝑖=1
= 0 (4.29) 
 
For mass transfer across an interface, the volumetric mass sources can be expressed in 
terms of mass fluxes: 
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Γ𝑖𝑗 = 𝑚𝑖𝑗𝐴𝑖𝑗  (4.30) 
 
where 𝑚𝑖𝑗 is the mass transfer per unit interfacial area from phase j to phase i and 𝐴𝑖𝑗 
is the interfacial area density between the phases. An interfacial area is commonly 
proportional to phase holdup. 
In biological systems where transfer between phases is important, such as the transport 
of O2 and CO2, the relationship between the dissolved gases in liquid and partial 
pressure in the gas can be established. 
Consider O2 in a two-phase system, the dynamic equilibrium between gas and liquid 
can be expressed according to Henry’s law because the solubility of the gas is 
considerably low in the liquid phase. Henry’s law is a linear relationship between the 
mole fraction of A dissolved in the liquid and the partial pressure of A in the gas phase. 
P𝐴𝑔 = 𝑯𝐶𝐴𝑙 (4.31) 
 
where 𝑯 is the Henry’s constant for component A in the liquid l. The Henry’s constant 
is known empirically for a wide range of material pairs, which can be found in most of 
chemical engineering handbooks. 
 
4.6 Computational Fluid Dynamics (CFD) 
 
The CFD software, CFX v.11.0 (Ansys), is used to simulate the flow and mass transfer 
in the airlift bioreactor employed in this study. The computations (presented in 
Chapter five) were performed on Windows XP (32 bit) PC with 2.8 GHz Intel 
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Pentium D, and 4 GB of RAM. The geometry of the airlift bioreactor is drawn by 
using Design Modeller which is part of the CFX software. The geometry is then 
discretised into smaller cells, known as computational grid or mesh. The mesh is 3D 
and contains tetrahedral cells with a finite size. The problem statement is defined in 
CFX-Pre, which followed by solving all differential equations in CFX-Solver and the 
solution can be processed and visualised by CFX-Post as shown in Figure 4.2. 
Geometry
Meshing
CFX-Pre
Solver Post-Processor
Pre-Processor
 
Figure 4.2 A schematic diagram of the process of simulation using CFX. CFX 
consists of three components: pre-processor, solver, and post-processor. In pre-
processor, the system of interest is drawn and is discretised into small cells, problems 
are set in CFX-pre. 
 
In Chapter five, in order to design airlift bioreactors using CFD, the steady state 
simulation was employed. Hydrodynamics such as gas holdups, liquid velocities, and 
shear rates were compared among three different designs of airlift bioreactor. 
However, in multiphase flow, numerical difficulties were commonly encountered 
(Bannari et al., 2012). In order to avoid these numerical difficulties, the transient 
simulations (presented in Chapter six) were calculated only the hydrodynamics until 
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convergence was obtained, followed by solving mass transfer of O2 to culture 
medium.  
 
4.6.1 Assumptions 
 
The following assumptions are made to simplify the calculation for the airlift 
bioreactor system. 
 Isothermal process 
 The flow inside the airlift bioreactor is laminar 
 The bubble size is constant: 1 mm in diameter 
 Ideal solution, Henry’s law, is used for dissolved oxygen 
 The gas sparger is modelled as a flat surface rather than its real 
configuration with, holes in a flat surface 
 The flow is axisymmetric and only a 30o segment rather than the whole 
system (360o revolution) is modelled to reduce the computational time. 
In biological systems where cell culture takes place, the temperature inside an 
incubator is controlled and kept constant. Therefore, the heat transfer effect is 
normally excluded from a simulation. The Reynolds number of flow inside an airlift 
bioreactor is usually low and well within the laminar flow regime because a culture 
medium containing serum can cause foams at high velocities. The diameter of air 
bubbles is assumed to be uniform with a fixed size. The diameter of the dispersed 
phase can be determined by either visual observation or by using a correlation. 
Henry’s law is applied to the ideal gas and the solubility of the gas in a liquid phase is 
considerably low.  
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4.6.2 Boundary conditions 
 
The continuity and momentum equations need to be solved subject to appropriate 
boundary conditions. For the airlift bioreactor modelled here, the following boundary 
conditions were specified. The gas phase is allowed to enter the bioreactor column via 
gas sparger whereas the liquid is maintained inside the bioreactor column. The inlet 
gas velocity was varied from 0.001 – 0.02 m ∙ s−1. A thin surface wall was applied at 
the draft tube of the airlift bioreactors. The outlet boundary is defined with the 
“degassing” boundary condition, which is only available for multiphase systems, with 
one fluid being continuous and another being a dispersed fluid or solid. Degassing 
boundary condition is used to model a free surface from which a dispersed phase is 
allowed to escape, but the continuous phase is not. This type of boundary condition is 
useful for modelling flow in bubble columns and can be applied to airlift bioreactors. 
At the draft tube walls as well as the column wall, a no-slip boundary condition is 
applied to the liquid phase and free slip for the gas phase. Finally, the ‘Symmetry 
planes’ were applied at the symmetry planes of the airlift bioreactors. 
The Grace drag model is used because it was recommended for modelling air/water 
system that are close to the present system. A high order differential scheme is 
employed for the advection terms and a residual target of 10-5 is set to control the 
convergence of solutions. 
 
  
 
 
 
 
 
 
5 THE DESIGN OF AIRLIFT BIOREACTORS 
 
5.1 Introduction 
 
An airlift bioreactor is a pneumatically agitating device which consists of the following 
sections: (1) the riser, where the gas is fed into the column via a gas sparger and the liquid is 
forced to flow upward, (2) the gas escapes from the column in the gas-liquid separator 
section; (3) whereas the liquid recirculates back to the bottom of the column via the 
downcomer. Airlift bioreactors have been widely used in many fields including chemical and 
biochemical applications (Chisti and Jauregui-Haza, 2002). Some examples of the use of 
airlift bioreactors are: (i) large-scale immobilisation of Penicillium chrysogenum (Keshavarz 
et al., 1990), (ii) fermentation of gluconic acid by fermentation (Znad et al., 2004; Sikula et 
al., 2007), (iii) the production of xylitol (Perez-Bibbins et al., 2014), (iv) waste water 
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treatment (Meng et al., 2004), and (v) biodiesel production from microalgae (Csavina et al., 
2011). In mammalian cell culture, there was an attempt to use sparged vessel, a type of airlift 
packed bed bioreactor, for culturing murine bone marrow cells (Highfill et al., 1996). 
An Airlift bioreactor does not need any mechanical stirrer to circulate a fluid inside the 
bioreactor, which make it easy to be sterilised for a contamination-free system. Oxygen 
transfer from gas phase to the liquid phase in the system is usually highly efficient. 
Moreover, the airlift bioreactor is not difficult to build, and its power consumption is lower 
than conventional stirred tank bioreactor (Martin and Vermette, 2005; Garcia-Ochoa and 
Gomez, 2009; Posten, 2009). In addition, the airlift bioreactor provides low shear stress 
environment, making it ideal for mammalian cell culture especially for embryonic stem cells, 
ESCs. The use of bioreactor could provide a 3D environment system which can mimic in vivo 
situation, and make it possible to scale-up the production of desired cells.  
In the airlift bioreactors, there are complex interactions among the various parameters. For 
example, gas holdup (gas volume fraction) may affect the mass and heat transfer as well as 
the liquid velocity. Another example is the cell viability depends on the shear stress during 
culture process. Figure 2.9 (Chapter two) would be used as a guide on how to design and 
consider the operating parameters in order to maximise the performance of the airlift 
bioreactors.  
Up to date, even though sparged-type bioreactors, such as airlift bioreactors, have been used 
for more than a decade, there are few applications in literatures which are related to tissue 
engineering and regenerative medicine. In other applications, the airlift bioreactor is 
considerably large (ca. more than 5 litre working volume). Due to the complexity of the 
parameters inside the airlift bioreactor, the performance of related parameters (such as phase 
holdup, liquid velocity, and mass transfer coefficient, etc.) depend on the size and 
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configuration of the bioreactor (Siegel and Merchuk, 1991; Merchuk et al., 1994; Gavrilescu 
and Tudose, 1998). Hence, correlations of parameters inside the airlift bioreactor obtained 
from experiments on other applications cannot be applied if the size and the configuration are 
different (Blazej et al., 2004a). Therefore, by using model-based design i.e. CFD would be a 
promising approach because it can account for the size and configuration effects, save the 
cost of experiment, and optimise the design before the bioreactor is built. Hence, the goal of 
this chapter is to design the airlift bioreactors for the stem cell bioprocessing application. The 
scale of the bioreactor in the stem cell application is considerably small compared to other 
biochemical usage such as waste water treatments and pharmaceutical industry.  
The objectives of the work presented in this chapter were (1) to simulate the in-house airlift 
bioreactor and (2) to design airlift bioreactors for differentiation of ESCs into pneumocytes 
type II by means of CFD. Three different airlift bioreactor designs were considered and 
simulated. The hydrodynamic result (gas holdup) was also validated from experimental data. 
 
5.2 Methodology 
 
5.2.1 Experimental setup 
 
A gas holdup experiment was performed on an in-house 100 mL internal loop airlift 
bioreactor, AL1 (Ismail, 2009). The dimension of this bioreactor is summarised in Table 5.3. 
The airlift bioreactor (AL1) was filled with deionised water. The gas phase, air, was 
introduced through a gas sparger. The superficial gas velocity was varied from 0.0016 – 
0.008 m ∙ s−1 (based on the gas sparger area, the gas volumetric flow rate were 20 – 100 mL ∙
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s−1, respectively). The conductivity probe (Oakton Conductivity Meter, CON 11 Series, 
Cole-Parmer Instrument Co. Ltd.) was placed above the sparger, at y = 90 mm. The 
measurement of the gas holdup in the bioreactor was correlated by the conductivity 
measurement based on Maxwell’s equation (Sigrist et al., 1980; Tavera et al., 1998): 
K
K0
=
Kd + 2K0 − 2ε(K0 − Kd)
Kd + 2K0 + ε(K0 − Kd)
 (5.1) 
 
where, K , K0, and Kd are the effective conductivity, conductivity  of continuous phase, and 
conductivity of dispersed phase, respectively, which can be measured. The gas holdup (𝜀) 
was then calculated based on the measured conductivities. 
 
5.2.2 CFD simulation setup 
 
The CFD multiphase simulation models were described in chapter four. This chapter was 
focused on the two-phase (gas-liquid) system. 
 
5.2.3 Grid independence study 
 
The accuracy of CFD simulations depends strongly on the quality and density of the 
computational mesh. Normally, the smaller the grid size, the more accurate the solutions are. 
However, a too fine grid takes a long computational time, so we should optimise the grid in 
order to obtain reliable results with a reasonable computational time. 
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The grid independence study was done on the in-house built airlift bioreactor (AL1) as shown 
in Figure 5.1. The working volume of the airlift bioreactor is 100 mL and the diameter of gas-
liquid separation zone is larger than the main column’s diameter. The superficial velocity of 
the gas phase in the simulation was at 0.3 m. s−1. 
 
 
Figure 5.1 A schematic diagram of drawing of in-house airlift bioreactor (AL1) and its 
dimensions (in mm). 
 
The meshing process is illustrated in Figure 5.2. Tetrahedral mesh, default setting by CFX, 
was used to discretise the flow domain of the airlift bioreactor. In order to reduce the number 
of computational cells and owing to geometrical symmetry, the simulations were performed 
on 1/12 of the system. The effect of grid size was studied on the following parameters: gas 
volume fraction (gas holdup) and superficial liquid velocity. In multiphase flow, superficial 
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velocity is defined as the volumetric flux, is effectively the volume rate of flow of the fluid 
divided by a unit cross-sectional area covered by all phases (Bird et al., 2002). 
 
Figure 5.2 A schematic diagram of meshing process in CFD model. An airlift bioreactor was 
discretised into small meshes. The tetrahedral meshes were used to discretised the bioreactor 
system into small control volumes. 
 
In a finite volume method, values are calculated at discrete places on a meshed geometry. 
Table 5.1 shows the number of nodes, number of elements, and computational time for 
varying degrees of refinement of the studied airlift bioreactor. The coarse mesh took less time 
in simulation than the fine grid, but the finest mesh, with 0.25 mm grid size, was beyond the 
capacity of the computer used for this project. The change of grid size from 0.5 mm to 0.4 
almost doubled both the number of elements (grids) and computational time. Therefore, the 
grid size needs to be optimised to satisfy both computational time and the accuracy of results. 
 
 
Meshing 
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Table 5.1 Computational time for each grid size. 
Grid size 
(mm) 
Number of 
nodes 
Number of 
elements 
(tetrahedral) 
Computational time 
2 3099 11619 0 hr 04 min 
1 17378 82914 0 hr 19 min 
0.5 129013 680934 2 hr 43 min 
0.4 249304 1339096 5 hr 08 min 
0.3 571759 3152022 - 
0.25 979115 5456006 - 
 
Optimal size of elements need to be identified in order to minimise a computational time 
while maintain accuracy of simulation results. Figure 5.3 demonstrates the comparison of 
results for 4 different mesh sizes, i.e. 2, 1, 0.5, and 0.4 mm. Steady state simulations were 
performed as a comparison. The convergence criterion was set at a target residual of 10-5 and 
the physical time step was set at 1 second. As a selected parameter inside an airlift bioreactor 
(AL1), the superficial liquid velocity was shown in the rainbow spectrum from low (blue) to 
high (red). As observed, the superficial liquid velocity was high at the middle of the draft 
tube and the velocity was zero at the bioreactor wall. It was confirmed that the no-slip 
boundary condition worked for the liquid phase. With the coarse mesh, the calculated 
superficial water velocity was not smooth, especially near the wall region. Visually, the 2-
mm grid and 1-mm grid was insufficient because the representative parameter, i.e. superficial 
water velocity, was not smooth in some areas such as near the wall, and the liquid-gas 
separation section. 
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2 mm 1 mm 
  
0.5 mm 0.4 mm 
  
 
Figure 5.3 A schematic diagram of comparison of the CFD results from different grid sizes 
in AL1. The simulation were run at 𝑢𝑔 = 0.3 m ∙ s
−1. The superficial liquid velocity was 
shown on a half of the symmetry plane. The finer grids, the more smooth of superficial liquid 
velocity was observed.  
 
Therefore, the 0.5 mm mesh with a near-wall refinement was run to compare the result. As 
observed from the results, the solution from the finer mesh was much smoother. 
| 93 
 
(a) 
Distance from the centre (m)
0.000 0.002 0.004 0.006 0.008 0.010 0.012 0.014 0.016
W
a
te
r
 s
u
p
e
r
fi
c
ia
l 
v
e
lo
c
it
y
 (
m
/s
)
0.0
0.1
0.2
0.3
0.4
0.5
1mm 
2mm 
0.5mm 
0.4mm 
Distance from the center (m)
0.000 0.002 0.004 0.006 0.008 0.010 0.012 0.014 0.016
W
a
te
r 
s
u
p
e
rf
ic
ia
l 
v
e
lo
c
it
y
 (
m
/s
)
0.00
0.02
0.04
0.06
0.08
0.10
0.12
0.14
0.16
0.18
x vs line2_1mm 
x vs line2_2mm 
x vs line2_0.5mm 
x vs line2_0.4mm 
 
(b) 
Distance from the centre (m)
0.000 0.002 0.004 0.006 0.008 0.010 0.012 0.014 0.016
W
a
te
r 
s
u
p
e
rf
ic
ia
l 
v
e
lo
c
it
y
 (
m
/s
)
0.0
0.1
0.2
0.3
0.4
0.5
1mm 
2mm 
0.5mm 
0.4mm 
 
 
Figure 5.4 Axial superficial water velocity profile with different grid sizes. (a) is correspond 
to water velocity at the middle of the draft tube (y = 34.25 mm), and (b) is correspond to a 
section above the draft tube (y = 66 mm). The simulation were run at 𝑢𝑔 = 0.3 m ∙ s
−1. 
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The axial superficial water velocity for different mesh sizes are shown in Figure 5.6 where 
data shown in Figure 5.4. The 2 mm grid size was too coarse for the system. The solution was 
found to be almost independent of the grid size at 0.5 mm (Figure 5.4, Figure 5.5, and Figure 
5.6). The 0.4 mm grid size is probably unnecessary because it required about twice of the 
computational time compared to the 0.5 mm grid size. Figure 5.5 and Figure 5.6 show a 
spatial distribution of liquid superficial velocity for the 0.4 and 0.5 mm grid (with the 
refinement of grids near the wall region; inflation layer in CFX technical term) size, 
respectively. The superficial liquid velocity contours, again, are independent of the grid size. 
Therefore the 0.5 mm grid size was chosen for the following study. 
 
Figure 5.5 Superficial liquid velocity contours using a grid size of 0.40 mm with local 
refinement in near wall boundary. The simulation were run at 𝑢𝑔 = 0.3 m ∙ s
−1. 
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Figure 5.6 Superficial liquid velocity contours using a grid size of 0.50 mm with local 
refinement in near wall boundary. The simulation were run at 𝑢𝑔 = 0.3 m ∙ s
−1. The grid 
adjacent to the wall should be fine enough to solve the boundary layer flow. 
 
5.3 Results and discussion 
 
5.3.1 Experiment validation 
 
The experiment was performed on the AL1 airlift bioreactor and values for gas holdup were 
obtained from Equation (5.1). The experiment was performed for six times replication. 
Details of the experiment were described in the methodology section 5.2.1. The comparison 
of gas holdup is shown in Figure 5.7 confirming that the CFD model, along with its 
assumptions, is valid for the two-phase simulation of the airlift bioreactor. Therefore, it is 
possible to use this model to design and optimise the airlift bioreactor with more confidence. 
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Figure 5.7 Comparison of gas holdup between measurements and CFD prediction. N = 6. 
The error bars represent ±SD (standard deviation). 
 
A comparison of the CFD simulation results and measured values of gas holdup is shown in 
Table 5.2. The CFD results were calculated by using equation (5.6). Percentages of the 
difference between the two values were also calculated. 
Overall, it was shown that the difference between CFD results and measured value of gas 
holdup were considerably close. Except the inlet gas flowrate at 20 mL ∙ min−1, the 
percentage of the difference was greater than 10% indicating that more replication might be 
needed. Moreover, the effect of bubble coalescence and breakup was excluded in this study. 
In order to capture more realistic phenomena, the bubble coalescence and bubble breakup 
might be included in the airlift bioreactor models (Liu et al., 2013; Qi et al., 2013). However, 
the computation time would need be adjusted because the more complex of the model, the 
longer time needed to simulate the system. 
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Table 5.2 Values of gas holdup from experiment versus CFD simulation. The percentages of 
the differences were calculated based on the measured values.  
Gas flowrate 
(mL/min) 
Measured gas 
holdup 
Simulated gas 
holdup 
% 
difference 
10 0.00186 0.001733 6.83% 
20 0.00543 0.003345 38.40% 
40 0.00831 0.006457 22.30% 
60 0.01020 0.009488 6.98% 
80 0.01310 0.012466 4.84% 
100 0.01590 0.015406 3.11% 
 
Some researchers found that the effect of lift force and virtual mass force in the CFD had no 
significant effects on the airlift bioreactor and bubble column (Tabib et al., 2008; Simcik et 
al., 2011; Wang and You, 2013). For this study, those forces were also not considered for the 
CFD simulation in order to make the calculation faster, hence, the faster computational time 
was achieved while maintained the accuracy of the models. 
 
5.4 Airlift bioreactor design 
 
There are four main areas in the airlift bioreactor: below draft tube, draft tube, above draft 
tube, and the downcomer (Figure 5.8). The main design dimensions were also labelled as it is 
shown in Figure 5.8. The main parameter design in this study is the aspect ratio (H/Dc) which 
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was equal to 10 in order to maximise the resident time of the gas phase and to make the 
system less fluctuates. 
Some configurations suggested by literatures were used as a guideline for the design of airlift 
bioreactor (discussed in chapter two). However, with the design of configurations can be 
changed before the bioreactor is built. It is different from the conventional way of designing 
the airlift bioreactor. Once, the bioreactor was designed and built, the only operating 
parameter that could be adjusted is superficial gas velocity in order to maximise the 
bioreactor performance (van Baten et al., 2003). 
 
 
Figure 5.8 A schematic diagram of the airlift bioreactor configuration and main design 
dimensions. H: height of the airlift bioreactor column, HS: top clearance, HB: bottom 
clearance, Dt: draft tube diameter, DC: column diameter, DS: liquid-gas separator diameter.  
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Most of chemical engineering equipment, such as reactors and bioreactors, are relied on rule 
of thumb (Branan, 2005). In this study, the airlift bioreactors were designed using 
dimensionless geometries suggested by literature and CFD simulation. Table 5.3 gives a 
summary of the dimensions of all models. The most important parameter is the working 
volume which was kept constant for all designs.  In the new designs (AL2 and AL3), the 
bottom section has a conical shape because it was recommended to reduce dead space volume 
as compared to a flat bottom (Vesvikar and Al-Dahhan, 2005). 
 
Table 5.3 The dimensions of the designed airlift bioreactors. 
 Symbol AL1 AL2 AL3 
Nominal volume V 1.2x105 mm3 1.2 x105mm3 1.2 x105mm3 
Total column height H 105 mm 280 mm 250 mm 
Liquid level height HL 95 mm 220 mm 200 mm 
Column diameter Dc 30 mm 28 mm 25 mm 
Draft tube height Ht 53.5 mm 180 mm 160 mm 
Draft tube diameter Dt 15 mm 17 mm 15 mm 
Top clearance hs 34 mm 20 mm 30 mm 
Gas separator diameter Ds 64 mm 28 mm 44 mm 
Gas separator height Hs 44 mm 80 mm 80 mm 
Bottom clearance hB 7.5 mm 20 mm 10 mm 
Inlet diameter di 16.25 mm 10 mm 10 mm 
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Table 5.4 summarises all analysis of the designed bioreactors in terms of their dimensionless 
values. The aspect ratio was increased from the existing airlift bioreactor in order to increase 
the residence time for a better mass transfer within the bioreactor. Furthermore, the ratio of 
draft tube to column diameter was also increased to minimise the dead space volume. The 
new designs (AL2 and AL3) have higher aspect ratio (10) than the in-house airlift bioreactor, 
AL1, which the aspect ratio is 3.5 (Ismail, 2009). The effect of aspect ratio on performances 
of airlift bioreactors was characterised by CFD simulations. 
 
Table 5.4 Dimensionless parameters of the designed airlift bioreactors 
Dimensionless value Symbol AL1 AL2 AL3 
Aspect ratio H/Dc 3.5 10 10 
Slenderness ratio Ht/Dc 1.783 6.429 6.400 
Ratio of draft tube to column 
diameter 
Dt/Dc 0.5 0.536 0.52 
Ratio of column to draft tube 
area 
Ac/At 4 3.481 3.698 
Ratio of riser to downcomer 
diameter 
Ar/Ad 0.330 0.402 0.370 
Disengagement ratio DR 0.703 1.331 0.797 
Draft-tube bottom clearance 
ratio 
HB/Dt 0.5 1.333 0.769 
Draft-tube top clearance ratio Hs/Dt 2.267 1.333 2.308 
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The common design of airlift bioreactor (AL2) was also simulated to compare with the 
existing one (AL1). It is shown in Figure 5.9, the concentric designs labelled as AL2 and 
AL3 have large degassing zones. These notations will be used further for the rest of this 
thesis. 
Figure 5.9 Airlift bioreactor designs with different configurations. The dimensions are shown 
in mm unit. AL1 is the in-house airlift bioreactor whereas AL2 and AL3 are the new design 
of airlift bioreactors. 
 
5.4.1 Gas holdup 
 
A symmetry plane was used in this study due to the aim of computational time reduction. It 
was exhibited before that the hydrodynamics were symmetrically distributed along the airlift 
bioreactors and bubble column (Feng et al., 2007; Ekambara and Dhotre, 2010; Bannari et 
al., 2011; Xu et al., 2012). 
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Figure 5.10 shows predicted gas holdup for different airlift bioreactor designs with a 
superficial gas velocity of 0.005 m/s. It is observed that the riser zone has higher gas holdup 
than the downcomer zone which is generally considered as a gas-free zone. This result is 
consistent with data found in the literatures, e.g. Chisti (1989) and Choi et al. (1995). The 
different of the fluid density in the riser and the downcomer creates circulation inside the 
airlift bioreactor. 
 
 
Figure 5.10 A schematic diagram comparison of gas holdup for all designs of airlift 
bioreactor. The simulation were run at 𝑢𝑔 = 0.005m ∙ s
−1. The circulation of the fluid inside 
the airlift bioreactor is induced by the difference of the global density in the riser and the 
downcomer.  
 
Gas holdup is the most important parameter characterising hydrodynamics and has a direct 
influence on oxygen transfer in airlift bioreactors Kawase et al. (1995). Accurate prediction 
of gas holdup can help determining the residence time of the gas in the liquid. Gas holdup in 
combination with the bubble size, influences the gas-liquid interfacial area which available 
 
AL1 AL2 AL3 
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for mass transfer. Gas holdup is an important parameter for airlift bioreactor design because 
total design volume of the bioreactor for any range of operating conditions depends on the 
maximum gas holdup that must be accommodated. A theoretical model for maximum gas  
holdup is presented in Equation (5.2) where parameters A and B depend on the flow regime 
and the flow behaviour index of the fluid (Chisti, 1989). 
𝜀 = 𝐴 ∙ 𝑢𝑔𝑟
𝐵  (5.2) 
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Figure 5.11 A graph of correlation between maximum gas holdup and superficial gas 
velocity. The data for gas holdup were collected at the middle of the column (i.e. y = 34.25, 
110, and 90 cm above the base of the airlift bioreactor for AL1, AL2, and AL3, respectively). 
 
The results from CFD simulations were used to fit Equation (5.2) as seen in Figure 5.11. It 
shows the relationship between maximum gas holdup and superficial gas velocity for all three 
designs with high degree of correlation, but for high superficial gas velocity (i.e. at 𝑢𝑔 =
0.1, 0.2 m ∙ s−1) this model seems not to be valid because the parameters A and B should be 
the same. The same properties of fluid were used in all simulations. Nevertheless, this model 
was adopted to predict the maximum gas holdup in our system for superficial gas velocities 
up to 0.01 m/s. 
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𝜀𝑟 = 1.5𝐹𝑟
0.87𝑀−0.4𝑋𝑡
−0.19𝑌𝑡
−0.2
 (5.3) 
 
𝜀𝑑 = 4.76𝐹𝑟
1.3𝐺𝑎−0.09𝑀−3.8𝑋𝑡
0.65
 (5.4) 
 
𝜀𝑡𝑜 =  𝜀𝑠 = 0.29𝐹𝑟
1.05𝑀−2.5𝑋𝑡
0.1𝑌𝑡
−0.07
 (5.5) 
 
The calculated gas holdup in the riser based on Equation (5.3) was found to be about 0.0003 
for all configurations but the results from the CFD simulations were 0.01, suggesting that this 
hydrodynamic property might depend on the airlift bioreactor size and/or the geometry of the 
airlift bioreactor. It was stated that correlations for volumetric mass transfer coefficient, 𝑘𝐿𝑎, 
and gas holdup are ‘type-specific’ as the geometry of the gaslift system has serious effects on 
the hydrodynamics (Petersen and Margaritis, 2001). Therefore, other correlations from the 
literature are invalid for our design. According to Equation (5.3) -  (5.5) which were taken 
from the literature (Merchuk et al., 1994), for a given bioreactor design, there is only one 
variable in these correlations, i.e. superficial gas velocity (ug). Hence the following 
correlations for existing designs can be obtained. 
𝜀𝑚𝑎𝑥 = 1.3552𝑢𝑔
0.9342           for AL1 (5.6) 
 
𝜀𝑚𝑎𝑥 = 1.6606𝑢𝑔
0.9636           for AL2 (5.7) 
 
𝜀𝑚𝑎𝑥 = 1.4993𝑢𝑔
0.9502           for AL3 (5.8) 
 
Equation (5.6) - (5.8) relate the maximum gas holdup to the superficial gas velocity for AL1, 
AL2, and AL3 respectively. 
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Figure 5.12 Graphs of radial distribution of gas holdup at a height of 34.25, 110, and 90 mm 
above the sparger for AL1, AL2, and AL3, respectively. The solid bars represent draft tube 
walls. 
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Figure 5.12 displays the radial profiles of gas holdup for all three designs. The data were 
collected at the middle of each airlift bioreactor. It can be observed that the gas holdup 
increases with the increase in superficial gas velocity. The new designs, AL2 and AL3, have 
the value of gas holdup higher than the existing design, AL1, for high superficial gas 
velocities, 0.01 and 0.02 m/s. However, from Figure 5.12, the distribution of the highest gas 
holdup value in AL1 is longer than AL2 and AL3, due to the fact that the AL1 design has a 
larger inlet gas diameter to draft tube diameter ratio (di/dt) – 1.08, 0.66 and 0.76 for AL1, 
AL2, and AL3 respectively. The increase of maximum zone of gas holdup value may cause 
by increasing of sparger diameter to equal or greater than draft tube diameter. 
 
5.4.2 Superficial liquid velocity 
 
The superficial liquid velocity of all airlift bioreactor is shown in Figure 5.13 which 
illustrates only the XY plane at Z = 0 in a half of the airlift bioreactor. The circulation of the 
liquid phase is induced by the inlet gas velocity which was kept constant at 0.005 m/s for this 
demonstration. 
The circulation of liquid in the airlift bioreactors is caused by the difference in bulk densities 
of fluids in the riser and the downcomer. As shown in Figure 5.14, the fluids move upward 
through the riser, and the gas exits the column in the gas separation zone whereas the liquid 
recirculates to the bottom via the downcommer. With CFD analysis, stagnant and slow flow 
zones can be identified and in this study the dead zone is defined as a region where the 
superficial liquid velocity is less than 1% of its maximum superficial liquid velocity for each 
simulation. The dead zone could be referred as a poor mixing zone which could lead to an 
accumulation of toxic metabolites, and therefore inhibit cell growth (Yeo et al., 2013). 
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Figure 5.13 A schematic diagram of superficial water velocity obtained from CFX 
simulation of all designs. The simulation were run at 𝑢𝑔 = 0.005m ∙ s
−1. 
 
Figure 5.14 A schematic diagram of velocity vector plot of superficial water velocity. The 
simulations were run at 𝑢𝑔 = 0.1  m ∙ s
−1. 
 
 
 
AL1 AL2 AL3 
AL1 AL2 AL3 
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It can be observed from Figure 5.13 that there is a vortex at the top of each airlift bioreactor. 
The new designs, AL2 and AL3, have improved the flow by reducing the vortex size. AL2 is 
potentially to have a smaller vortex than the AL3. 
Table 5.5 shows the percentage of dead zone in all three designs. The size of the dead zone 
volume is in the order of AL1 < AL2 < AL3. The dead zone volume can be reduced by 
increasing gas velocity input, however, only a slight reduction was observed. Dead zones are 
undesirable because there is no mixing in these regions, thus reducing the effective airlift 
bioreactor volume. It has been mentioned that the ratio of draft tube to the column diameter 
and the degree of conically shaped bottom of the airlift bioreactor give a strong effect on 
minimising dead zone volume (Vesvikar and Al-Dahhan, 2005). 
 
Table 5.5 Dead zone volume (as a percentage of volume) in different bioreactor designs. 
Gas velocity (m/s) AL1 AL2 AL3 
0.001 8.43% 13.01% 14.94% 
0.005 7.15% 14.09% 14.61% 
0.010 9.06% 11.43% 13.19% 
0.020 8.53% 9.81% 12.92% 
 
The shape of the velocity profile across airlift bioreactor, similar to flow in a pipe, depends 
on the flow, either it is laminar or turbulent. If the flow is laminar, the velocity distribution at 
a cross section will be parabolic if the flow is fully developed. In turbulent flow, a fairly flat 
velocity distribution exists across the section, resulting in a more uniform profile. The 
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velocity of the fluid which is in contact with the wall is essentially zero (due to no-slip 
boundary condition) and increases the further away from the wall. 
Figure 5.15 shows both the superficial gas and liquid velocities. It can be observed that gas 
velocities are virtually zero in the downcomer section which means that only liquid 
recirculates in the airlift bioreactor while the gas exits the column at the top of the airlift 
bioreactor. From the CFD simulations, both gas and liquid phases can be considered to be in 
a laminar flow regime according to the parabolic shape of its velocity profile across the airlift 
bioreactors. The calculated Reynolds number (Re) confirmed that all the simulations are in 
the laminar flow regime (See Appendix II).The higher the input gas velocity, the higher 
superficial liquid velocity was observed. The new designs of airlift bioreactors, AL2 and 
AL3, provide a higher superficial liquid velocity with the same input gas velocity. Despite the 
fact that both designs have smaller area of gas distributor (sparger), they still provide a higher 
liquid circulation rate. Furthermore, the predicted superficial gas velocities for AL2 and AL3 
designs are closer to those expected from the input velocities. 
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Figure 5.15 Radial distribution of superficial liquid and gas velocities at heights 34.25, 110, 
and 90 mm above the sparger for AL1, AL2, and AL3 respectively. The solid bars represent 
the draft tube wall. 
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5.4.3 Shear rate 
 
The shear rate, ?̇? (s-1) in a two-dimensional flow is defined as (Nielsen et al., 2003):  
?̇? =
𝑑𝒖𝑦
𝑑𝑧
 (5.9) 
 
where z is the direction perpendicular to the direction of the flow. The dynamic viscosity, 𝜂 
(𝑘𝑔 ∙ 𝑚 ∙ 𝑠−1), of a fluid is related to the shear stress ,𝜏 (𝑁 ∙ 𝑚2), and the shear rate shown in 
equation (5.11) is for the one-dimensional case. 
𝜏 = −𝜂?̇? (5.10) 
 
For Newtonian fluids, (such as water, fermentation broths containing yeasts or bacteria) the 
viscosity is independent on the shear rate—i.e. it is constant—whereas for Non-Newtonian 
fluids: fermentations involving filamentous fungi or fermentation in which polymers are 
excreted (Nielsen et al., 2003). For this work, the fluids were considered as water-like 
property, therefore, the rheology based on Newtonian fluids (Blazej et al., 2004b) was used in 
the CFD calculations. 
Correlations for shear rate (?̇?) in terms of the superficial gas velocity have been proposed in 
literatures (Murray Moo-Young, 1987; Chisti and Mooyoung, 1988; Kar et al., 2005) and 
these are: 
?̇? = 2800𝑢𝑔    for 𝑢𝑔 ≤ 0.08 m/s (5.11) 
 
?̇? = 1000𝑢𝑔    for 𝑢𝑔 ≤ 0.04 m/s (5.12) 
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The average shear rate inside the airlift bioreactors is shown in Figure 5.16. It can be clearly 
noted that all airlift bioreactor designs provide a relative low shear rate environment 
compared to the typical shear rate tolerance, 1500 s-1, in mammalian cell culture systems. 
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Figure 5.16 A graph of the average shear rate inside the airlift bioreactors. 
 
Equation (5.11) seems to be a better prediction model of average shear rate than Equation 
(5.12). It was observed that for superficial gas velocity less than 0.01 m ∙ s−1 , and this 
equation can be used to predict the average shear rate in the airlift bioreactor system. The 
design which has no separator (AL2) provides a slightly lower shear rate than the designs 
with a separator (AL1 and AL3). 
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5.4.4 Improvement of the design 
 
The benefit on using CFD on designing the bioreactor over the conventional chemical 
engineering when the bioreactor is able to simulate and the spatial distribution of parameters 
is possible to observe before the real bioreactor is built. Hence, some modifications on 
bioreactor geometry are feasible. Figure 5.17 shows the example of how a modification of 
geometry (sparger area) affects the hydrodynamic parameter; radius distribution of gas 
holdup. 
Figure 5.17 shows the improvement of the airlift bioreactor designs, AL2 and AL3. The 
simulations were run at 0.01 m.s-1 superficial gas velocity. For both designs, a larger sparger 
area resulted in a larger gas holdup area. Hence, the dead zones are reduced when the velocity 
increases. 
The strategy for designing of airlift bioreactor in this study is summarised in Figure 5.18. The 
working volume was 120 mL which was the same as the in-house airlift bioreactor or AL1 
(Ismail, 2009). The aspect ratio (the ratio of height to diameter of the airlift bioreactor) was 
10 in order to increase the residence of the gas inside the airlift bioreactor. The other ratios 
were reported in literatures for a guideline. The CFD simulations were performed for both 
hydrodynamics and mass transfer but the most important parameter is the shear rate which 
was monitored to be under mortality threshold (less than 1500 s-1). The design can be 
adjusted and the CFD calculations could be simulated again until all criteria are met. As 
resulted from the CFD-based design airlift bioreactor, the proper materials can be selected to 
fabricate the airlift bioreactors. Finally, the airlift bioreactor can be tested in a cell culture, i.e. 
for expansion and differentiation of murine embryonic stem cell toward alveolar progenitor 
cells. 
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Moreover, this CFD-based design strategy can be modified by changing design’s criteria, 
bioreactor geometry and etc. This design strategy can benefit on cost saving for experiment 
prior to the bioreactor testing. 
 
 
Figure 5.17 The improvement of the airlift bioreactor designed by varying the sparger 
diameter. The simulations were run at superficial gas velocity 0.01 m.s-1. The gas holdup data 
were collected at the middle of each bioreactor (i.e. 34.25, 110, and 90 mm above the base of 
the airlift bioreactor). The CFD can be used to reduce the dead zone in the airlift bioreactors. 
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Figure 5.18 The schematic diagram of a design strategy in this study. The working volume 
and the aspect ratio were fixed. After the geometry of the airlift bioreactors were designed, 
then, they were simulated by CFD. The most important hydrodynamic parameter in this study 
is shear rate which was made sure to be under 1500 s-1.  
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5.5 Summary 
 
In this chapter, hydrodynamics (gas holdup, superficial liquid velocity, superficial gas 
velocity, and shear rate) of the airlift bioreactors was analysed by means of CFD. The 
influences of superficial gas velocity on gas holdup, superficial liquid velocity, and shear rate 
are in a good agreement with the theory and data from literatures. 
Gas holdup is a parameter that depends on detailed geometry of the airlift bioreactor so 
correlations from literatures do not apply to the present study. Relevant correlations of the 
superficial gas velocity and the maximum gas holdup for each three bioreactor designs were 
obtained and can be used in further optimisation of these designs.  
Spatial distributions of the superficial liquid velocity as well as dead zone volume have been 
examined based on the CFD simulation results. Stagnant zones, which were defined as 1% of 
maximum superficial liquid velocity in each case of simulation, were observed in the airlift 
bioreactor. Moreover, by adjusting geometry of airlift bioreactor could minimise the stagnant 
zones. 
It has been confirmed that the airlift bioreactors offer a reasonably low shear environment 
which does not affect the conventional cell culture system. Observation on the shear rate 
resulted in lower value than the tolerance for mammalian cells in all studied airlift bioreactor 
configurations. Moreover, it has been shown that the correlation of superficial gas velocity 
and average shear rate from literatures can be used in the current airlift bioreactor designs for 
gas velocities less than 0.01 m/s. 
The study has demonstrated that CFD is an effective tool for predicting hydrodynamics 
properties of the fluids in airlift bioreactors. It could be potentially used in developing scale 
up strategies. 
  
 
 
 
 
 
 
6 AIRLIFT BIOREACTOR FOR EMBRYONIC STEM 
CELL DIFFERENTIATION INTO PNEUMOCYTES: 
THE SIMULATION OF AIRLIFT BIOREACTORS 
 
6.1 Introduction  
 
Embryonic stem cells (ESCs) hold hopes for regenerative medicines because they can 
grow indefinitely and differentiate into the desired linages to replace the lost or 
damaged cells in a body. Comparing to adult stem cells, which are resided in the 
specific organs, ESCs have more potential to differentiate into all three germ layers 
(ectoderm, mesoderm, and endoderm) whereas the adult stem cells have the specific 
direction to become the cells which the adult stem cells are found. ESCs are defined as 
the inner cell mass of the blastocyst stage (day 3.5 for mouse and day 4 – 5 for human) 
after the fertilisation of a sperm and an egg. These ESCs can grow and differentiated 
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in vivo to build up all over 200 cells found in a human body. Therefore, the 
regenerative medicine can harness this principle to grow and differentiate the ESCs in 
vitro to restore the lost or damaged cells and organs. 
Many works have been attempted to differentiate ESCs to all three germ layers in 
order to recreate the damaged cells or organs. However, the differentiation of ESCs 
into epithelial cells in the lung is still in an infant stage, it can be dated back in 2002 
when the differentiation of murine ESCs were differentiated into type II pneumocytes 
(one type of epithelial cells in the lung) but the efficiency of the differentiation is very 
low (Ali et al., 2002). Moreover, it has been shown that the differentiated cells cannot 
maintain their genotypes ex vivo for longer than 2 weeks (Siti-Ismail et al., 2012). A 
successful of producing lung epithelial cells can save millions of patient worldwide 
(Ott et al., 2010). 
Traditionally, ESCs are grown as a monolayer in a petri dish or T-flask which makes it 
a labour-intensive process and difficult to scale-up to meet the clinical requirement 
cell number. Moreover, the 2D (2-Dimentional) environment cannot mimic the 3D 
structure found in vivo. Therefore the 3D systems are needed to overcome the 
limitations of the 2D system cultures. There are attempts to use bioreactors as a 3D 
culturing for cells and embryonic stem cells. The murine embryonic stem cells were 
successful scale-upped in spinner flask bioreactor (Fernandes-Platzgummer et al., 
2011) to meet the clinical application number: e.g. 1010 hepatocyte cells are need for 
hepatic failure (Tzanakakis et al., 2000). The rotating wall vessels were also use for 
lung (Siti-Ismail et al., 2012), bone (Hwang et al., 2009), and red blood cells (Fauzi et 
al., 2012) tissue engineering from ESCs. However, different kind of cells might need 
different types of bioreactors because organs/cells in the body experience different 
environments.  
| 119 
 
According to the lung structure, an alveolus (where the CO2/O2 exchange occurs) is 
exposed to the atmosphere directly. In order to mimic an environment in vivo, an 
airlift bioreactor was proposed to be used in lung epithelial cell differentiation. The 
airlift bioreactor is pneumatic induce device. A gas, usually air, is fed at the base of 
the bioreactor. Therefore, the gas is directly exposed to cells inside the airlift 
bioreactor. Moreover, the mass transfer of oxygen is high inside the airlift bioreactor.  
One of main problems of the use of bioreactor for stem cell application is the 
parameters (flow profile, dissolved oxygen, shear distribution, etc.) online 
measurement (Ye et al., 2006). Measuring probes occupy space. Moreover, 
bioreactors for tissue engineering application are considerably small compared to 
those which were used in biochemical process such as photobioreactors and 
fermenters. Therefore, the use of computational tools to access the process variables is 
needed and computational fluid dynamics (CFD) is most promising candidate because 
the CFD can predict the flow pattern or the variables (such as oxygen) in spatial 
distribution. CFD was introduced in chemical engineering field by simulating in 
severe reactor condition and fermenter (Moilanen et al., 2005). Recently, the use of 
CFD is extended to tissue engineering application. The rotating wall vessels were 
simulated by CFD to optimise the rating speed prior to the conduction of the (Consolo 
et al., 2012). The hydrodynamics of the different size of wave bioreactors was also 
accessed by CFD (Oncul et al., 2010) in order to simulate the shear stress level at 
various operating conditions. 
In the past, the simulations of airlift bioreactors by CFD were limited to the study of 
hydrodynamic properties (Mudde and Van Den Akker, 2001; Oey et al., 2001; van 
Baten et al., 2003b; van Baten and Krishna, 2003) due to the limitation of 
computational power. Recently, there have been improvements on computational 
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power and the use of cluster computer; hence, a couple of hydrodynamics and mass 
transfer was feasible. For example, a transient model was developed for three-phase 
airlift loop reactor in which hydrodynamics, mass transfer, and bioreaction were 
included (Wang et al., 2011). In this chapter, the hydrodynamic and mass transfer of 
oxygen was included in CFD simulation of three different designs of airlift bioreactors 
that targeting to use in lung tissue engineering applications. 
The main objectives of this chapter are (1) to simulate the airlift bioreactors in a 
transient behaviour, (2) to simulate the mass transfer pattern of the airlift bioreactors 
in both normoxia (20% O2) and hypoxia (5% O2) conditions, and (3) to consider the 
effect of solid phase to the simulation of the multiphase bubble column. 
 
6.2 Methodology 
 
In addition to models mentioned in chapter 4, the models for three-phase system were 
presented here.  
In the Eulerian models, the volume-averaged mass and momentum conservation 
equations are given by (i) the continuity equation (Chapter 4: equation (4.2)), (ii) the 
momentum equation (equation (4.3)), and (iii) the momentum exchange between the 
gas and liquid phase (equation (4.4)) for gas-liquid system and the momentum 
exchange between the solid and liquid phase (in gas-liquid-solid system) is given by: 
𝑀𝑙,𝑠 = [
3
4
𝐶𝐷,𝑙𝑠
𝑑𝑠
𝜌𝑙] 𝜀𝑠(𝒖𝑠 − 𝒖𝑙)|𝒖𝑠 − 𝒖𝑙| (6.1) 
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where 𝐶𝐷 is the drag coefficient and 𝑑 is the diameter. The Grace drag force model 
was chosen for liquid-gas system where the dispersed phase is very diluted (Clift et 
al., 1978). In case of gas-solid-liquid (g-s-l) system, the drag coefficient exerted by the 
solid phase to the liquid phase, 𝐶𝐷,𝑙𝑠, was calculated by the Wen Yu drag model 
(Wang et al., 2011): chapter 4 (equation 4.21 – 4.22) and 𝑑𝑠 is the solid (alginate 
bead) diameter (2 mm). 
The lift force was also included in g-s-l system. The lift force acts on the direction 
vertical to the direction of the two dispersed phase: gas and solid. The lift forces for 
gas and solid were defined as:  
𝑀𝐿,𝑙𝑔 = 𝐶𝐿𝜌𝑙𝜀𝑔(𝒖𝑔 − 𝒖𝑙) × (∇ × 𝒖𝑙) (6.2) 
 
𝑀𝐿,𝑙𝑠 = 𝐶𝐿𝜌𝑙𝜀𝑠(𝒖𝑠 − 𝒖𝑙) × (∇ × 𝒖𝑙) (6.3) 
  
where 𝐶𝐿is the lift coefficient and its value is 0.5 (Tabib et al., 2008) and ∇ × 𝒖𝑙 is 
curl (𝒖𝑙). 
The species transport equation: 
𝜕(𝜀𝑖𝜌𝑖𝑥𝑘)
𝜕𝑡
+ 𝛻 ∙ (𝜀𝑖𝜌𝑖𝑥𝑘𝒖𝑖) = 𝛻 ∙ (𝜀𝑖
𝜇𝑖
𝑆 𝑐𝑘
𝛻𝑥𝑘) + 𝜀𝑖𝑅𝑘 (6.4) 
 
The Eulerian-Eulerian multiphase model was used for the simulation of the airlift 
bioreactors by Ansys CFX software. The continuous fluid is water and the dispersed 
phase is air. The properties of these phases were summarised in Table 6.1.Table 6.2 
summarises all the models, boundary conditions, and the time step which were used in 
the simulations. The Hexagonal grids were used due to the faster convergence can be 
achieved while the simulation results can be compared to tetrahedral grids which was 
used in chapter 5. 
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Table 6.1 Fluid properties in CFD calculation.  
Fluid Density (𝐤𝐠 ∙ 𝐦−𝟑) Viscosity ( 𝐤𝐠 ∙ 𝐦−𝟏 ∙ 𝐬−𝟏) 
Water 997 𝟏. 𝟖𝟑𝟏𝒙𝟏𝟎−𝟓 
   
Air 1.185 𝟖. 𝟖𝟗𝟗𝒙𝟏𝟎−𝟒 
(diameter: 1 mm)   
 Surface tension coefficient 
 0.072 𝐍 ∙ 𝐦−𝟏 
 
The simulation is three-dimensional structure but only 1/12 of the reactor was 
simulated by the assumption of the symmetry planes. The grace interphase drag model 
is suitable for the system which is close to water and gas system and the dispersed 
phase (gas) holdup is relatively low compared to the continuous phase. 
 
Table 6.2 CFX settings.  
CFX step Feature Details 
CFX-Mesh Mesh shape Hexagonal 
   
Ansys CFX-Pre Simulation type 3D, Unsteady state 
 Fluid type General fluid 
 Domain type Single domain 
 Turbulent model Laminar 
 Drag model Grace 
 Heat transfer None 
 Buoyant flow  
 Multiphase Gas, liquid 
 Interphase transfer Particle model 
 Boundary conditions Inlet (subsonic) 
  Outlet (Degassing) 
  Symmetry plane 
  Wall: Thin surface 
  Wall: Free slip (gas) 
Wall: No-slip (water) 
 Time step 0.01 s 
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For 60-second transient time, the 1 – 4 days of CPU (central processing unit) time was 
observed in each case. The simulations were run on Windows XP (32 bit) PC with 2.8 
GHz Intel Pentium D, and 4 GB RAM. For the mass transfer—600 second transient 
time—6 days of CPU time was observed each case. The simulations were run on the 
Linux (64 bit) workstation with 2.0 GHz AMD Athlon Dual Core Processor, and 2 GB 
RAM.  
There are three different airlift bioreactors were simulated in this study. AL1 has 
lower aspect ratio (the ratio of the height to the diameter of the column) than the other 
two airlift bioreactors. AL2 is similar to the conventional bubble column despite there 
is the concentric tube, draft tube, inside the column to separate the riser and the 
downcomer of the airlift bioreactor. AL3 has the bigger the gas separation section, 
which is similar to AL1. The larger gas separation zone is suitable for the 3-phase 
system where encapsulated cells or microbial are cultured inside the bioreactors. 
 
6.3 Results and discussions  
 
6.3.1 Improvement of computational time by changing the mesh shape 
 
The nature of the multiphase, gas-liquid, system in airlift bioreactor, is transient 
system which means the parameters are varied with time. So, in this chapter, the 
simulation scheme was changed from steady-state to transient simulation but the 
simulation time was increased dramatically. In order to simulate 10-second of 
simulation time–as shown in Figure 6.1–it required 2.5 days of the CPU time. A 
similar problem was found in a literature (van Baten et al., 2003a), it took, by 
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workstations, 2 days and 7 days computational time for the 2D and 3D simulation, 
respectively. That made it difficult to simulate the more details in the airlift bioreactor 
system such as three-phase system, mass transfer, and cell growth. Therefore, the 
improvement of computational time is needed. 
From Figure 6.1 (b), the simulated results –gas holdup and superficial liquid velocity– 
are presented with varying of time. The simulation was conducted for the AL2 
configuration. For the gas holdup, it reached steady state since 4 seconds whereas the 
superficial liquid velocity might need longer than 10 seconds to reach the steady state. 
 
(a)                         (b) 
Figure 6.1 The AL2 transient simulation. (a) a sampling point. (b) a transient 
simulation results. The simulation were run at 𝑢𝑔 = 0.01m ∙ s
−1.  
 
Even though the tetrahedral mesh is the default setting for the CFD software (Ansys 
CFX) which was used in this study, the tetrahedral meshes might make the 
computational time longer due to the higher element in a system. Therefore, the 
different mesh shape, hexahedra as shown in Figure 6.2, was used in the simulation in 
Time (s)
0 2 4 6 8 10 12
G
a
s
 h
o
ld
u
p
 (
 )
0.01975
0.01980
0.01985
0.01990
0.01995
0.02000
S
u
p
e
rf
ic
ia
l 
liq
u
id
 v
e
lo
c
it
y
 (
m
/s
)
0.2118
0.2120
0.2122
0.2124
0.2126
0.2128
Gas holdup
Superficial liquid velocity (m/s)
(0, 0.11,0) 
| 125 
 
order to reduce the computational time. The number of the elements in the system was 
reduced from 405332 to 8055 which is 50 times reduction. The Figure 6.3 shows the 
results (gas holdup and superficial liquid velocity), the hexagonal mesh was shown in 
a solid line whereas the tetrahedral mesh was shown in dash line. The computational 
time for 10 seconds simulation time was 60 hours and 1.6 hour for tetrahedral mesh 
and hexahedral mesh, respectively. The hexagonal mesh made the simulation around 
38 times faster. 
 
Figure 6.2 Tetrahedral and hexagonal mesh shapes for AL2. The number of meshes 
was reduced from 405332 to 8055, therefore, the faster computational time was 
achieved.  
 
When compare the results from the tetrahedral and hexagonal meshes (see Figure 6.3), 
the gas holdup was nearly identical but the superficial liquid velocity from hexagonal 
mesh was slightly higher than the superficial liquid velocity from the tetrahedral mesh. 
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Therefore, the hexagonal mesh (as shown in Figure 6.4) was used in discretisation 
process in CFD simulation in order to reduce the computational and make it feasible to 
add more complexity to the model.  
Figure 6.3 The transient simulation results of different mesh shapes. The results were 
taken at the centre of the AL2 (0 m, 0.11 m, 0 m). 
Figure 6.4 The airlift bioreactors in hexagonal mesh. 
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6.3.2 Improvement of computational time by varying turbulent closures and 
drag force models 
 
A minimisation of computational time of CFD simulation—while maintaining the 
result accuracy—is important. The turbulent model (𝑘 − 𝜖) was used to compare to 
laminar model in order to minimise the computational time and to test the validity of 
the turbulent model in this study (Figure 6.5). Different drag force models (Grace and 
Schiller-Naumann) were implemented in the CFD simulation of the airlift bioreactor 
(AL1). The 𝑘 − 𝜖 turbulent model was a default model which was used in many CFD 
study on airlift bioreactor (van Baten and Krishna, 2003; Tabib et al., 2008; Wang et 
al., 2011). 
In a validity of turbulent model in this study, from Figure 6.5, the 𝑘 − 𝜖 turbulent 
model was under predicted the gas holdup values from experiment results which were 
described in chapter five. Comparing the laminar model and turbulent model, the 
laminar model was closer in term of gas holdup prediction. Therefore, the laminar 
model would be more suitable in this study. Even though, the turbulent model can 
reduce the computational time by half, e.g. it took 17 hours by simulating AL1 with 
laminar model and Grace drag force but only 8 hours for the turbulent model. The 
turbulent model added dissipation terms so it was easier to converge. 
The Reynolds number dependent drag force (Schiller-Naumann) was compared with 
the Grace drag force which is determined by Eötvös number. The Schiller-Naumann 
drag over predicted the gas holdup where the Grace drag model under predicted the 
gas hold as it is shown in Figure 6.5. The comparison was performed with laminar 
model. 
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Figure 6.5 Comparison of different turbulent models and different drag force models. 
The simulations were run by varying the 𝑢𝑔 = 0.001 − 0.01 m ∙ s
−1 which were 
equivalent to 12 – 124 mL/min based on the sparger area. The experiments were 
presented in at dot and the error bars represented the standard deviation. The laminar 
model together with Grace drag model represent in solid line where the turbulent 
model (𝑘 − 𝜖) was presented in a dot line. The dash line presented the laminar model 
with Schiller-Naumann drag model. 
 
At 𝑢𝑔 = 0.01 m ∙ s
−1, it took 26 hours for laminar model with Schiller-Naumann 
model but the simulation converged faster with the laminar model with Grace drag 
model (17 hours). 
There was 1.8% difference between the two drag force models in the CFD simulation. 
The Schiller-Naumann predicted the slightly higher value of the gas holdup in the 
AL1 design. The Figure 6.6 shows the transient simulation of the airlift bioreactor 
which took the sampling point was at the middle of the draft tube (34.25 cm above the 
gas sparger).  
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Figure 6.6 Comparison between Grace and Schiller-Naumann models. The simulation 
was run at 𝑢𝑔 = 0.005 m ∙ s
−1 on the AL1 design. The sampling point was at 34.25 
cm above the gas sparger.  
 
Due to the simulation time concern, the Grace drag force was used in the CFD 
simulation of airlift bioreactors for the rest of the study. 
 
6.3.3 Superficial liquid velocity 
 
The spatial distribution of the superficial liquid velocity was investigated for three 
different airlift bioreactors, as shown in Figure 6.7 and Figure 6.8. All bioreactors 
were simulated at inlet gas velocity (𝑢𝑔) = 0.02m ∙ s
−1. The legend spectrum is range 
from low velocity (blue) to high velocity (red). 
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Figure 6.7 Spatial distribution of superficial liquid velocity of the airlift bioreactor: 
AL1. The simulations were run at 𝑢𝑔 = 0.02m ∙ s
−1. The arrows show the direction of 
the superficial liquid velocity. 
 
It was observed that the high velocity is at the riser section in all bioreactors and the 
near zero velocity was observed at the wall of the bioreactor due to the no-slip 
boundary condition. The arrows inside the airlift bioreactors represent the liquid 
vector where the tip of arrow shows the direction of the velocity vector. The flow 
patterns were observed as the following:  
i. The liquid moved upward which was induced by the gas velocity. 
ii. When the liquid reached the gas separation section, the gas will leave the 
column, and the different pattern of eddy was also observed. A large eddies 
were observed in a larger gas separation section, AL1 and AL3, designs 
whereas the AL2 provided smaller vortices. Liquid moves to the degassing 
AL1 
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zone where most of mixing takes place, due to the ring vortices formed above 
the draft tube (Freitas and Teixeira, 1998). 
iii. Finally, the liquid moved slowly, through the downcomer, to the bottom of the 
columns. From (i) – (iii) is called a circulation pattern, which continually 
occurs as long as the gas is supplied to the system, inside the airlift bioreactor.  
 
 
Figure 6.8 Spatial distribution of superficial liquid velocity of the airlift bioreactors 
for AL2 and AL3. The simulations were run at 𝑢𝑔 = 0.02m ∙ s
−1. Arrows , which 
represent the direction of the superficial liquid velocity, show that the liquid moves 
upward in the riser then circulates down to the bottom via the downcomer. 
 
 
AL2 AL3 
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The liquid circulation, in term of the superficial liquid velocity, is shown in Figure 
6.10. The airlift bioreactors were simulated at the various inlet velocity ranging from 
0.001 – 0.02 m ∙ s−1. The sampling was at the middle of each column—47.5, 110, and 
100 cm above the base of each column for AL1, AL2, and AL3, respectively. The 
transient simulation was run until 60 seconds of the simulation time. For AL2 and 
AL3 the steady state was reach at 10 seconds, except the AL2 (at 0.005 m ∙ s−1) was 
achieved the steady state at more than 10 seconds of the process time. For the lower 
aspect ratio airlift bioreactor, AL1, the steady state condition only achieved at a low 
inlet gas velocity. Small fluctuations were observed at the gas inlet velocity 0.005 m ∙
s−1. The higher inlet gas velocity, the more fluctuation of superficial liquid velocity 
was observed. The trend also shows that the steady state might not be achieved. 
The axial distribution of the superficial liquid velocity (Figure 6.9 (b), (d), and (f)) 
was the data which were extracted when the system reached the steady stage or after 
60 seconds of the process time. The sampling point is at the middle point of each 
column (x,y,z) = (0, ymid, 0), where ymid is 47.5, 110, and 110 cm for AL1, AL2 and 
AL3, respectively. It was observed that the higher inlet gas velocity, the higher 
superficial gas velocity in all cases. Solid bar in Figure 6.9 (b), (d), and (f) are 
represented draft tube walls which separated a riser and a downcomer. The riser is the 
middle section of the column where the downcomer is the section which is near the 
outer column. The liquids move upward, and then move downward slowly to the 
bottom of the column. The superficial liquid velocity patterns of the AL2 and AL3 
design are clearer than AL1. It might be the fluctuation pattern and the steady state 
was not archived in the AL1. 
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Figure 6.9 The transient approach to steady state of superficial liquid velocity (left) 
and the axial distribution of the superficial liquid velocity (right). The solid bars 
represent the walls of the airlift bioreactors.  
 
Hence, the computational fluid dynamics (CFD) can be used to design and 
characterise the airlift bioreactors. In case of AL1, the CFD can be used to guide the 
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operating condition for the less fluctuation of superficial liquid velocity. On the other 
hand, the AL2 and AL3 can be designed and make sure the fluctuation is not observed 
before the bioreactors are built. 
 
6.3.4 Gas holdup 
 
The gas holdup, or gas fraction, in the airlift bioreactors is related to other parameters 
such as mass transfer coefficient, heat transfer coefficient, and liquid velocity. 
Therefore, the precise prediction of the holdup is important for airlift bioreactor 
operation. Figure 6.10shows the transient simulation results of the studied airlift 
bioreactors. The simulation time is 60 seconds which is enough to capture the transient 
to steady of the airlift bioreactors. The sampling points are the middle of each 
bioreactor: 47.5, 110, and 100 cm above the base of AL1, AL2, and AL3, respectively. 
From Figure 6.10 (c) and (e) for the AL2 and AL3, the steady state was observed 
within 10 seconds from the starting time. Again, from Figure 6.10 (a), the fluctuation 
of the gas holdup was observed when increasing the inlet gas velocity. 
Nevertheless, the holdup at 60 seconds of the process time was extracted and plot 
along the middle line in each bioreactor as it is shown in Figure 6.10 (b), (d), (f) to 
represent the gas holdup at the steady state condition. It was observed that gas holdup 
increases with increasing of gas inlet velocity in all airlift bioreactors. Dark bars are 
denoted the draft tube walls in each airlift bioreactor. It was suggested that the 
circulation inside the airlift bioreactor was due to the difference in the density of the 
fluid in the riser and the downcomer section of the bioreactor (Chisti, 1989). It is 
observed that the gas is only retained in the riser. It means that the fluid density in the 
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riser is less than the downcomer section because the fluid density is the mixture 
density of the gas and the liquid. 
 
Figure 6.10 The transient approach to steady state of superficial gas holdup (left) and 
the axial distribution of the gas holdup (right). The solid bars represent the walls of 
airlift bioreactors. 
6.3.5 Shear rate 
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The shear rate simulations are shown in Figure 6.11. The sampling points are at the 
middle of each airlift bioreactor which is 47.5, 110, and 100 cm above the base of the 
airlift bioreactor for AL1, AL2, and AL3, respectively. For the transient simulation, 
the simulation time is 60 seconds and at the end of transient time, the shear rate data 
were extracted and plot as the axial distribution along the middle line in each airlift 
bioreactor. 
For AL1, the higher inlet gas velocity (varied from 0.001 – 0.02 m ∙ s−1 ), the higher 
shear rate was observed and there are fluctuations at the high inlet gas velocity. The 
results also suggested that at high inlet gas velocity, 0.01 and 0.02 m ∙ s−1, cells might 
experience a different shear rate and it is not suitable for cells because cells might be 
shocked due to the change in operating parameters. From Figure 6.11 (b), it was 
observed that at the near wall region, the shear rate is higher than the other regions. 
The shear rate at the riser is also higher than the downcomer section. There is not 
much difference between 0.01 and 0.02 m ∙ s−1 axial distribution line, that might due 
to the fluctuation at the end of the simulation time but this fluctuation was detected in 
Figure 6.11 (a).  
In AL2 and AL3, the trends of shear rate are similar. The shear rate increases with 
increasing the gas inlet velocity. The maximum shear rate was observed around the 
middle distance between the centre of the draft tube and the draft tube wall. In the 
downcomer section, the shear rate is considerably lower than the riser section but the 
minimum shear rate was observed at the middle distance between the draft tube wall 
and the airlift bioreactor wall. 
For all airlift bioreactors in this study, the results from the simulations suggested that 
the shear rate values are lower than critical value which can be harm to the 
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mammalian cells (Karkare, 2000). Therefore, in theory, the embryonic stem cells can 
be grown inside the airlift bioreactors without the damage from the shear force. 
 
Figure 6.11 The transient approach to steady state of shear rate (left) and the axial 
distribution of the shear rate (right). The solid bars represent the walls of the airlift 
bioreactors.  
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6.3.6 Oxygen transfer 
 
In Figure 6.12, the ratio of dissolved oxygen (CL) to the equilibrium value of the 
dissolved at 37 oC was plot along the process time, 600 second. The simulations were 
run on the workstation on the computer server. The CPU time was up to 5 days for 
each run of the simulation at high superficial gas velocity (0.02 m ∙ s−1). At the 
starting point of the, the dissolved oxygen was set at 0  mmol ∙ m−3. 
An example of experiments that measured mass transfer coefficients, 𝑘𝐿𝑎, in gas-
liquid system is saturation method with discontinuous switch from nitrogen (N2) to 
oxygen (O2). Water was stripped by N2 until the dissolved-O2 concentration was 
almost zero. Then, air was sparged into a bioreactor, while simultaneously the 
dissolved-O2 concentration in the water was monitored (Letzel et al., 1999). If the 
liquid is well mixed, the concentration is described by: 
𝑑𝐶
𝑑𝑡
= 𝑘𝐿𝑎(𝐶
∗ − 𝐶) 
(6.5) 
 
where C is dissolved-O2 concentration, C
* the oxygen saturate concentration at gas-
liquid interface. Equation 6.5 can be integrated at time = 0 s (the starting point of the 
experiment) and C(t=0) = 0.  
𝐶(𝑡) = 𝐶∗[1 − 𝑒−𝑘𝐿𝑎𝑡] (6.6) 
 
𝑘𝐿𝑎 in 6.6 can be determined by a regression or the slope of ln (C
* - C(t)) vs t plot. 
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Figure 6.12 The CFD simulation of mass transfer in the airlift bioreactors. In a normal 
operating condition of the stem cell culture, the temperature is set at 37 oC which the 
equilibrium of oxygen in a culture medium is 0.223 mmol ∙ m−3. 
 
There were similar trends from all designs of the airlift bioreactors: the higher the inlet 
gas velocity, the faster equilibrium was reached. For AL1, the time for the equilibrium 
is around 200, 100, and 50 seconds for the inlet gas velocity at 0.005, 0.01, and 
0.02 m ∙ s−1, respectively. AL2 and AL3 reached the equilibrium at the similar time 
for the gas inlet velocity of 0.01 and 0.02 m ∙ s−1: The equilibrium time is 300 
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seconds for the gas inlet velocity of 0.005 m ∙ s−1 and 200 seconds for the gas inlet 
velocity of 0.01 m ∙ s−1. The equilibrium was reached faster for the gas velocity of 
0.02 m ∙ s−1, the equilibrium of AL2 is 120 seconds whereas the AL3 is 180 seconds. 
The AL1 reached the equilibrium faster than the AL2 and AL3 because the sparger 
area of the AL1 is larger than the spargers of the AL2 and AL3. Therefore, the oxygen 
transfer occurred faster.  
The data from Figure 6.12 were used to calculate the mass transfer coefficient (𝑘𝐿𝑎) 
by solving the equation (6.7). The higher the inlet gas velocity (𝑢𝑔), the higher mass 
transfer coefficient was observed. 
Table 6.3 summarises all calculated mass transfer coefficients (𝑘𝐿𝑎) from AL1, AL2, 
and AL3 designs of the airlift bioreactors. The operating condition was under 
equilibrium of normoxia; 20% of oxygen by volume.  
 
Table 6.3 The summary of the mass transfer coefficient under normoxia condition.  
 
u
g
(m/s) AL1 AL2 AL3 
0.005 0.02808 0.01640 0.01570 
0.01 0.04977 0.02521 0.02729 
0.02 0.09075 0.04458 0.04232 
 
 
𝐶𝐿
𝐶𝐿
∗ = 1 − 𝑒𝑥𝑝 (−
𝑘𝐿𝑎
1 − 𝜀𝐺
∙ 𝑡) (6.7) 
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𝐾𝐿𝑎 = 2.474𝑢𝑔
0.846                      for AL1 (6.8) 
 
𝐾𝐿𝑎 = 0.732𝑢𝑔
0.721                      for AL2 (6.9) 
 
𝐾𝐿𝑎 = 0.708𝑢𝑔
0.715                      for AL3 (6.10) 
 
The equation (6.8) - (6.10) are the correlation of the mass transfer coefficient and the 
inlet gas velocity for the AL1, AL2, and AL3, respectively. The r2 of the correlations 
are more than 0.99 for all equations.  
When the volumetric mass transfer coefficient was compared with the literature as 
shown in Figure 6.13 and Table 6.4, it was found that the mass transfer efficient is 
higher than wave bioreactors and spinner flasks. It confirmed that the airlift bioreactor 
is suitable for cells which demand or expose the high oxygen concentration. In the 
airlift bioreactor, the mass transfer of oxygen occurs via the interface between the gas 
bubble and the liquid phase whereas the spinner flask occur at the head space of the 
flask and the wave the mass transfer is driven through the permeable membrane. 
 
 
 
 
 
 
| 142 
 
Table 6.4 Mass transfer coefficients in wave bioreactor and spinner flaks  (Singh, 
1999). 
 
 
 
 
 
 
 
Figure 6.13 The mass transfer coefficient in wave bioreactors and spinner flasks. It 
was Adapted from Singh (1999). 
 
For the inlet gas velocity of 0.01 m ∙ s−1, the equivalent volumetric mass transfer 
coefficient is 180, 90, and 98 hr−1 for AL1, AL2, and AL3, respectively. The AL1 has 
higher volumetric mass transfer coefficient because of the larger sparger area where 
the AL2 and AL3 have the same sparger area. It also suggested that the airlift 
bioreactor configuration also affected the mass transfer behaviour. 
Figure 6.14 shows the spatial distribution of the dissolved oxygen of the AL1 under 
the normoxia condition (20% oxygen). The inlet gas velocity was sat at 0.005 m ∙ s−1. 
The colour legend ranges from low oxygen content (blue) to high dissolved oxygen 
(red). The equilibrium dissolved oxygen at the operating temperature, 37 oC, was 
around 0.229 mol ∙ m−3. The dissolved oxygen increases with increasing of the time 
and the reaches equilibrium around 200 – 300 seconds from the starting time which 
the dissolved oxygen was at 0 mol ∙ m−3. 
kLa in wave bioreactor versus spinner flasks 
Liquid (mL) kLa in wave bioreactor kLa in Spinner 
flasks 
100 1.61 hr-1 (in 2 L bag) 1.94 hr-1 
500 3.5 hr-1 (in 2 L bag) 1.15 hr-1 
1000 3 hr-1 (in 2 L bag) 0.9 hr-1 
10000 4 hr-1 (in 20 L bag) 0.4 hr-1 (estimated) 
100000 4 hr-1 (in 200 L 
bag) 
- 
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Figure 6.14 Snapshots of the spatial distribution of the dissolved oxygen in AL1. The 
oxygen concentration ranges from 0 molm-3 (blue) to 0.2355 molm-3 (red). The 
simulation were run at 𝑢𝑔 = 0.005 m ∙ s
−1. 
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Figure 6.15 The CFD simulation of mass transfer in the airlift bioreactors under 
hypoxia condition. 
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Table 6.5 summaries calculated mass transfer coefficients (𝑘𝐿𝑎) under hypoxia 
condition, 5% oxygen by volume, of all designs of the airlift bioreactors.  
 
Table 6.5 The summary of the mass transfer coefficient under hypoxia condition 
 
 
 
 
 
* The equilibrium dissolved oxygen (CL*) ~ 0.022 mol ∙ m−3. 
 
A maximum cell concentration (𝑥𝑚𝑎𝑥) can be calculated from equation (6.11). 
𝑥𝑚𝑎𝑥 =
𝑘𝐿𝑎
𝑞0
𝑐𝐿
∗
 
(6.11) 
 
Where 𝑞0 is the specific rate of oxygen consumption rate. For the example of the AL3 
at the superficial gas velocity 𝑢𝑔 = 0.005 m ∙ s
−1, 𝑘𝐿𝑎 = 0.0195 s
−1. The average 
rate consumption of oxygen of human dermal fibroblasts is 1.19𝑥10−17 mol ∙
cell−1s−1(Streeter and Cheema, 2011). For the 100 mL bioreactor, it can 
accommodate 3.6 billion cells. One of examples of scale-up system based on adherent 
cell culture is multilayer flasks (6,300 cm2 surface area for 10-layer vessel) which 
allow 500 – 600 million cells to be harvested (Rowley, 2010). It showed that the 
designed airlift bioreactor can accumulate very high production of cells. 
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Figure 6.16 The spatial distribution of the dissolved oxygen in AL1 under the hypoxia 
condition. The oxygen concentration ranges from 0 molm-3 (blue) to 0.0237 molm-3 
(red). The simulation were run at 𝑢𝑔 = 0.005 m ∙ s
−1. 
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6.3.7 The effect of the solid on the bubble column 
 
The purpose of this section is to demonstrate how flexibility of using CFD to simulate 
a bioreactor system, a bubble column in this case. Figure 6.17 and Figure 6.18 show 
the gas holdup of the 3-phase and 2-phase, respectively. The inlet gas velocity was set 
at 0.005 m ∙ s−1. The system which used in this simulation is the modified AL1. The 
system is called bubble column because the draft tube was removed from the system. 
 
 
Figure 6.17 The spatial distribution of the gas holdup under 3-phase system. The 
simulation were run at 𝑢𝑔 = 0.005 m ∙ s
−1. The gas holdup values range from 1x10-15 
(blue) to 0.04597 (red).  
 
It was observed that the gas enter the base of the bubble column, noticeably from a 
very high gas holdup. At the top part of the bubble column (near the gas-liquid 
separation section in airlift bioreactor), there are areas which occupied by the gas near 
the wall of the column. The flow of the gas inside the bubble column is less uniform 
than the circulation pattern in the airlift bioreactor (AL1) where the gas was 
maintained in the draft tube and left the column at the gas-liquid separation section. 
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When comparing two-phase (Figure 6.17) and three-phase system (Figure 6.18), The 
gas holdup at the bottom of the of the three-phase system is higher than the two-phase 
system. At the middle of the column, the three-phase system had less gas holdup 
because the space has be shared with the solid phase (hydrogel). 
 
Figure 6.18 The spatial distribution of the gas holdup under 2-phase system. The 
simulation were run at 𝑢𝑔 = 0.005 m ∙ s
−1. The gas holdup values range from 1x10-15 
(blue) to 0.04597 (red). The mean diameter of hydrogel is 2 mm and the initial volume 
fraction is 0.02. The hydrogel bead density 1050 𝑘𝑔 ∙ 𝑚−3. 
 
The flow pattern of the gas inside the bubble column in both two-phase and three 
phase system are similar manner except the gas holdup in two-phase system is a bit 
lower than the three-phase in some areas.  
Figure 6.19 shows the spatial distribution of the solid holdup, alginate bead, in the 
bubble column. The operating condition is the same as described in Figure 6.17 and 
Figure 6.18. It was observed that the alginate beads are mainly at the bottom of the 
column because the induced force from the inlet gas is not enough to lift the solid 
particles upward. The very high solid hold (0.94) was observed near the sparger area. 
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Figure 6.19 The spatial distribution of the solid holdup under 3-phase system. The 
simulation were run at 𝑢𝑔 = 0.005 m ∙ s
−1. The gas holdup values range from 1x10-15 
(blue) to 0.9412 (red). 
 
The three-phase system simulation might need more adjustment in order to give more 
details, such as the circulation of hydrogel bead inside the bubble column. The 
presented results were transient-simulation for 20 seconds which took a day and 4.5 
hours to finish. The Wen Yu drag force was used for solid-liquid interphase 
momentum transfer correlation which same as the one used in a literature (Wang et 
al., 2011). Moreover, the lighter density (1003 𝑘𝑔 ∙ 𝑚−3) of alginate bead was used in 
a CFD calculation (Consolo et al., 2009). The real measurement of the hydrogel 
density might be needed. 
However, with the current computational power which was used in this study. It might 
not be suitable to add more complexity in the calculation. The higher computational 
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power is required for the CFD calculation that related to three-phase system and 
biochemical reactions. 
 
6.4 Summary 
 
In this chapter, the three different configuration airlift bioreactors were simulated by 
means of the computational fluid dynamics (CFD). Transient simulation results 
revealed many phenomena in the airlift bioreactors. The computational was 
significantly improved by the change of the domain from the default setting, 
tetrahedral, to the hexagonal grids. The computational time was improved by 38 times 
faster; therefore, it might be possible to add more details into the multiphase airlift 
bioreactor models. 
For the hydrodynamicsgas holdup, superficial liquid velocity, and the shear rate the 
CFD can be used to characterise and troubleshoot the operating condition of the airlift 
bioreactors. CFD can predict the conditions which the fluctuation of the parameters 
will occur.  
For the mass transfer simulation, the CFD can predict the volumetric mass transfer 
coefficients which are higher than other type of bioreactors, i.e. spinner flasks and 
wave bioreactors, in biotechnology industry. The airlift bioreactors are suitable for the 
process in which the oxygen is the limiting reagent in the biochemical reaction. 
The CFD is flexible and be able to capture all the change of the airlift bioreactor in 
terms of size and configuration. The same model can be used either for the airlift 
bioreactor or the bubble column, the airlift bioreactor which the draft tube was 
removed. 
  
 
 
 
 
 
 
 
7 STEM CELL BIOPROSESSING: CULTURING OF 
MURINE EMBRYONIC STEM CELLS IN AN 
AIRLIFT BIOREACTOR 
 
7.1 Introduction 
 
Stem cell bioprocessing relies on robust and reproducible culture conditions and 
processes (Placzek et al., 2009). Figure 7.1 describes the principle designs for stem 
cell bioprocessing including process requirements, process function, and process 
components. There are many issues which are included in the process requirements 
such as bioprocess characterisation, bioprocess monitoring, bioprocess control, 
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automation, data management, regulation, validation, quality assurance, harvesting, 
storage, and transportation. Process function consists of organogenesis, integration, 
functionality, longevity, and immunogenicity. Process components consist of cells, 
signals, scaffolds, and bioreactors.  
This chapter is considered as a part of process components which is focusing on the 
3D (3-Dimentional) culture of the murine embryonic stem cells (mESCs) in an airlift 
bioreactor as well as the use of calcium-alginate hydrogel as a cell scaffold. 
 
 
Figure 7.1 A schematic diagram describes design principles of stem cell 
bioprocessing adapted from Placzek et al. (2009). 
 
Bioreactors have been used for culturing embryonic stem cells because they provide a 
3D environment and the possibility of the clinical relevant quantity cell production. 
Some of the bioreactors that have been used in culturing different cells are rotating 
wall vessels (Hwang et al., 2009; Siti-Ismail et al., 2012), stirred bioreactor (He et al., 
Design principles for stem cell 
bioprocessing
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Process 
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Process 
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2012), spinner flask (Akasha and Elouz, 2012), and perfusion bioreactor (Bauwens et 
al., 2005). 
Recently, an airlift bioreactor has been introduced to be used for culturing the cells 
and this bioreactor has been applied in the culture of murine bone marrow cells 
(Highfill et al., 1996). Although this system provides a homogeneous environment and 
it is possible to sample and scale up, there is a problem associated with bubbles during 
operation. As culture medium contains serum, foams are normally generated when gas 
was sparged into the system as the gas velocity increased. 
One of the benefits using the airlift bioreactor in stem cell application is this system 
can mimic the environment in the lung where an air directly exposes to alveolus cells, 
such as pneumocyte cells. Therefore, the use of airlift bioreactor not only increases the 
cell number up to a standard to be used for clinical application but also mimics the 
environment in the lung. In order to harness the benefit of the airlift bioreactor, the 
main problem of using this bioreactor needs to be addressed. 
To overcome the problem with bubbles formation in bioreactor system, researchers 
have used antifoam solution that plays an important role in bioreactor scale up where 
the sparging gas was involved. Foaming in the bioreactor can cause many problems 
such as in the system sterilisation (Varley et al., 2004), efficiency during removing the 
exhausted gases, and disturbance during monitoring equipment in the process. 
Therefore, in many bioprocess, foam control strategy is really important to consider 
(Hesse et al., 2003; Yeh et al., 2006; Routledge et al., 2011). 
In this chapter, the ultimate goals are (1) to determine the toxicity of antifoams on 
mESCs and the feasibility of the use of antifoams in sparged-type bioreactor for foam 
control purpose and (2) to culture the mESCs in an airlift bioreactor.  
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These goals of this chapter could be achieved by applying some objectives which are: 
(1) to study the toxicity of the antifoams used toward the murine embryonic stem cells 
(mESCs) and (2) to study the feasibility of culturing of mESCs in the airlift bioreactor 
(AL1). 
 
7.2 Methodology 
 
The mESCs were expanded in tissue culture flasks (as described in chapter 3). In order 
to employ the 3D environment, encapsulation of cells in alginate hydrogels were 
applied (see section 3.1.3). Some experiments which were related to this chapter were 
discussed in here. 
 
7.2.1 The study of antifoam toxicity 
 
The encapsulated mESCs were cultured in the maintenance medium (components of 
culture medium were discussed in chapter 3). The study was conducted in 6-well 
plates, as shown in Figure 7.2. The medium to the bead ratio was 1 mL per 10 beads 
(20 beads per well were used). The antifoams used in this study were antifoam A, and 
antifoam 204 (both were from Sigma-Aldrich). The antifoam A is an active silicone 
polymer 100 % whereas antifoam 204 is a mixture of organic polyether dispersion. 
The concentrations of all antifoams were varied from 0 to 0.02% (by volume). 
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Figure 7.2 A picture of 6-well plate showed a study of antifoam toxicity. 
Encapsulated mESCs were cultured for 7 days. 
 
Two groups were studied: (1) a group of 3D static culture which the encapsulated cells 
were placed in static condition of tissue culture flask or well-plates (as illustrated in 
Figure 7.2) and identified as batch culture. The number of cells per bead was 
determined by MTS assay. The supernatant of fresh and used culture media were 
analysed their compositions, nutrients and metabolites, by the Bioprofiler; and (2) a 
group of 3D air lift bioreactor system. 
 
7.2.2 Culture of 3D encapsulated mESCs in an airlift bioreactor 
 
Encapsulated mESCs (1000 beads) were cultured in the airlift bioreactor (AL1), 
supplemented with 100 mL of the maintenance media. A schematic diagram as shown 
in Figure 7.3 explained the experiment setup for the culture in the airlift bioreactor 
(AL1). The gas, 5% CO2 in air, inside the incubator was pumped to the airlift 
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bioreactor through the flow meter in order to regulate the flow rate of the gas. The 
exhausted gas then escaped from the top of the airlift bioreactor. The air filters were 
designed in the flow system to ensure the sterilisation of the airlift bioreactor system. 
A control experiment of the culturing of encapsulated mESCs in the airlift bioreactor 
and the bubble column was encapsulated mESCs in calcium-hydrogels (500 beads) 
culturing in a T-175 flask (with 50 mL culture medium). 
 
Figure 7.3 A schematic diagram in airlift bioreactor setup. The airlift bioreactor 
system consisted of air pump, flow meter, filters, and the airlift bioreactor. The use of 
filters can ensure the sterile condition inside the airlift bioreactor. 
 
All compartments of the bioreactor system were put inside the well temperature 
controlled incubator at 37 oC with oxygen content at 20%. 
The study of mESC culture in airlift bioreactor was performed up to 7 days of culture 
and with a batch mode of culture. The proliferation was assessed by MTS. Details of 
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Filter 
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live/dead assay, MTS assay, cell’s imaging, nutrient and metabolite analysis, and 
statistical analysis were described in chapter 3. 
 
7.3 Results and discussion 
 
7.3.1 The effect of the 2D and 3D system to mESCs 
 
Figure 7.4 shows top view of the encapsulated mESCs in calcium-alginate hydrogel 
(bead) which taken by confocal microscope (Leica camera, Germany). The beads are 
homogeneous and the sizes of beads were 2.3 mm in diameter. The hydrogel 
encapsulation is an attractive candidate for the 3D platform for the cell culture in 
tissue engineering and regenerative because of their uniform size of the hydrogel bead 
which makes the operations in the bioreactor homogeneous and subsequent products 
are the similar quality. 
Alginate beads which have similar properties are found to have pore size of 0.5 – 1.0 
µm which equals to 66.2 kDa and 97.4 kDa from the permeability analysis (McConell 
et al., 2004; Randle et al., 2007). Important molecules such as LIF (20 – 60 kDa), 
oxygen (32 Da), and glucose (18 Da) were not limited their transport through beads by 
the pore size of the alginate beads. The mESCs which have the diameter of 20 µm 
were retained inside the alginate beads. Large molecules such as the smallest 
immunoglobulin: immunoglobulin G (IgG) antibodies with a molecular weight of 150 
kDa would not pass through the bead. This could avoid problem with immune 
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rejection during transplantation by using alginate hydrogel as protective agent (Lanza 
et al., 1995). 
 
Figure 7.4 A picture shown encapsulated mESCs in alginate-hydrogel beads. The 
cells remain single cell suspension in the beads. The beads had the diameter of 2.30 
mm. The image was taken at 4x magnification of the objective lens. 
 
Figure 7.5 shows difference shape of cell morphology in 2D and 3D culture. Routine 
mESCs culture is normally expanded on 2D T-flasks which has some limitations: (1) 
the 2D system does not represent 3D in vivo microenvironment; and (2) the 2D system 
cannot provide a higher number of cells for clinical application on a limited area. The 
mESCs are normally passaged on day 3 (70-80% confluence) of the culture. Normally 
30 million cells were obtained from a monolayer culture on T-75 flask. Besides, each 
passaging process exposed the cells to chemical or mechanical disruption which affect 
the cell viability. In contrast to 2D culture condition, mESCs cultured on static 3D 
system can be maintained in alginate beads without involving any passaging step that 
exposed the cells to chemical or mechanical disruption. Moreover, after 3 days on 3D 
static culture (Figure 7.6), higher cell expansion was obtained up to 1×105 cells per 
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single alginate bead. For each set of experiment run, 500 beads were prepared and 
after 3 days in cultured, cells were produced up to 50 million of total cell in the 
system. This benefits on overcoming the space limitation and higher mass production 
of cells in each culture. 
Figure 7.5 shows morphology of cells in 2D and 3D system on day 3 of culture period. 
In comparison, the 3D culture can maintain the 3D structure of the cells (Mroue and 
Bissell, 2013). Moreover, future approach by using hESCs culture in alginate beads 
showed that the level of cells pluripotency (undifferentiated stage) was remained high 
even after 260 days ub culture without any passaging process (Siti-Ismail et al., 2008). 
 
(a) 2D culture  (b) 3D culture  
  
 
Figure 7.5 Pictures showed different morphology (shape) of cells in culture. (a) cells 
cultured on 2D (T-flask) formed flatted colony-shape with (b) cells cultured on 3D 
alginate bead remained as single cell suspension. On the 3D system, the mESCs 
experience the 3D environment which is surrounded by alginate solution and nearby 
cells. (a): 10x objective, (b): 4x objective 
 
 
200 µm 1000 µm 
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7.3.2 Effect of antifoams on mESC proliferation 
 
The encapsulated mESCs were cultured in static condition up to 7 days. An amount of 
2 mL of maintenance medium was used per 20 alginate beads. The maintenance 
medium was changed every other day. Surface-active antifoams were also added into 
the culture medium. Studies have shown that surface-active antifoams can minimise 
cell damage by decreasing cell-bubble attachment, but must be evaluated for stem-cell 
toxicity (King and Miller, 2007).  
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Figure 7.6 A graph of the proliferation growth of mESCs cultured in different type of 
antifoams up to day 7 which assessed by MTS assay (n=3). Antifoam A exhibited a 
higher cell growth compared to antifoam 204 which indicated less cytotoxic effect to 
the cells. 
 
As shown in Figure 7.6, the growth proliferation of mESC was assessed by the MTS 
assay up to day 7. Each absorbance collected at 490 nm is proportional to the viable 
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cells in the culture. The silicon-based antifoam, antifoam A, has no effect on the 
mESC proliferation when compared to control group i.e. no antifoam system.  
A mixture of non-silicone organics in a polyol dispersion (Antifoam 204) was found 
not suitable for mESC bioprocessing, although antifoam 204 was used in pullulan 
production by Aureobasidium pullulans ATCC 42023 (West and ReedHamer, 1995). 
Hence, the selection of antifoams is a crucial step in stem cell bioprocessing because it 
might lead to the cell toxicity effect during the beginning of bioprocess. 
The ideal antifoams should not affect the growth proliferation of stem cells and their 
differentiation capacity. In a bioreactor system in which sparged gas is introduced to 
the system and the use of antifoams is important when applying sparged gas into the 
bioreactor system to control foam formation. 
Figure 7.7 shows glucose profiles during 3D static culture of mESCs obtained from 
the Bioprofiler. In this study, the fresh media were supplied every other day in order to 
provide a high concentration of glucose to the mESCs. Based on the manufacturer 
datasheet, the glucose level of fresh media is 25 mM. In embryonic stem cell culture, 
the main nutrient source is glucose. The mESCs consumes glucose during the culture. 
Monitoring the glucose concentration is an analogous to monitoring the proliferation 
of the cells. We found that the antifoam A has similar trend of the glucose 
consumption as the non-antifoam system suggests that the antifoam is safe to use for 
culturing mESCs. However, the glucose profiles in the medium with antifoam 204 
remained high during the culture which might relate to the low proliferation of the 
mESCs in this system. 
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Figure 7.7 A graph of Glucose profiles from different groups of mESCs cultures in 
antifoam study. The culture medium was refreshed every other day. Hence, on day 2, 
the glucose level of antifoam 204 containing culture was at the same level with the 
fresh medium indicating that there was no proliferation of mESCs during the cell 
culture which may lead to cell death.  
 
In mammalian cell culture, cells secrete waste metabolites such as lactate after a 
respiratory cycle during the cell growth. Hence, the more lactate concentration, the 
more proliferation of the cells. As shown in Figure 7.8, the lactate profile can be used 
as an indicator for the cell growth. Based on MTS assay profiles from antifoam 204 
group, the lactate level was very low after a day of the culture indicating that the cells 
had very low growth rate that may lead towards cell death from cytotoxicity effect of 
the substance, the antifoam 204. Precisely, the lactate level is at 0 mM because the old 
media were discarded and replaced by the fresh media every other day. 
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Figure 7.8 A graph of lactate profiles during the culture of mESCs in the antifoam 
study up to day 7 of culture. 
 
Figure 7.9 shows morphologies of the encapsulated mESC in alginate bead on day 5 
of the culture. The pictures were selected from antifoam study but it shows similar 
trend was also observed. The viable cells formed a bigger size of colonies while the 
dead cells remained as a single cell form.  
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0% antifoam A 0% antifoam 204 
  
0.02% antifoam A 0.02% antifoam 204 
  
 
Figure 7.9 Morphology observed by light microscope of encapsulated mESCs on day 
5 of culture. The mESCs on the absent of antifoams formed  bigger colonies but the 
mESCs in antifoam 204 system remained single cell suspension meaning there was 
adverse effect of the antifoam to the mESCs growth. 10x objective.  
 
Figure 7.10 shows the morphologies of mESCs assessed by light microscope and 
fluorescent microscopes for live/dead analysis. The viable cells formed bigger 
colonies over the culture period while the dead cells remained as a single cell in 
culture. For this live/dead analysis, the viable cells were stained with Calcein AM 
(green) while the non-viable cells were stained with Ethidium homodimer-1 (red). 
Based on the picture, more dead cells were observed from antifoam 204 (mixture of 
organic polyether) culture, indicating that this antifoam is toxic to mESCs. 
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(A) 0% antifoam (B) 0.02% antifoam 204 
  
(C) 0% antifoam (D) 0.02% antifoam 204 
  
 
Figure 7.10 Pictures of morphology and viability assay of encapsulated mESCs on 
day 7 of culture. Live/dead analysis (A and B) was observed by fluorescence 
microscope. Calcein AM (green) staining indicated viable cells and non-viable cells 
were stained by Ethidium homodimer-1 (red). Light microscope was used to capture 
of morphologies of non-antifoam culture (C) and 0.02% (by volume) of antifoam 204 
(D). mESCs formed larger colonies as the proliferation proceeded, whereas they 
remained single cell suspension when there was no proliferation. (C) and (D): 10x 
objective. (A) and (B): 20x objective.  
 
Figure 7.11 shows morphologies and florescent images of the live/dead analysis. The 
encapsulated mESCs were assessed on day 7 of culture. The concentrations of 
antifoam A have no effect on the mESC morphology and their proliferation (Figure 
7.6). Recent studies on the effect of antifoam to the mESCs have suggested that 
0.0125% of antifoam C was suitable for the culture of mESC in a stirred tank 
bioreactor which formed satisfied embryo bodies (Schroeder et al., 2005). 
200 µm 200 µm 
200 µm 200 µm 
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(A) 0.01% antifoam A (B) 0.02% antifoam A 
  
(C) 0.01% antifoam A (D) 0.02% antifoam A 
  
 
Figure 7.11 Pictures of Morphologies and viability assay of encapsulated mESCs on 
day 7 of culture by varying concentration of antifoam A. Live/dead analysis (A and B) 
was observed by fluorescence microscope. The viable cells were stained by Calcein 
AM (green) where the non-viable cells were stained by Ethidium homodimer-1 (red). 
The light microscope was used to observe the cell morphologies: (C) 0.01% (by 
volume) and (D) 0.02 (by volume) antifoam A. The large colonies of cells indicated 
that the cell growth was promoted inside the alginate hydrogels. (A) and (B): 20x 
objective. (C) and (D) 10x objective.  
 
7.3.3 Airlift bioreactor versus static culture 
 
Figure 7.12 shows top, side, and front views of the airlift bioreactor (AL1). The details 
of this airlift bioreactor were given in chapter 5 of this thesis. The materials used in 
the airlift bioreactor are summarised in Table 7.1. The Delrin rod was used in the draft 
200 µm 200 µm 
200 µm 200 µm 
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tube, sparger, and the column cover section. The Delrin rod or polyoxymethylene was 
normally used in as part of component in a bioreactor (Penick et al., 2005). 
 
 
Figure 7.12 A schematic diagram of drawing for the AL1 for bioreactor assemble. 
The dimensions were shown in millimetre unit.  
 
Table 7.1 Summary of materials used in the airlift bioreactor assemble.  
Component Material 
Outler column Polycarbonate (Metal & Plastic Ltd, UK) 
Draft tube Delrin rod (Metal & Plastic Ltd, UK) 
Sparger Delrin rod (Metal & Plastic Ltd, UK) 
Column cover Delrin rod (Metal & Plastic Ltd, UK) 
 
Figure 7.13 demonstrates the culture of encapsulated mESCs in the airlift bioreactor 
(AL1). An amount of 1,000 encapsulated cells in calcium-alginate beads were 
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prepared which supplemented with 100 mL of mESC maintenance medium. The beads 
were taken and analysed with MTS assay and confocal microscope every other day. 
The control group i.e. 3D static culture contained 500 encapsulated beads in T-175 
flasks was prepared. The 3D static was supplied with 50 mL of mESC maintenance 
medium in order to keep the same medium to bead ratio as in the airlift bioreactor 
system. The T-175 flasks were used because they could provide more surface area for 
maximising oxygen transfer from an incubator environment to the culture medium and 
to the alginate bead surface. The oxygen is a limiting factor in many tissue 
engineering applications and regenerative medicine (Bambrick et al., 2011). 
 
 
Figure 7.13 A schematic diagram of mESCs experiment cultured in airlift bioreactor 
(AL1) inside 5% CO2 incubator. 
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Figure 7.14 shows MTS assay for encapsulated mESCs cultured in 3D static and airlift 
culture. Both airlift bioreactor and 3D static culture were batch system. As shown in 
Figure 7.13, it is possible to make the airlift bioreactor as a continuous system but the 
purpose of this initial stage is to confirm if there is possibility for encapsulated mESCs 
to be successfully cultured in the airlift bioreactor. Therefore, the airlift bioreactor 
system was designed as simple as possible in order to make easy for detecting any 
troublesome. The data from MTS assay was analysed every 2 days, starting from day 
1 of the culture. The growth kinetic of the mESCs in the 3D static culture was 
increased until it reached the stationary phase up to day 5 but in this set of experiment, 
the growth of the encapsulated mESCs was decreased from day 5 to day 7. This 
probably caused by the depletion of nutrients or the metabolite toxicity due to the 
accumulation of lactate and ammonium (NH4
+) in the system. 
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Figure 7.14 A graph of MTS analysis of mESCs in both airlift bioreactor and static 
culture. Both 3D static and airlift bioreactor system were performed in batch culture. 
The decease of cell growth from day 3 to day 7 probably caused by the depletion of 
nutrients. 
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The antifoam, 0.01% antifoam, used in this study is non-toxic to the encapsulated 
mESCs. From Figure 7.14, it shows that the death rate of encapsulated mESCs in the 
airlift bioreactor is higher than their growth rate. It was observed that there were 
viable cells on both day 1 and 3 but the cells were non-viable afterwards. The reason 
why the encapsulated mESCs cannot survive inside the airlift bioreactor would 
probably cause by the material used for assembling the airlift bioreactor. Although, the 
main column of the airlift bioreactor is made by polycaponate which were widely used 
in tissue engineering as a scaffold or the bioreactor component (Altmann et al., 2011; 
Kim et al., 2011), there are controversial issues of using Delrin, polyoxymethylene, in 
tissue engineering application. In human mesenchymal stem cells (MSCs) 
differentiation study (Penick et al., 2005), the conditioned media obtained from long-
term exposure to polyoxymethylene was used during the differentiation process. 
Within the 20 times autoclave and the 3rd week of the differentiation process, the 
conditioned media was not affecting the hMSCs proliferation or differentiation. In 
other case, polyformaldehyde is not suitable for expansion of hematopoietic 
progenitor cells (LaIuppa et al., 1997). Acetal resin was also reported to have 
cytotoxic effect on the fibroblasts growth (Ata and Yavuzyilmaz, 2009).  
The Delrin® which is produced by Dupont™ is known as many names such as 
polyoxymethylene (POM), acetal resin, polyformaldehyde. The simple molecular 
formula is (CH2O)n. Suggestions on selection of the materials, especially the Delrin 
rod, are (1) carefully screen the potential released substances from the Delrin rod 
which might be toxic to the cultured cells, or (2) by using any possible alternative 
materials, such as polycarbonate or glass, that could resist the heat during the 
autoclave process.  
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Figure 7.15, which corresponded to Figure 7.14, shows metabolite and nutrient 
profiles for the encapsulated mESCs cultured in 3D static and airlift bioreactor. The 
pH level was shown only for the 3D static culture because the analysis of the pH from 
the Bioprofiler was not accurate for frozen samples. Hence, the fresh samples are 
recommended for the analysis of pH form the machine. However, the pH level of the 
3D static culture was 7.4 which mean the media were still in the buffer capacity. The 
mESCs consumed glucose and secreted lactate as a waste metabolite. For glucose 
consumption, the less glucose concentration in the culture, the more cell growth was 
observed. 
 
Figure 7.15 A graph of metabolite profiles of airlift bioreactor and static culture, N=1. 
Results, such as pH at day 3 and lactate level at day 1, are not shown here because 
their values are out of the detectable range of a machine (Bioprofiler 400). 
 
Based on the growth rate in 3D static culture, the glucose concentration was decreased 
with culture time up to day 7. The fresh medium was supplied at day 0 with the 25 
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mM of glucose and concentration on day 7 of the culture was 8 mM. However, the 
glucose concentration in the airlift bioreactor remained high throughout the culture 
period indicating that the dead rate was higher than the growth rate of mESCs. In 
contrast, lactate level in the airlift bioreactor was low, almost not secreted in the 
system. These findings corresponded to the high glucose profile in the culture 
indicating that no nutrient consumption with less lactate secretion. On the other case, 
the lactate level in the 3D static system was increased over the culture period. On day 
1 of the 3D static culture, the lactate level was under the measurable level, i.e. below 2 
mM. However, the lactate secretion was increased between day 5 and 7 which 
probably might lead to the metabolic stress on mESCs. The growth of mESCs was 
also dropped during the period (Figure 7.14). In order to maximise the stem cell 
bioprocess efficiency, the removal of the waste metabolites is needed. The removal of 
metabolites could be achieved by running the bioprocess in continuous mode or 
changing the fresh medium frequently. 
Figure 7.16 shows MTS assay of sparged bioreactors and 3D static culture. The 
sparged bioreactors are consisted of the normal sparged bioreactor (shown in Figure 
7.17) and a bubble column bioreactor which modified from AL1 airlift bioreactor 
design. The draft tube, made by Delrin rod, was removed therefore the remaining 
column is called bubble column. This modification is flexible in term of geometry for 
the sparged type bioreactors, i.e. the bubble column and airlift bioreactor.  
This section emphasised on; (1) to test the cytotoxicity of the Delrin rod which were 
made in other parts and (2) to study the effect of the sparged gas on mESCs. 
Based on MTS assay profile, (Figure 7.16), it showed some cytotoxic effects mostly 
because of leaching substance which possibly contained formaldehyde from the Delrin 
| 173 
 
rod leaching during the mESC culture. This problem is probably caused by leaching 
process of the substance during the sterilisation step by autoclaving. The maximum 
repeated autoclave of the Delrin rod in the bioreactor must be identified to ensure that 
there are no leaching substances from the materials. A high quality of Delrin rod must 
be selected and the autoclave cycle should not be more than 20 cycles (Penick et al., 
2005). 
 
 
Figure 7.16 A graph of MTS assay of sparged bioreactors and 3D static culture.* p < 
0.05 (n=3, One-way ANOVA by SigmaStat 3.5). All cultures were performed in batch 
cultures. 
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Figure 7.17 shows the experiment setup for sparged bioreactor. The system was 
designed similar to the airlift bioreactor system. The gas inside an incubator was 
passed through the air pump (right), flow meter and filter before released into the 
sparged bioreactor. The gas (5% CO2 in air) was fed to the sparged bioreactor at the 
top of bioreactor and the exhausted gas escaped using the different tube at the top of 
the bioreactor. Filters were placed at the inlet and the outlet of gas source to ensure the 
sterilisation step for the system. 
Figure 7.16 shows the comparison between the control group (3D static culture) and 
the experiment group (sparged bioreactor) for mESCs maintenance and expansion 
during the beginning of the culture which resulting in the sparged gas was not toxic to 
the mESCs. It was observed from the airlift bioreactor system that if there is any 
cytotoxicity to the mESCs, it should be affected the culture during the early stage of 
growth. The growth of the mESCs in 3D static culture was higher than the sparged 
bioreactor, which shown by the statistical analysis. For the sparged type bioreactors, 
including airlift bioreactor and bubble column, the mass transfer of the oxygen was 
higher than the conventional flask culture due to the fact that direct gassing was 
supplied to the system. At the beginning of the culture, mESCs preferred a low oxygen 
level to maintain their pluripotency and expand the number of cells. A higher oxygen 
level might involve during stage of mESCs maturation. 
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Figure 7.17 A picture of mESC experiment culture set-up for the sparged bioreactor. 
 
7.4 Summary  
 
In this chapter, the stem cell bioprocessing of embryonic stem cell needs bioreactor 
system for a high number of cells. 
In the sparged bioreactors, such as airlift bioreactor, foaming is one of the main 
problems that need to be solved before considering other parameters in the system. It 
has shown that the silicone based antifoam, Antifoam A is safe for mESCs growth but 
the Antifoam 204 is toxic to the mESCs. 
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Figure 7.18 A schematic diagram of guideline for success culture of mESCs in the 
airlift bioreactors. 
 
A guideline for successful bioprocessing of mESCs in the airlift bioreactors is shown 
in Figure 7.18. Firstly, operators need to be trained to ensure the sterilisation technique 
and reproducible manners are under controlled. The gas which used to sparge into the 
system must be tested for toxicity level on the cells that grown inside the airlift 
bioreactors. The antifoams are the main agents that used to control foams in the 
system. The suitable antifoam must be identified for particular cell lines. The use of 
antifoam might be cell line dependent. The materials used for the system contraction 
must be safe for a long term use. In cell culture applications, the systems are routinely 
autoclaved at a high temperature and pressure for sterilisation purpose. The materials 
need to be confirmed that they will not release any toxic agents which potentially 
harmful to the cell growth. 
 
  
 
 
 
 
 
 
8 DIFFERENTIATION OF MURINE EMBRYONIC 
STEM CELLS TOWARDS TYPE II PNEUMOCYTES 
IN A 3D SPARGED BIOREACTOR  
 
8.1 Introduction 
 
Lungs are the largest organs that contact to an outside atmosphere and their main 
function is for gas (CO2/O2) exchange, which makes them venerable to the 
environment. Therefore, lung diseases are among of leading causes of death 
worldwide For example, emphysema (Figure 8.1) is defined as the dilation of the 
airspaces with destruction of alveoli (Bourke and Burns, 2011). Currently, the only 
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treatment available for emphysema as well as the end-stage lung diseases is to perform 
lung transplantation (Bishop and Polak, 2007). 
 
Figure 8.1 A schematic picture showing a normal lung structure and alveoli affected 
by emphysema. (http://www.britannica.com/EBchecked/topic/351473/lung). The left 
is shown the normal lung physiology while the right one shows the alveoli that 
affected by emphysema: the wall of the alveoli lose their elasticity and become 
enlarged.  
 
In the alveoli, there are two main types of cells: type I and type II pneumocytes. The 
type I pneumocytes are identified as squamous cells, cover almost 95% of the alveoli 
and responsible for the gas exchange. The type II pneumocytes are defined as cubical 
cells that produce lung surfactants which prevent the alveoli from collapsing. 
Moreover, the type II pneumocytes act as a local progenitor cells in the alveoli, 
meaning that they can differentiate into types I cells. 
In mouse development (Figure 2.4), before the pseudogladular stage is the embryonic 
stage which the formation lung budding from the foregut endoderm, and formation of 
trachea and main stem bronchi (Warburton et al., 2000; Shi et al., 2007). The lungs 
developed from endodermal lineages which depicted at E9.5 to E10. As it shown in 
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Figure 2.4, mouse embryo undergoes the development of the lung when the mouse 
alveolar cells are firstly detected in canalicular stage (E16.5 – 17.5). 
In the recent years, there have been many attempts that use embryonic stem cells in 
cell therapy for diseases associated with lungs such as respiratory distress syndrome 
(RDS) and emphysema. The embryonic stem cells (ESCs) have special properties: i.e. 
they have ability to unlimited expand and pluripotency in vitro culture. The 
differentiation of ESCs into type II pneumocytes were reported in both mouse (Ali et 
al., 2002; Rippon et al., 2004; Cohen et al., 2006; Rippon et al., 2006; 
Samadikuchaksaraei and Bishop, 2007; Winkler et al., 2008; Roszell et al., 2009a; Lin 
et al., 2010) and human (Samadikuchaksaraei et al., 2006; Wang et al., 2007; Siti-
Ismail et al., 2008; Wang et al., 2010). The most established differentiation protocols 
are currently involved embryoid bodies (EBs) except for protocol on using 
“dissociation seeding” (Roszell et al., 2009b). The differentiation of murine ESCs 
using 3D, alginate bead, and the use of the rotating wall vessel bioreactor (RWVs) 
improved the efficiency of the differentiation significantly (Siti-Ismail et al., 2012). 
Nonetheless, little attention has been paid to an effect of sparging gas on the 
differentiation of embryonic stem cells into the alveolar progenitor cells. 
From the previous chapter, an effect of antifoams on mESCs was addressed. 
Therefore, a use of antifoam in sparged bioreactors is possible to reduce problems 
associated with foam formation such as the CO2 removal efficiency. 
The goal of this chapter is to differentiate mESCs into pneumocyte type II cells in 3D 
environment. The objectives of this study are: (1) to study the effect of A549 
conditioned media on the differentiation of encapsulated mESCs into pneumocyte type 
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II cells; and (2) to identify the effect of sparging gas on the differentiation of 
encapsulated mESCs into the alveolar progenitor cells, type II pneumocytes. 
 
8.2 Methodology 
 
The expansion of mESCs and A549 cell line on 2D culture system were described in 
chapter 3 as well as the encapsulation and decapsulation processes for 3D culture 
system. The single step differentiation of mESC toward alveolar type II pneumocytes 
was performed in 3D system, in alginate beads. 
For cell characterisations such as cell morphology, live/dead assay, and MTS assay 
were detailed in section 3.2, 3.5, and 3.6, respectively. A gene expression profile was 
quantitatively analysed using real-time polymerase chain reaction (PCR). 
 
8.2.1 Real-time PCR 
 
RNA extraction and cDNA synthesis were described in chapter 3. Real-time PCR was 
done using SensiFASTý SYBR Hi-ROX Kit (Bioline Reagents Ltd) and detected by 
the Applied Biosystems StepOnePlus™ Real-Time PCR System (AB Applied 
Biosystems, Warrington, UK). The PCR reaction mix contained the ingredients which 
are shown in Table 8.1. 
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Table 8.1 A real-time PCR reaction mixture.  
Reagents Amount (µL) 
2X SensiFAST SYBR Hi-ROX mix 10 
10 µM forward primer 0.8 
10 µM reverse primer 0.8 
Template 2.0 
H2O 6.4 
Total  20 
 
The primers used in the chapter are summarised in Table 8.2. Gene expression profile 
can be used as the indicator for the cell differentiation process.  
PCR conditions included an initial polymerase activation of 2 minutes at 95 oC, 
followed by 40 cycles of PCR consisting of 2 seconds at 95 oC, 10 seconds annealing 
at 60 oC, and 5 seconds at 72 oC. Threshold cycle (Ct) values were analysed using 
2−∆∆𝐶𝑡 method (Livak and Schmittgen, 2001; Cohen et al., 2006). 
Amount of relative gene expression was normalised to an endogenous reference gene 
and relative to day 0 of the cells in a sparged bioreactor. A relative gene expression 
(RGE) was calculated using: 
RGE = 2−∆∆𝐶𝑡 (8.1) 
where ∆Ct = Ct (gene of interest) − Ct (house keeping gene), and ∆∆Ct =
∆Ct (test sample) − ∆Ct (day 0 of the sparged bioreactor). 
 
 
| 182 
 
Table 8.2 RT-PCR primer sequences (murine ES cells). GAPDH: Glyceraldehyde 3-
phosphate dehydrogenase, SPC: Surfactant protein c, FoxA2: Forkhead box protein 
A2, and Oct4: Octamer-binding transcription factor 4. 
Gene Primer sequence (5’ – 3’) Annealing 
temp. (ºC) 
Amplicon 
size (bp) 
GAPDH F: TGTGTCCGTCGTGGATCTGA 
R: CCTGCTTCACCACCTTCTTGA 
59 76 
SPC F: CAGCTCCAGGAACCTACTGC 
R: CACAGCAAGGCCTAGGAAAG 
63 200 
FoxA2 F: TGGTCACTGGGGACAAGGGAA 
R: GCAACAACAGCAATAGAGAAC 
59 289 
Oct4 F: GCCTTGCAGCTCAGCCTTAA 
R: CTCATTGTTGTCGGCTTCCTC 
54 127 
 
8.3 Results and discussion 
 
The mESCs were encapsulated in hydrogel beads as the method described in chapter 
3. The encapsulated mESCs were cultured in a sparged bioreactor as it is depicted in 
Figure 8.2, and the experiment was performed in a fed-batch mode. A culture medium 
was changed every two days.  
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Figure 8.2 Schematic of sparged bioreactor system. A gas inside an incubator was 
sparged into a sparged bioreactor. Filters (0.22 µm pore size) were used to sterile the 
inlet and outlet gas. 
 
Figure 8.2 shows a flow diagram of the sparged bioreactor system. The gas inside an 
incubator was fed by using air pump to the top of the sparged bioreactor. After the 
mass transfer of oxygen from the gas phase to the liquid phase (culture medium) 
occurred, the exhausted gases, such as CO2, was discharged from the top the sparged 
bioreactor through the 0.22 µm filter. The gas flowrate was at 20 mL ∙ min−1. A 3D 
static culture in a T-175 flask was used as a control of the culturing and differentiating 
mESCs in the sparged bioreactor. Culture medium was refreshed as the same manner 
as the one in the sparged bioreactor. 
The CFD models which were developed in chapter 5 and 6 were used to simulate the 
sparged bioreactor as shown in Figure 8.3. The simulation was at the inlet gas velocity 
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of 0.01 m ∙ s−1 (26.50 mL ∙ min−1. based on a sparger area) and only the medium 
containing region was simulated. The Figure 8.3 shows the gas holdup in the sparged 
bioreactor. The colour contour represents high gas holdup (red) and low gas holdup 
(blue). 
 
Figure 8.3 The CFD simulation of the sparged bioreactor. The sparged bioreactor was 
simulated by CFD software (CFX v. 13). The geometry of the bioreactor was same 
dimensions as the one used in this experiment. The CFD simulation was based on two-
phase (gas-liquid) and Eulierian-Eulierian mutilphase simulation as described in 
chapter 4.  
 
The gas holdup is an important parameter in the sparged-type bioreactor which affects 
heat and mass transfer, and liquid velocity in the bioreactor (Chisti, 1989). As it is 
shown in Figure 8.3, a gas, gas holdup = 1.00, was fed at the top of the sparged 
bioreactor then the gas was discharged near the bottom of the sparged bioreactor. This 
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ensures an oxygen transfer from a gas phase to a liquid phase (culture medium). The 
combination of exhausted gases and unused oxygen moved upward then escaped from 
the culture media and finally was discharged out from the sparged bioreactor. The 
green areas in Figure 8.3 represent an area in which a mixture of gas and liquid taking 
place. From CFD result, it is possible to use CFD as a characterise tool in tissue 
engineering and regenerative medicine where the use of detection probes in 
bioreactors is impractical (Patrachari et al., 2012). The sparged bioreactor in this study 
is relatively small (c.a. 100 mL working volume), therefore, the use of measuring 
probes is difficult.  
The bioreactor culture was performed inside humidified incubator with 5% CO2 in air. 
Figure 8.4 shows an experiment setup for the mESCs differentiation into the alveolar 
progenitor cell, pneumocyte type II. The media contained as a pH indicator which we 
can use as a guide for changing the media when it becomes acid. The media was 
changed every 2 or 3 days depending on the growth of differentiated mESCs. 0.01% 
(by volume) antifoam A (Sigma-Aldrich, UK) was added to culture medium in order 
to reduce foam formation in the culture. 
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Figure 8.4 The sparged bioreactor setup for the differentiation of mESCs into alveolar 
progenitor cells. Phenol red containing medium can be used as an indication for acidic 
condition (yellow, pH 6.8) and basal condition (dark pink, pH 8.2). 
 
8.3.1 Morphology of murine embryonic stem cells 
 
A light microscope was used to observe mESC morphology inside alginate beads. A 
colony size is one of indicators that can be used to identify the growth of the 
encapsulated mESCs. Figure 8.5 shows some pictures from a light microscope during 
5 weeks of differentiation process. On day -3 (the starting day of the expansion 
process (Figure 8.5)), the mESCs in both 3D static culture and sparged bioreactor are 
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similar pattern in term of sizes and morphologies—the mESCs remain single cell 
suspension in calcium-alginate hydrogels. On day 7 (Figure 8.5 and Figure 8.6), the 
growth of the differentiated mESC in 3D static culture is greater than differentiated 
mESCs in sparged bioreactor, larger of the cell colonies were observed. On day 14 - 
15, the growth of the differentiated mESCs is the same trend. In the 3D static culture 
system, the outgrowth of differentiated mESCs was observed from the hydrogel while 
the mESCs in sparged bioreactor are growing inside the hydrogels (Figure 8.5 and 
Figure 8.6). The result indicated that there are some space limitations in the 3D static 
system since the mESCs grow faster than in the sparged bioreactor. However, day 15 
is the middle of a standard protocol (Siti-Ismail et al., 2012). In order to let the mESCs 
fully matured, a trade-off between the growth rate and the differentiate capability is 
needed. The mESCs might grow faster but they are not desired mature cells yet. 
Moreover, during the first 15 days of the differentiation process, the alginate beads 
retained their spherical shape. The similar beads were reported that there is no 
limitation of the mass transfer of main nutrients (such as glucose and oxygen) and 
metabolite wastes (Randle et al., 2007). 
 
  
| 188 
 
 
Figure 8.5 The micrographs of encapsulated mESCs during the differentiation 
process. A single cell suspension was observed at the beginning of the differentiation 
process, the single cells start to form small aggregates that grew larger over time. The 
encapsulated mESCs were cultured in the sparged bioreactor (A, C, and E) and the 
static culture (B, D, and F). The scale bars are 1000 µm. 
Sparged bioreactor 3D Static culture 
Day -3 Day -3 
  
Day 7 Day 7 
  
  
Day 15 Day 15 
  
1000 µm 
1000 µm 
1000 µm 
1000 µm 
1000 µm 
1000 µm 
(A) (B) 
(C) (D) 
(E) (F) 
| 189 
 
Figure 8.6 The micrographs of the differentiated mESCs during the differentiation of 
mESCs into pneumocyte type II cells. Large cell aggregates on day 7 became the 
larger aggregates on day 15 of differentiation process. It was indicated that mESCs 
grew over the time. The scale bars are 200 µm. The objective magnification are 10x 
(A and B) and 20x (C and D).  
 
As the differentiated mESCs in the 3D static culture grown faster than the cells in 
sparged bioreactor, there are some outgrowths of cells which then grew and adhered 
on a flask. Figure 8.7 showed the outgrowths of cells which adhered to a flask which 
used for the 3D static culture system. The attached cells were observed epithelia-like 
cells which are the morphology of the alveolar progenitor cells (McQualter et al., 
2010; McQualter and Bertoncello, 2012). However, in the lung, there many types of 
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epithelia but the micrographs (Figure 8.7) can be used as one of the indicators to 
observe that the mESCs already differentiated to epithelium cells. The differentiated 
cells need to be characterised with other techniques such as PCR to confirm that they 
are lung epithelium cells.  
 
Figure 8.7 The outgrowth of differentiated mESCs in 3D static culture system. 
Morphologies of cells indicated the epithelial-like cells. A Pneumocyte type II cell is 
one of epithelial cells in human body. The scale bar is 200 µm. 
 
 
Figure 8.8 The A549 cell line on 2D culture system. The A549 exhibited the epithelial 
cells which attached to the surface of a tissue culture flask. The scale bar is 200 µm. 
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The micrographs of the outgrowth cells which adhered to a flask and the A549 cell 
line, the human pneumocyte type II carcinoma cells. Both cells are the same in term of 
morphology of cells on 2D culture system. 
In this study, mESCs were encapsulated in alginate hydrogel beads as a 3D system for 
cell culture. Microencapsulation of mESCs in alginate beads provides a system that 
felicitates diffusion of nutrients and waste. Moreover, this system may ultimately 
assist in developing scalable stem cell differentiation strategies (Maguire et al., 2006). 
From Figure 8.9, the outgrowth of cells from both sparged bioreactor and 3D static 
culture can form sphere-like shapes which the sizes are 150 – 200 µm. However, the 
mouse average alveolus’ size is 60 – 70 µm (Chang et al., 2013). Mice foetal 
pulmonary cells were seeded into collagen-matrigel microcapsules scaffolds and lung 
alveolus-like structures was reconstructed in vitro. It was reported that the alveolus 
structures had a diameter of 200 – 300 µm (Zhang et al., 2011). 
 
Figure 8.9 Micrographs of differentiated mESCs in week 5 of differentiation. The 
micrographs of alginate beads show that there were space limitation inside alginate 
bead, therefore, there were outgrowth of cells outside alginate beads. The outgrowth 
cells formed a sphere-like structure.  
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Day 35 Day 35 
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The sparged bioreactor was operated under the ambient atmospheric pressure that 
could explain why the diameter of the alveolus-like structures are bigger those found 
in vivo. Sizes of alveolar airsacs started to stabilise at 20 – 25 cm H2O (0.019 – 0.024 
atm) of inflation pressure (Namati et al., 2008) indicating that the pulmonary pressure 
in the lung is slightly higher than atmospheric pressure. 
Furthermore, an observation showed that the differentiation of mESCs in the calcium-
alginate hydrogel might not be suitable for the 30-day protocol as there was limitation 
on space noticing from the micrographs (Figure 8.9). Similar problem was also 
reported for the differentiation of mESCs into osteogenic lineage (Hwang et al., 
2009). 
 
8.3.2 Live/dead assay 
 
The ability to maintain encapsulated mESCs alive during the differentiation process is 
crucial. Figure 8.10 shows the fluorescent images of the live/dead assay. The calcien 
acetoxymethyl (calcien AM) enters the cell membranes of the viable cells and is 
converted to calcien by intracellular esterases then expresses the green fluorescence. 
The nucleic acid of the membrane damaged cell, non-viable cells, bound to ethidium 
homodimer-1 and expresses the red florescence. According to the 3D structure of the 
calcium-alginate hydrogels, it is very difficult to get a clear fluorescent image if the 
colony of cells is not large enough. Therefore, it needed to wait until day 7 of the 
differentiation process. On day 7, it was observed that the viable colonies (green 
colonies) of mESCs in 3D static culture were larger in size than the mESC colonies in 
the sparged bioreactor. Both systems supported the growth of encapsulated mESCs 
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during the differentiation process until week 5. Even though, it was observed more 
dead cells at the end of culture period. 
From the live/dead assay, it has shown that the encapsulated mESCs could be 
maintained in culture for long time (up to 5 weeks in this study). This 3D culture 
system could be used in regenerative medicine and drug discovery applications 
(Placzek et al., 2009). However, the differentiated mESCs from both 3D static culture 
and the sparged bioreactor needed to be characterised further to confirm their 
phenotype. A common cell characteristic technique is polymerase chain reaction 
(PCR), and quantitative-PCR was used in this study to quantify gene expression from 
differentiated mESCs. 
 
 
 
 
 
 
 
 
 
 
 
| 194 
 
Day 0 
 
Sparged bioreactor Static culture 
Day 7 Day 7 
  
  
Day 35 Day 35 
  
 
Figure 8.10 The live/dead micrographs of differentiated mESCs (A). Viable cells 
were stained with green fluorescence calcien AM, whereas non-viable cells (red) were 
stained by ethidium homodimer-1. The use of capsulation mESCs in alginate beads 
provided a 3D environment in both 3D static culture (C, E) and a sparged bioreactor 
(B, D) for 5 weeks in culture.  
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8.3.3 Gene expression 
 
The differentiated mESCs on day 30 of the differentiation process were compared to 
the total mouse lung mRNA as it is shown in Figure 8.11. The mRNA of differentiated 
mESCs was extracted. All mRNA sample were used to synthesis the cDNA. The gene 
expression was detected by the real-time PCR. From Figure 8.11, the SPC gene (type 
II pneumocyte) of the encapsulated cells in the sparged bioreactor was expressed 
higher than the mESCs in 3D static condition by 1 order of magnitude whereas the 
SPC level of the total mouse lung RNA was observed higher than the encapsulated 
mESCs by 5 in order of magnitude. For the pluripotency marker (Oct4), all samples 
remain low. Interestingly, the endoderm marker (Foxa2) of the encapsulated mESCs 
in the sparged bioreactor was achieved as the highest compared to the rest of sample. 
This result indicated that the mESCs were derived into endodermal lineage. As 
embryonic stem cells have the pluripotency property, it is possible that the 
differentiated cells are heterogeneous cell types. Therefore, the separation might be 
needed to purify the desired population of cells. 
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Figure 8.11 A comparison of the gene expressions between the mouse lung mRNA 
and the extracted mRNA from the differentiated mESCs. The relative expression was 
calculated based on a house keeping gene (GPDH) and the expression of SPC on 3D 
static culture. 
 
Figure 8.12 shows the gene expression profile of the differentiation of mESCs toward 
the alveolar type II cell (endodermal lineage) along the time of development or 
differentiation. The Oct4, pluripotency gene, remained high at the embryonic stage or 
the undifferentiated cells. In mESCs, the pluripotency was maintained high in the 
present of leukaemia inhibitory factor (LIF). The Foxa2 and SPC increased in the time 
during the culture. 
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Figure 8.12 Selected gene expression profiles of the undifferentiated mESCs and the 
alveolar type II cells. mESCs: murine embryonic stem cells, ALII: Alveolar type II 
cells. An expression of pluripotent gene (Oct4) is less expressed when mESCs 
undergoes the differentiation whereas the endodermal and type II pneumocyte markers 
are highly expressed when the maculation of ALII occurs.  
 
The Oct4 (Pluripotency) decreased while the FoXA2 (Endoderm marker) increased 
during the differentiation process as shown in Figure 8.13.  
The dotted lines represented the gene expression of sparged bioreactor, while the solid 
lines represented the gene expression profiles of the differentiated mESCs in 3D static 
culture up to day 15 of the differentiation, the encapsulated mESCs in 3D static 
culture tended to differentiate slightly faster than in the sparged bioreactor. It was 
observed by a higher expression of Foxa2 marker. From day 15 onward, the 
encapsulated mESCs in the sparged bioreactor have potential to differentiate than in 
the 3D static culture. At the end of the differentiation process, the encapsulated 
mESCs in the sparged bioreactor has a higher expression of the Foxa2 gene and a low 
expression of pluripotency marker (Oct4). 
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(B) Endodermal marker 
 
Figure 8.13 Gene expression profiles of the Foxa2 (B) and Oct4 (A) genes during the 
differentiation process. The genes of interest were normalised to Oct4 mRNA levels in 
sparged bioreactor. The pluripotent cell (Oct4) decreased when increasing of 
differentiation time where the endodermal marker (FoXA2) increased over the 
differentiation period. 
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Surfactant protein C (SPC) is highly expressed for pneumocyte type II cells 
(McQualter et al., 2010). Figure 8.14 shows SPC profile of the 3D culture in both 
static condition and sparged bioreactor. The differentiation is 30-day process and the 
data were collected every 5 and 7 days. At the beginning of the differentiation, the 
encapsulated mESCs in the static culture showed a higher expression of SPC than in 
the sparged bioreactor. In 3D static culture, the SPC expression increased in time 
during the culture. The SPC reached a maximum level on day 14 and remained low 
throughout the differentiation process. In the sparged bioreactor, differentiated mESCs 
expressed a lower level of SPC than in 3D static culture at the beginning of the 
differentiation process (up to day 14). At day 14, the differentiated cell might reach 
the canalicular stage (E16.5 – E17.5) of the lung development, the type II pneumocyte 
maker (SPC) was highly expressed in both system. SPC still remained highly 
expressed during the differentiation process for the sparged bioreactor whereas the 3D 
static culture cannot maintain the alveolar type II cells after 2 weeks of the 
differentiation. 
Moreover, the gestation of mice is around 18 – 22 days. The culture of the mESCs 
began at E3.5 so after the differentiation of mESCs 15 – 19 days, the high expression 
of the alveoli should be expected. In mouse development, the baby mice experience 
the ambient gas after they born (E18.5). Considering results from 3D static culture and 
the sparged bioreactor, after 2 weeks of the differentiation, the mESCs is at the end of 
the gestation so the ambient is needed for the lung cell maturation. That was why it 
was observed the high expression of SPC in the sparged bioreactor. In 3D static 
culture where the mass transfer of oxygen is more limited. It cannot provide the 
environment which support the fully maturation of the lung cells (Siti-Ismail et al., 
2012). 
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Figure 8.14 SPC expression profiles of the differentiated mESCs. The SPC expression 
represents the marker for type II pneumocyte cells. The expression of SPC increased 
when A549 conditioned medium was introduced as a differentiation medium of 
mESCs towards pneumocyte type II cells. After day 20 of differentiation process, the 
SPC expression of differentiated cells in the sparged bioreactor was higher than those 
in 3D static culture. 
 
8.3.4 The effect of conditioned-media on mESCs differentiation into alveolar 
type II cells 
 
As shown in Figure 8.15, there are many growth factors involved in lung 
development. For example, FGF and PDGF promote alveolisation. In this study, the 
conditioned-media was used from the lung carcinoma cell line A549 as a promoter for 
the mESCs differentiation in to the alveolar progenitor cells.  
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Figure 8.15 A Schematic chart of growth factors involving in lung development 
(Desai and Cardoso, 2002). BMP, bone morphogenetic protein; EGF, epidermal 
growth factor; FGF, fibroblast growth factor; GM-CSF, granulocyte macrophage-
colony stimulating factor; PDGF, platelet-derived growth factor; TGF, transforming 
growth factor; VEGF, vascular endothelial growth factor. 
 
As it was expected, there are many studies suggested that A549 cell secreted many 
growth factors which suitable for lung development as it is summarised in Table 8.3. 
Table 8.3 summaries secreted growth factors found in the A549 conditioned-medium. 
Combining the knowledge of growth factors which related to the lung development, 
the secreted growth factors from A549, and our experiment, the combination of these 
growth factors, in Table 8.3, can be used for a defined medium condition.  
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Table 8.3 The growth factors found in A549-conditioned medium. TGFβ, 
transforming growth factor beta; EGF, epidermal growth factor; FGF2, fibroblast 
growth factor 2; BMP, bone morphogenetic protein; NFG, nerve growth factor; 
PDGF, platelet-derived growth factor; VEGF, vascular endothelial growth factor; 
GM-CSF, granulocyte macrophage-colony stimulating factor; IL-6, Interleukin-6; IL-
8, Interleukin-8.  
Growth factor References 
TGFβ (Siegfried, 1987; Benson et al., 1996) 
EGF (Siegfried, 1987) 
FGF2 (Berger et al., 1999) 
BMP (Langenfeld et al., 2005) 
NFG (Pons et al., 2001) 
PDGF (Shimizu et al., 2000) 
VEGF (Shenberger et al., 2007) 
GM-CSF (Arnold et al., 1994) 
IL-6 (Crestani et al., 1994) 
IL-8 (Kaza et al., 2011) 
 
However, there is few literatures reported FGF10 in A549 conditioned media although 
the FGF10 was reported as an important growth factor for the lung development 
(Sekine et al., 1999). Hence, for the higher efficacy of the alveolar progenitor cell 
production from ESCs, the FGF10 must be added into the differentiation media for the 
full development of the lung cells. 
Figure 8.16 and Figure 8.17 show the glucose and lactate profiles in the 3D static 
culture and the sparged bioreactor for mESC differentiation into alveolar progenitor 
cells. For the glucose consumption, encapsulated mESCs in 3D static culture 
consumed glucose more than the cells in sparged bioreactor. Both systems have very 
high concentration of lactate because the systems were operated in fed-batch mode, 
therefore, the continuous bioprocess is needed to reduce the toxic metabolites. 
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Figure 8.16 Glucose profiles during the mESCs differentiation into ALII cells. The 
medium was refreshed every 3 days. Over the differentiation process, the glucose 
levels were more than 0 mmol ∙ L−1 indicating that the nutrient is available for 
mESCs.  
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Figure 8.17 Lactate profiles during the mESCs differentiation into ALII cells. The 
initial level of lactate were under the toxic level, 55 mM, to the mammalian cell 
proliferation (Ozturk et al., 1992). 
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8.4 Summary 
 
In this chapter, the mESCs were differentiated into alveolar progenitor cells 
(pneumocyte type II cells). The encapsulation process was used to provide the 3D 
environment for the mESCs. 
From chapter 7 which suggested the use of glass in bioreactors for tissue engineering 
and regenerative medicine applications, the sparged bioreactor in this chapter was 
made by glass. It has been shown that the glass sparged bioreactor is suitable for cell 
culture in this application for differentiate mESCs into pneumocyte type II cells. 
The computational fluid dynamics (CFD) simulation can be used as a characterised 
tool in bioreactors where the use of measuring probes is impractical. In this chapter, 
CFD was used to simulated gas-liquid culture system to ensure the delivery of gas into 
the sparged bioreactor. 
In current protocol, the tedious process of embryoid body (EB) formation was 
bypassed and it makes the process simpler for a less the experienced operator/scientist. 
It was observed the alveolar progenitor cell marker (SPC) was expressed since two 
weeks after the differentiation process. Results showed that the 3D calcium-alginate 
hydrogel bead can accommodate the mESCs growth up to 5 weeks. 
It was found that the sparging gas is important for the maturation of the alveolar 
progenitor cells. Without the sparging gas, the differentiated mESCs lost their 
phenotype during the in vitro culture. 
 
 
  
 
 
 
 
 
 
9 CONCLUSIONS AND RECOMMENDATIONS  
 
9.1 Conclusions 
 
This study was carried out using sparged-type bioreactors i.e. an airlift bioreactor and 
a normal sparged bioreactor for murine embryonic stem cell proliferation and 
differentiation toward pneumocyte type II cells and some conclusions from the study 
were drawn as follows: 
Chapters 5 described on the fundamentals of using computational fluid dynamics 
(CFD) to design airlift bioreactors. Several models have been developed and some 
parameters have been validated with the experimental data which were in a good 
agreement with the developed models. The models are multiphase, gas-liquid system, 
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and three different designs of airlift bioreactors were considered. The working volume 
of the airlift bioreactors in this study is considerably small (c.a. 100 mL) which is 
suitable to apply in tissue engineering and regenerative medicine applications. 
In chapter 6, details on the multiphase models were added. The new features were 
included a transient simulation, and solid phase were added. The simulations required 
more computational power therefore they were performed on the workstation in a 
computer grid server. The multiphase CFD models, for the airlift bioreactors, can 
capture operating conditions in which the fluctuation of the parameters occurs.  CFD 
is a powerful tool for bioreactor design, characterisation, and trouble shooting. 
Combining the chapter 5 and 6, the fundamentals of CFD simulation for multiphase 
flow in embryonic stem cell application was established. The models could be used as 
a tool for a new design system or fine-tuning of an existing design. The models are 
flexible for different types of sparged bioreactor, i.e. a bubble column, an airlift 
bioreactor, and a simple sparged bioreactor. The two-phase (gas, liquid) and three-
phase (gas, liquid, solid) could be implemented in the CFD models. 
In order to develop the stem cell bioprocess of the sparged bioreactors, the antifoam 
toxicity on the murine embryonic stem cells must be identified. In chapter 7, a study 
showed that silicone based antifoam (antifoam A) is suitable for the bioprocess of the 
mESCs in a sparged bioreactor. The study also found that materials of the bioreactor 
components are also effect mESCs proliferation. Delrin rod, polyoxymethylene, might 
decay to a toxic substance due to the repeated autoclave activity for several times. The 
materials for the bioreactor components should be suitable to be used for standard 
medical and should tolerate high temperature (121 oC) and high pressure (15 psi). 
Moreover, the sparging from a conventional incubator, i.e. 5% CO2 in air, is non-toxic 
| 207 
 
to the mESCs. Therefore, the oxygenation from the gas source inside the incubator is 
feasible. 
Chapter 8 described a differentiation process of mESCs into the alveolar progenitor 
cells, pneumocyte type II cells. A single step protocol has been developed bypassing 
the tedious process of embryoid body (EB) formation. A defined basal medium 
(IMDM/F12K) has been used. This can reduce the cost of the bioprocessing culture: 
10 times less for the cost of basal medium alone. The differentiated cells showed the 
genotype of the pneumocyte type II cells (the alveolar progenitor cells). We also found 
that maturation of the alveolar progenitor cells depend on the sparged gas. The 
differentiated mESCs expressed high SPC maker after 2 weeks of the differentiation 
which rarely found in literatures without gas-liquid interface. In this study, it showed 
that the sparged bioreactor system could maintain the differentiated mESCs up to 5 
weeks in culture. 
 
9.2  Recommendations 
 
In summary, this thesis presented all preliminary works for a better understanding of 
stem cells bioprocessing towards lung cells differentiation using spared-type 
bioreactors, including airlift and bubble column bioreactor. This work is believed to 
have a significant importance for tissue engineering of lung cells providing some 
similar conditions in alveolus regions of human body. Further studies are importance 
in order to fully accomplish the other beneficial parameters for a better used in tissue 
engineering and regenerative medicine application. 
| 208 
 
For the computational fluid dynamics (CFD) model for multiphase bioreactor, the 
models could be extended for cell growth kinetic, oxygen and nutrient consumption. 
The parameters in the growth kinetic and the consumption rate can be obtained from 
experiment in static or dynamic condition. The high performance computer is needed 
for the extended models. A stepwise solution strategy (Elqotbi et al., 2013) could be 
used to solve (1) fluid flow field, (2) oxygen mass transfer, and (3) biochemical 
reaction. Moreover, an open source CFD software e.g. Openfoam could be 
implemented in a design and simulation of airlift bioreactor in order to reduce the cost 
of software subscription. The use of open source CFD software will enable users to 
modify models that use in problem solvers. 
From chapter 5; 6; and 7, the two new designs were designed and a material that used 
to fabricate the airlift bioreactors was recommended. Glass-type airlift bioreactors are 
feasible to build and test for culture mESCs or hESCs. The glass-type airlift 
bioreactors are expected to tolerate the autoclave cycle which was used to sterilise a 
bioreactor system. Moreover, simulations confirmed that a shear rate inside the airlift 
bioreactors is under the lethal threshold. 
Chapter 7 and 8 explained the use of a sparged bioreactor which showed satisfactory 
results in terms of oxygen transfer and cell maturation in the lung development but the 
mode of the operation is fed-batch due to the preliminary testing. The continuous 
bioprocess is feasible and it will make the bioprocess automation. Moreover, 
metabolic stress from toxic metabolites, such as lactate and ammonia, was minimised. 
The ability to generate lung and airway epithelial cells from human pluripotent stem 
cells (hPSCs) would be the ultimate goal in regenerative medicine, modelling of lung 
disease, drug screening, and studies of human lung development (Green et al., 2013). 
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A current protocol for the mESCs differentiation into pneumocyte type II cells could 
be used as a simple translation for culturing and differentiating human ESCs and 
human iPS cells with some modification on the specific growth factors used in the 
conditioned medium. 
In order to make the lung tissue engineering close to the clinical applications, animal 
model would be needed (Soh et al., 2012). As mentioned in chapter 2, tissue 
engineering is a multidisciplinary field that would require expertise in many fields. 
Biologists who are expert in animal model would be required for testing the 
differentiated cells in an animal. Effects of ESC-derived pneumocytes on the animal 
such as tumour formation and immunorejection would be suggested to a further study. 
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I. Appendix 1 
WHO member stages 
 
Table I.1 WHO member staged categorised by the annual income 
Income category  Countries 
High Andorra, Aruba, Australia, Austria, Bahamas, Bahrain, Belgium, Bermuda, 
Brunei Darussalam, Canada, Cayman Islands, Channel Islands, Cyprus, 
Denmark, Faeroe Islands, Finland, France, French Polynesia, Germany, Greece, 
Greenland, Guam, Iceland, Ireland, Israel, Italy, Japan, Kuwait, Liechtenstein, 
Luxembourg, Monaco, Netherlands, Netherlands Antilles, New Caledonia, New 
Zealand, Northern Mariana Islands, Norway, Portugal, Qatar, Republic of 
Korea, San Marino, Singapore, Slovenia, Spain, Sweden, Switzerland, United 
Arab Emirates, United Kingdom, United States of America, United States 
Virgin Islands 
Upper middle American Samoa, Antigua and Barbuda, Argentina, Barbados, Botswana, 
Brazil, Chile, Costa Rica, Croatia, Czech Republic, Dominica, Estonia, Gabon, 
Grenada, Hungary, Isle of Man, Latvia, Lebanon, Libyan Arab Jamahiriya, 
Lithuania, Malaysia, Malta, Mauritius, Mexico, Oman, Palau, Panama, Poland, 
Puerto Rico, Saint Kitts and Nevis, Saint Lucia, Saudi Arabia, Seychelles, 
Slovakia, Trinidad and Tobago, Uruguay, Venezuela (Bolivarian Republic of) 
Lower middle Albania, Algeria, Belarus, Belize, Bolivia, Bosnia and Herzegovina, Bulgaria, 
Cape Verde, China, Colombia, Cuba, Djibouti, Dominican Republic, Ecuador, 
Egypt, El Salvador, Fiji, Guatemala, Guyana, Honduras, Iran (Islamic Republic 
of), Iraq, Jamaica, Jordan, Kazakhstan, Kiribati, Maldives, Marshall Islands, 
Micronesia (Federated States of), Morocco, Namibia, Occupied Palestinian 
Territory, Paraguay, Peru, Philippines, Romania, Russian Federation, Saint 
Vincent and the Grenadines, Samoa, Serbia and Montenegro, South Africa, Sri 
Lanka, Suriname, Swaziland, Syrian Arab Republic, Thailand, The former 
Yugoslav Republic of Macedonia, Tonga, Tunisia, Turkey, Turkmenistan, 
Vanuatu 
Low Afghanistan, Angola, Armenia, Azerbaijan, Bangladesh, Benin, Bhutan, 
Burkina Faso, Burundi, Cambodia, Cameroon, Central African Republic, Chad, 
Comoros, Congo, Côte d’Ivoire, Democratic People’s Republic of Korea, 
Democratic Republic of the Congo, Equatorial Guinea, Eritrea, Ethiopia, 
Gambia, Georgia, Ghana, Guinea, Guinea-Bissau,  Haiti, India, Indonesia, 
Kenya, Kyrgyzstan, Lao People’s Democratic Republic, Lesotho, Liberia, 
Madagascar, Malawi, Mali, Mauritania, Mongolia, Mozambique, Myanmar, 
Nepal, Nicaragua, Niger, Nigeria, Pakistan, Papua New Guinea, Republic of 
Moldova, Rwanda, Sao Tome and Principe, Senegal, Sierra Leone, Solomon 
Islands, Somalia, Sudan, Tajikistan, Timor-Leste, Togo, Uganda, Ukraine, 
United Republic of Tanzania, Uzbekistan, Viet Nam, Yemen, Zambia, 
Zimbabwe 
 
Source: http://www.who.int/mediacentre/factsheets/fs310/en/index.html 
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Leading causes of dead worldwide 
 
Table I.2 Leading causes of mortality rate of Low-income countries 
Low-income countries Deaths in millions % of deaths 
   
1. Lower respiratory infections 1.05 11.3% 
2. Diarrhoeal diseases 0.76 8.2% 
3. HIV/AIDS 0.72 7.8% 
4. Ischaemic heart disease 0.57 6.1% 
5. Malaria 0.48 5.2% 
6. Stroke and other cerebrovascular disease 0.45 4.9% 
7. Tuberculosis 0.40 4.3% 
8. Prematurity and low birth weight 0.30 3.2% 
9. Birth asphyxia and birth trauma 0.27 2.9% 
10. Neonatal infections 0.24 2.6% 
 
Table I.3 Leading causes of mortality rate of Middle-income countries 
Middle-income countries Deaths in millions % of deaths 
1. Ischaemic heart disease 5.27 13.7% 
2. Stroke and other cerebrovascular disease 4.91 12.8% 
3. Chronic obstructive pulmonary disease 2.79 7.2% 
4. Lower respiratory infections 2.07 5.4% 
5. Diarrhoeal diseases 1.68 4.4% 
6. HIV/AIDS 1.03 2.7% 
7. Road traffic accidents 0.94 2.4% 
8. Tuberculosis 0.93 2.4% 
9. Diabetes mellitus 0.87 2.3% 
10. Hypertensive heart disease 0.83 2.2% 
   
 
Table I.4 Leading causes of mortality rate of High-income countries 
High-income countries Deaths in millions % of deaths 
1. Ischaemic heart disease 1.42 15.6% 
2. Stroke and other cerebrovascular disease 0.79 8.7% 
3. Trachea, bronchus, lung cancers 0.54 5.9% 
4. Alzheimer and other dementias 0.37 4.1% 
5. Lower respiratory infections 0.35 3.8% 
6. Chronic obstructive pulmonary disease 0.32 3.5% 
7. Colon and rectum cancers 0.30 3.3% 
8. Diabetes mellitus 0.24 2.6% 
9. Hypertensive heart disease 0.21 2.3% 
10. Breast cancer 0.17 1.9% 
   
 
 
 
| 236 
 
 
Table I.5 Leading causes of mortality rate of the world 
World Deaths in millions % of deaths 
1. Ischaemic heart disease 7.25 12.8% 
2. Stroke and other cerebrovascular disease 6.15 10.8% 
3. Lower respiratory infections 3.46 6.1% 
4. Chronic obstructive pulmonary disease 3.28 5.8% 
5. Diarrhoeal diseases 2.46 4.3% 
6. HIV/AIDS 1.78 3.1% 
7. Trachea, bronchus, lung cancers 1.39 2.4% 
8. Tuberculosis 1.34 2.4% 
9. Diabetes mellitus 1.26 2.2% 
10. Road traffic accidents 1.21 2.1% 
   
 
Table I.2 - Table I.5 are the data in 2008 while the Table I.6 is the data for 2001. The trend of the 
leading cause of death was nearly the same. 
 
Table I.6 Leading Causes of Death in 2001. 
Developing Countries Number of 
Deaths (10-3) 
Developed Countries Number of 
Deaths (10-3) 
    1. HIV/AIDS 2 678     1. Ischaemic heart disease 3 512 
    2. Lower respiratory 
infections 
2 643     2. Cerebrovascular disease 3 346 
  3. Ischaemic heart disease 2 484 
    3. Chronic obstructive pulmonary 
disease (COPD) 
1 829 
    4. Diarrhoeal diseases 1 793     4. Lower respiratory infections 1 180 
    5. Cerebrovascular disease 1 381     5. Trachea/bronchus/lung cancers 938 
    6. Childhood diseases 1 217     6. Road traffic accidents 669 
    7. Malaria 1 103     7. Stomach cancer 657 
    8. Tuberculosis 1 021     8. Hypertensive heart disease 635 
    9. Chronic obstructive 
pulmonary disease 
(COPD) 
748     9. Tuberculosis 571 
10. Measles 674 10. Self-inflicted 499 
    
 
Source: WHO World Health Report 2002 (World Health Organization., 2002).  
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II. Appendix 2: Reynold number of liquid inside airlift bioreactors 
 
The flow in a pipe is considered as a laminar flow as long as the Reynolds number is less than 2000 
(Darby, 2001). The calculated Reynolds numbers of the airlift bioreactors are shown in Figure II.1, 
and it was confirmed within the 0.001 – 0.02 m ∙ s−1 of superficial gas velocity that the flows were in 
laminar regime.  
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Figure II.1 Reynold number of the liquid phase under different design of airlift bioreactor. 
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III. Appendix 3: Spatial distribution of interested characteristics inside 
airlift bioreactors. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure III.1 Superficial liquid velocity distribution of the AL2 design 
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Figure III.2 Superficial liquid velocity distribution of the AL3 design. 
 
  
0.001 m/s 0.005 m/s 
  
0.01 m/s 0.02 m/s 
| 240 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure III.3 Superficial liquid velocity distribution of the AL1 design. 
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IV. Appendix 4: Axial distribution of interested characteristics inside 
airlift bioreactors 
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Figure IV.1 Radial distribution of average shear rate at a height of 34.25, 110, and 90 mm above the 
sparger for AL1, AL2, and AL3 respectively. 
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V. Appendix 5: Henry’s law 
 
Using Henry’s law to calculated the equilibrium dissolved oxygen (Atkins and De Paula, 2006) 
Example:  Estimate the molar solubility of O2 in water at 25oC and a partial pressure of 21 kPa, its 
partial pressure in the atmosphere at sea level.(H = 7.92x104 mol/(kPakg) at 25oC) 
 
Henry’s law 
22 OO
CHP   
kgmolx
molkgkPax
kPa
H
P
C
O
O /109.2
1092.7
21 4
14
2
2




  
The molality of the saturated solution is therefore 0.29 mmolkg-1 
The molecular weight of O2 = 32 g/mol 
OHkg
Okg
x
mol
Okgx
OHkg
molx
2
262
3
2
3
1028.9
10321029.0







 
Hence, the amount of dissolved oxygen is about 9.28 ppm 
 
CFX v.11 was used to simulate the dissolved oxygen in the airlift bioreactor and it was simulated in 
steady state condition by using the same Henry’s law constant but different partial pressure of oxygen. 
It is simulation the partial of oxygen is 0.21 atm in normal atmosphere at 298.15 K (25oC). So, if we 
convert 0.21 atm to kPa we got 21.28 kPa (1 atm = 101.325 kPa) which is not the same as previous 
example. The distribution of O2 inside the airlift bioreactor is showed in Figure V.1. The O2 
concentration varies from 8.82 to 8.88 ppm (2.20-2.54% difference) which is close to equilibrium 
concentration from Henry’s law. 
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Figure V.1 Oxygen distribution inside airlift bioreactor. 
 
The Henry’s law constant as a function of temperature was obtained from (Saatdjian, 2000). Figure 
V.2 shows the solubility of oxygen in water, increasing of temperature the less of oxygen that can 
dissolve. The decrease in solubility of gases with increasing temperature is an example of the 
operation of Le Chatelier's principle. The heat or enthalpy change of the dissolution reaction of most 
gases is negative, which is to say the reaction is exothermic. As a consequence, increasing the 
temperature leads to gas evolution.  
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Figure V.2 Solubility of oxygen vs temperature. 
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VI. Appendix 6: Classification of non-Newtonian fluids 
 
Non-Newtonian fluids are defined as all fluids that do not obey Newton’s of viscosity: when a stress 
is applied to a fluid, the velocity gradient in the direction perpendicular to the stress is proportional to 
the applied shear stress. 
𝜏𝑦𝑥 = −𝜂
𝑑𝑣𝑥
𝑑𝑦
 
Where 𝜂 is the viscosity. 
The Figure VI.1 shows the simple shearing action; the size of strain or angle of deformation, 𝛾, is 
exaggerated and based on this responses under these circumstance, different types of non-Newtonian 
fluids can be defined. 
Figure VI.1 Simple shearing of a fluid (Wilkes, 2006). The strain angle, 𝛾, is exaggerated. 
 
𝑑𝛾 𝑑𝑡⁄ =  ?̇?, the rate of increase of the angle of the rate of deformation, it can be used interchangeably 
terms such as the rate of shear and the strain rate. 
Newtonian fluid exhibit a linear response to the apply strain rate. The slope of shear stress/strain rate 
is the Newtonian viscosity, 𝜂, which is constant and independent of the strain rate. Examples of 
x 
y 
𝛾 
𝜏𝑦𝑥  
𝑣𝑥  
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Newtonian fluids are gases, water, liquid hydrocarbon, and most low molecular weight organic 
liquids. 
Pseudoplastic (Figure VI.2) or shear thinning fluids exhibit a viscosity that decreases with increasing 
strain rate. Most polymer solutions and polymer melts are shear-thinning fluids. 
 
Figure VI.2 Stess/strain rate behaviour of various fluids (Wilkes, 2006). 
 
Dilatant or shear-thickening fluids exhibit a viscosity that increases with increasing strain rate. Sand 
and cornstarch in water are examples of dilatant fluids which are less common than pseudoplastic 
fluids. 
From Figure VI.2, a finite stress is required before the Bingham-plastic fluid flows. Once the fluid 
flows, the viscosity of a Bingham plastic fluid can be constant. Examples of Bingham-plastic fluids 
are ketchup, mayonnaise, toothpaste, blood, many pints, printers’ ink, and slurries of particles (such as 
coal) in liquids. 
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VII. Appendix 7: The design parameters of airlift bioreactors. 
 
Table VII.1 Gas holdup calculation based on equation 2.18 – 2.20.  
Dimensionless value AL1 AL2 AL3 
 
0.5 1.333 0.769 
 
2.267 1.333 2.308 
 0.533 0.25 0.44 
 
   
 5.82915E-05 6.03374E-05 6.38551E-05 
 0.000291457 0.000301687 0.000319275 
 0.000582915 0.000603374 0.000638551 
 0.001165829 0.001206748 0.001277102 
 3.32E+17 2.70E+17 1.92E+17 
r     
 0.000386788 0.000498129 0.0004152 
 0.001568835 0.002020439 0.001684073 
 0.002867302 0.003692681 0.003077918 
 0.005240461 0.006748975 0.005625397 
d     
 4.90E-06 7.72E-05 1.11E-05 
 3.97E-05 6.26E-04 8.99E-05 
 9.78E-05 1.54E-03 2.21E-04 
 2.41E-04 3.79E-03 5.45E-04 
Ts       
 4.40354E-05 0.000347463 8.17312E-05 
 0.000238627 0.0018829 0.000442901 
 0.000494085 0.0038986 0.000917039 
 0.001023018 0.008072168 0.001898756 
    
 
 
 
  
tt dhX /B
tst dhY /
cs ddM 4/
5.0)/( cg dguFr 
smug /001.0
smug /005.0
smug /01.0
smug /02.0
Ga
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VIII. Appendix 8: Growth rate of mouse pneumocyte type II in vitro 
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Figure VIII.1  Growth rate of mouse pneumocyte type II 
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IX. Appendix 9: Calibration curve of encapsulated mESCs in alginate 
bead 
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Figure IX.1 Calibration curve of encapsulated mESCs in alginate beads assessed by MTS assay.  
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X. Appendix 10: RT-PCR of differentiated mESCs 
 
The 100bp DNA Ladder (Promega) was used as a ladder reference. From the manufacturer 
instructions, the 500bp fragment is present at increased intensity. Lane 1 represents the DNA ladder, 
lane 2 and 3 are the samples—day 14 of the differentiated mESCs—, lane 4 is the blank sample, and 
lane 5 and 6 is the duplicate of the lane 2 and 3, respectively. The lane 3 had more cDNA sample. The 
smaples were test for SPC (marker for type II pneumocytes) mark which has the sequence as the 
following: Forward: GTTCGACAGTCAGCCGCATC, Reward: GGAATTTGCCATGGGTGGA, 
and the amplicon size 182 (bp).  
 
 
Figure X.1 the RT-PCR of differentiated mESCs showing the expression of pneumocyte type II. 
 
 
 
 
 
1 2 3 5 6 4 
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XI. Appendix 11: Cell viability in the sparged bioreactor 
 
 
Figure XI.1 Differentiated mESCs in the sparged bioreactor on day 20. 
 
 
Figure XI.2 Differentiated mESCs in the sparged bioreactor on day 30. 
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XII. Appendix 12: Real-time PCR primers 
 
Table XII.1 Real time PCR primers. 
Oligo sequence (5' to 3') Oligo name 
GCTCTTTTCCAGCCTTCCTT Sense-b-actin 
CGGATGTCAACGTCACACTT Antisense-b-actin 
CTTCAGACCTTGGCGTTGGA Sense-Insulin I 
ATGCTGGTGCAGCACTGATC Antisense-Insulin I 
TGTGTCCGTCGTGGATCTGA Sense-GAPDH 
CCTGCTTCACCACCTTCTCGA Antisense-GAPDH 
TTGTCGTGGTGATTGTAGGG Sense-SPC 
AAGGTAGCGATGGTGTCTGC Antisense-SPC 
GGAACACCAGTGAACAGGCTATG Sense-SPB 
AAACTGTTCACACTTTTGCCTGTCTA Antisense-SPB 
CCAACAAGGAAGCAATCTGACAT Sense-SPD 
CAAGACAAGCATGGAGAGAAAGG Antisense-SPD 
CAGCTGAAGAGACTGGTGGAT Sense-CC10 
TGTTAGATTTTCTCCGTGAGCTT Antisense-CC10 
TCCTCGGAAAGACAGCACAG Sense-TTF-1 
CATCGACATGATTCGGCGT Antisense-TTF-1 
AGCTCAGCGGTCTACTATTGCA Sense-Sox17 
GGTCGGCAACCGTCAAAT Antisense-Sox17 
CATCCGACTGGAGCAGCTA Sense-Foxa2 
TGTGTTCATGCCATTCATCC Antisense-Foxa2 
GTTGGAGAAGGTGGAACCAA Sense-Oct4 
TCTTCTGCTTCAGCAGCTTG Antisense-Oct4 
TCTTGTGGGGATCTACTTCACC Sense-AQP5 
TGAGAGGGGCTGAACCGAT Antisense-AQP5 
GGACATCTCTACACTGTTCCCA Sense-Cav1 
CGCGTCATACACTTGCTTCT Antisense-Cav1 
TGCAGGGGATGAAACGCAG Sense-Pdpn 
GCCAACTATGATTCCAACCAGG Antisense-Pdpn 
GAGGAGCTTCAGACTGCACTC Sense-SPA 
AGACTTTATCCCCCACTGACAG Antisense-SPA 
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XIII. Appendix 13: Discretisation and solution theory 
 
Discretisation is a class of numerical methods of approximating differential equations using a system 
of algebraic equations set at different discrete locations in space and time (Ansys, 2006). 
Numerical discretisation 
 
Analytical solutions to the Navier-Stokes equations exist only for only simplest of flows under ideal 
conditions. In order to obtain solutions for real flows, a numerical approach must be adopted. The 
equations are replaced by algebraic approximations that can be solved using numerical method. 
Discretisation of the governing equations 
ANSYS CFX uses an element-based finite volume method, the spatial domain is discretising into 
small meshes. The mesh is used to construct finite volumes, which are used to conserve relevant 
quantities such as mass, momentum, and energy. The mesh can be three dimensional or two 
dimensional structures (Figure XIII.1). 
 
Figure XIII.1 Control volume definition showing in two-dimension.  
 
 
 
 
 
 
 
  
 
 
Node Control volume 
Element 
Element centre 
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The conservation equations for mass, momentum, and passive scalar, expressed in Cartesian 
coordinates: 
𝜕𝜌
𝜕𝑡
+
𝜕
𝜕𝒙𝑗
(𝜌𝑈𝑗) = 0 
𝜕
𝜕𝑡
(𝜌𝑈𝑗) +
𝜕
𝜕𝒙𝑗
(𝜌𝑈𝑗𝑈𝑖) = −
𝜕𝑃
𝜕𝒙𝑖
+
𝜕
𝜕𝒙𝑗
(𝜇𝑒𝑓𝑓 (
𝜕𝑈𝑖
𝜕𝒙𝑗
+
𝜕𝑈𝑗
𝜕𝒙𝑖
)) 
𝜕
𝜕𝑡
(𝜌𝜑) +
𝜕
𝜕𝒙𝑗
(𝜌𝑈𝑗𝜑) =
𝜕
𝜕𝒙𝑗
(Γ𝑒𝑓𝑓 (
𝜕𝜑
𝜕𝒙𝑗
)) + 𝑆𝜑 
These equations are integrated over each control volume, and Gauss’ Divergence Theorem is applied 
to convert volume integrals involving divergence and gradient operators to surface integrals. If control 
volumes do not deform in time, then the time derivatives can be moved outside of the volume 
integrals and the integrated equations become: 
𝜕
𝜕𝑡
∫ 𝜌 𝑑𝑉
𝑉
+ ∫ 𝜌𝑈𝑗
𝑆
𝑑𝑛𝑗 = 0 
𝜕
𝜕𝑡
∫ 𝜌𝑈𝑗  𝑑𝑉
𝑉
+ ∫ (𝜌𝑈𝑗𝑈𝑖)
𝑆
𝑑𝑛𝑗 = − ∫ 𝑃
𝑆
𝑑𝑛𝑗 + ∫ 𝜇𝑒𝑓𝑓 (
𝜕𝑈𝑖
𝜕𝒙𝑗
+
𝜕𝑈𝑗
𝜕𝒙𝑖
)
𝑆
𝑑𝑛𝑗 + ∫ 𝑆𝑈𝑖
𝑉
𝑑𝑉 
𝜕
𝜕𝑡
∫ 𝜌𝜑 𝑑𝑉
𝑉
+ ∫ 𝑃(𝜌𝑈𝑗𝜑)
𝑆
𝑑𝑛𝑗 = ∫ (Γ𝑒𝑓𝑓 (
𝜕𝜑
𝜕𝒙𝑗
))
𝑆
𝑑𝑛𝑗 + ∫ 𝑆𝜑
𝑉
𝑑𝑉 
where V and s represented volume and surface region of integration and dnj are the differential 
Cartesian components of outward normal surface vector. The volume integrals represent source and 
accumulation terms, and the surface integrals represent the summation of the fluxes. 
The next step in the numerical algorithm is to discretise the volume and surface integrals. To illustrate 
this step, consider a single element in Figure XIII.2. 
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Figure XIII.2 Mesh element. ip: Integration point. 
 
Volume integrals are discrerised within each element sector and accumulated to control volume to 
which the sector belongs. Surface integrals are discretised at the integration points (ipn) located at the 
centre of the each surface segment within an element and then distributed to the adjacent control 
volumes. Because the surface integrals are equal and opposite for control volumes adjacent to the 
integration points, the surface integrals are guaranteed to be locally conservative. 
After discretising the volume and surface integrals, the integral equations become: 
𝑉 (
𝜌 − 𝜌0
∆𝑡
) + ∑ 𝑚𝑖𝑝̇
𝑖𝑝
= 0 
𝑉 (
𝜌𝑈𝑖 − 𝜌
0𝑈𝑖
0
∆𝑡
) + ∑ 𝑚𝑖𝑝̇
𝑖𝑝
(𝑈𝑖)𝑖𝑝 = ∑(𝑃∆𝑛𝑖)𝑖𝑝
𝑖𝑝
+ ∑ (𝜇𝑒𝑓𝑓 (
𝜕𝑈𝑖
𝜕𝒙𝑗
+
𝜕𝑈𝑗
𝜕𝒙𝑖
) ∆𝑛𝑗)
𝑖𝑝𝑖𝑝
+ 𝑆𝑈𝑖
̅̅ ̅̅ 𝑉 
𝑉 (
𝜌𝜑 − 𝜌0𝜑𝑖
0
∆𝑡
) + ∑ 𝑚𝑖𝑝̇
𝑖𝑝
𝜑𝑖𝑝 = ∑ ((Γ𝑒𝑓𝑓 (
𝜕𝜑
𝜕𝒙𝑗
)) ∆𝑛𝑗)
𝑖𝑝
𝑖𝑝
+ 𝑆𝜑̅̅ ̅𝑉 
where 𝑚𝑖𝑝 = (𝜌𝑈𝑗∆𝑛𝑗)𝑖𝑝, V is the control volume, ∆𝑡 is the time step, ∆𝑛𝑗 is the discrete outward 
surface vector.  
 
 
 
 
 
 
 
 
Sectors 
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ip2 
Element centre 
n3 
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n2 
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XIV. Appendix 14: High Aspect Ratio Vessel 
 
A culture of encapsulated mESCs in alginate beads is shown in Figure XIV.1. Each High aspect ratio 
vessel contained 500 of culture medium and 500 alginate beads. 
 
 
Figure XIV.1 Schematic of pictures of high aspect ratio vessels (b) and the vessel that used in CFD 
calculation (a). The vessels was discretise into 24856 elements in CFD calculation.  
 
The same principle of multiphase CFD simulation was applied in order to calculate a liquid velocity 
(Figure XIV.2). It is shown that liquid velocity was found to be higher at the near wall regime in 
HARV bioreactor.  
 
24856 Hexagonal grids 
(a) (b) 
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Figure XIV.2 CFD calculation of HARV at 20 rpm.  
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XV. Appendix 15: A sparged bioreactor 
 
The sparged bioreactor, which was use in chapter 8, was simulated using CFD. The dimensions of the 
sparged are shown in Figure XV.1 whereas a meshing are shown in Figure XV.2 and Figure XV.3. 
 
Figure XV.1 Dimensions of the sparged bioreactor which was used in chapter seven and eight in this 
thesis. 
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Figure XV.2 A side view of the sparged bioreactor. The total elements are 41475. 
 
 
Figure XV.3 A top view of the sparged bioreactor.  
 
 
 
